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 Abstract 
Approximately, 2/3 of patients with a spinal cord injury (SCI) suffer from chronic pain, 
leading to a reduction in quality of life. The prevalence of chronic central neuropathic pain 
(CNP) in the SCI population is 40%. Recent neuroimaging studies provided evidence that 
CNP is accompanied by modified brain activity at surface and deep cortical levels and that 
CNP is resistant to different pharmacological and non-pharmacological treatments. 
 Our current knowledge on how CNP affects the brain activity of SCI patients is mainly 
based on fMRI studies. Although these studies provide precise spatial localisation of brain 
regions most affected by CNP, they indirectly measure brain activity through measuring 
blood oxygenation. Therefore they lack information specific to neuronal activity such as 
dynamic, time and frequency dependant oscillatory activity of cortical structures. 
Therefore, in Phase 1 of this study, electroencephalogram (EEG) activity of paraplegic 
patients with CNP (PWP) is compared with the EEG activity of able-bodied (AB) 
participants and paraplegic patients without CNP (PNP). It was found that CNP leads to 
frequency dependant EEG signatures both in the relaxed state and during motor tasks that 
are not restricted to the cortical representation of the body part perceived as being painful. 
The pharmacological treatment of CNP has a number of side effects and does not provide 
significant pain relief. The effect of non-pharmacological treatments is inconsistent. 
Neurofedback (NF) is a non-pharmacological treatment, based on the voluntarily 
modulation of brain activity to control pain intensity. Using NF training the patient can 
learn and apply a mental strategy to control pain, without the need for an external device. 
However, NF requires a large number of training sessions to learn the necessary mental 
strategy. Therefore, in Phase 2 of this study, the effect on pain intensity of a large number 
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of NF sessions, using different NF training protocols, was assessed. The clinically and 
statistically significant reduction of pain observed in this study demonstrates that NF 
training has the potential to manage chronic CNP in paraplegic patients. This study also 
provides evidence that the reduction of pain achieved using NF training may not be due to 
a placebo effect. Furthermore, the study demonstrates the immediate global effect of NF 
training on power and coherence.  
To date, no neuroimaging studies that have applied NF training with patients with CNP 
have shown changes in brain activity before the first and after the last training session. 
Therefore, in phase 3 of this study, the long-term neurological effect of NF training was 
assessed using EEG. This study provides evidence that NF training does not only induce an 
effect on spontaneous EEG activity, but also induces changes on evoked EEG activity.    
In conclusion, this study compared the EEG activity of three groups (AB, PWP, and PNP) 
and found that CNP (PWP group) leads to frequency dependant dynamic oscillatory 
signatures. The study also reported that NF training has a potential to reduce pain and this 
reduction of pain might not be an effect of placebo. Furthermore, it was found that NF 
training induce long-term changes in the EEG activity recorded in relaxed state and during 
motor tasks. This long-term change in EEG activity was noticed at the surface and deep 
cortical structures.  
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 Overview of Chapters 
Chapter 1: Background 
This chapter provides brief overview of physiology and anatomy of brain and spinal cord, 
and spinal cord injury. Pain is one a major consequences of the spinal cord injury, 
therefore this chapter also discussed pain pathways, types and mechanism of pain. 
Furthermore, this chapter also provides information of different neuroimaging techniques, 
neurofeedback, and mathematical methods involved in processing electroencephalogram 
signals.  
Chapter 2: Brain Plasticity and Pain Management 
This chapter first discuss changes in the brain in patients with only spinal cord injury and 
patients with injury and pain. This chapter also discussed effect of different 
pharmacological and non-pharmacological treatments on pain, focussed on non-
pharmacological treatments. At the end of this chapter, we presented our three hypotheses. 
Chapter 3: Dynamic Oscillatory signatures of Central Neuropathic Pain in Spinal 
Cord Injury     
This is a first experimental chapter of this thesis. This chapter is called as a ‗Phase 1‘ or 
‗diagnostic phase‘ of the thesis. In this chapter we will present frequency dependant brain 
dynamic signatures of central neuropathic pain in patients with spinal cord injury 
(objective 1).  
 
xvii 
 
Chapter 4: Experimental Evaluation of Neurofeedback Protocols for the Treatment 
of Central Neuropathic Pain Following Spinal Cord Injury 
This is a second experimental chapter of this thesis. This chapter is called as a ‗Phase 2‘ or 
‗treatment phase‘ of the thesis. In this chapter we present effect of neurofeedback training 
on pain and EEG (objective 2). 
Chapter 5: Long-term Neurological outcomes of Neurofeedback Training on Central 
Neuropathic in Paraplegic Patients 
This is a third experimental chapter of this thesis. This chapter is called as a ‗Phase 3‘ or 
‗neurological outcomes‘ of the thesis. In this chapter we will discuss long-term effect of 
neurofeedback training on brain activity (objective 3). 
Chapter 6: General Discussion 
This chapter proposed different mechanisms of neurofeedback for treatment of pain. At the 
end of chapter we show limitations, applications of a study and future work. We also 
highlight how our research contributed to add new findings to the past literature. 
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Chapter 1. Background 
This chapter is divided into three sections. The first section provides an overview of the 
physiology and anatomy of the brain and spinal cord, and the consequences of a spinal 
cord injury (SCI). Chronic pain is one of the consequences of SCI. Therefore, this section 
also provides information about pain pathways, the classification of pain and mechanisms 
of chronic neuropathic pain (NP). The second section briefly compares different 
neuroimaging technologies, focusing only on electroencephalogram (EEG). Following this, 
voluntarily brain modulation technique i.e. neurofeedback (NF) and its applications are 
discussed. The third section of this chapter describes different signal processing methods 
used in processing EEG. 
Section I. Physiology and Anatomy 
1.1. Brain 
The brain is a part of the central nervous system and is protected by the skull, cranial 
meninges and cerebrospinal fluid. It is responsible for integrating and processing the 
cognitive, emotions, sensory and motor functions 
1
. The brain is divided into four main 
parts 
2
: cerebrum, cerebellum, diencephalon and brain stem (Figure 1.1). The cerebellum 
receives proprioceptive information from the spinal cord, and motor information from the 
cerebral cortex. It maintains balance and equilibrium 
2
. The brain stem relays information 
from the cerebrum to the spinal cord and cerebellum, and vice versa. It controls autonomic 
2 
 
functions 
2
. The diencephalon is a structural and functional link between cerebral 
hemispheres and brain stem. The walls and floor of the diencephalon are composed of the 
thalamus and the hypothalamus respectively 
2
. 
Figure 1.1: Parts of the brain 3 
 
The thalamus is responsible for conveying sensory information to the motor and sensory 
regions of cerebral cortex. Therefore, it is known as a ‗gateway to the cortex‘. There are 
five groups of thalamic nuclei 
2
: the anterior, medial, ventral, posterior and lateral thalamic 
nuclei. The function of each group is listed in Table 1.1 
2
. 
The hypothalamus is involved in basic functions like eating, sexual function, 
temperature control and circadian rhythm, in addition to those associated with the limbic 
system 
2
. 
The Cerebrum is the largest brain structure. It is involved in processing somatic sensory 
and motor information, problem solving, conscious thoughts, feeling and cognitive 
functions 
2
.  The cerebrum is divided into two hemispheres 
2
: left and right. The left 
3 
 
cerebral hemisphere controls muscles of the right side of the body, while the right 
hemisphere control muscles of the left side of the body. The two hemispheres have 
different function, even though they look almost identical. The left hemisphere is involved 
in language processing and performing logical and exact mathematical computations. The 
right hemisphere is involved in face recognition, performing estimate calculations and 
emotions.  
Table 1.1: Functions of thalamus nuclei 2 
Group/ Nuclei Functions 
Anterior Part of the limbic system 
Medial Integrates sensory information for projection to the frontal lobe 
Ventral Projects sensory information to the primary sensory cortex; relays 
information from the cerebellum and basal nuclei to the motor area of 
the cerebral cortex 
Posterior Integrates sensory information and projects to the association areas of 
the cerebral cortex   
Lateral Integrates sensory information and influences emotional states 
 
The cerebral hemispheres consist of 
4
: (i) a heavily wrinkled outer layer gray matter 
called the cortex/ cerebral cortex, and (ii) a deep-lying structure called the subcortex. Each 
cortical and sub-cortical region can be represented by ‗Broadman area (BA)‘. The cortical 
map prepared by Korbinian Brodmann in 1909 is known as BA. It describes 47 patterns of 
cellular organization in the cortex based on cytoarchitectonics 
2
 (Figure 1.2). 
The cerebral cortex is divided into four lobes 
4
 (Figure 1.3): frontal, parietal, temporal 
and occipital. It contains different functional areas 
2
: the motor cortical areas, sensory 
4 
 
cortical areas, association areas, visual cortical area, auditory cortical area, cingulate 
cortical area and insular cortical area (Figure 1.4). The somatosensory input and motor 
output of each body part has its own somatotopical representations in the cortex called a 
homunculus 
5
 (Figure 1.5). 
                          
Figure 1.2: Brodmann areas representation 6 
 
 
Figure 1.3: Lobes of the brain 3 
 
The Motor cortex is a term that describes regions of the cerebral cortex involved in the 
planning, control, and execution of voluntary motor functions. The main motor cortical 
areas include the primary motor cortex (M1), premotor cortex (PMC), Supplementary 
Motor cortex (SMC) 
7
.  
Frontal Lobe 
Temporal Lobe 
Occipital Lobe 
Parietal Lobe 
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Figure 1.4: Motor and sensory cortical areas of the brain 
3
 
 
 
Primary Motor Cortex (M1): The surface of the precentral gyrus contains the M1. It is 
located in the frontal lobe and is represented by BA 4. It controls voluntary movements by 
controlling somatic motor neurons in the brain stem and spinal cord. The topographical 
representation of muscle areas of the body in the M1 are shown in Figure 1.5.  
Premotor Cortex (PMC): The PMC lies 1-3 cm anterior to the M1 in the Frontal lobe and 
is represented by BA 6. The topographical representation is roughly the same as in M1 but 
movement patterns generated by the nerve signals in the PMC are complex (e-g position of 
the shoulder and arms). It is responsible for preparation of movements.  
Supplementary Motor Cortex (SMC): The SMC is involved in planning complex 
movements and in co-ordinating movements involving both hands. It is represented by BA 
8. 
Supplementary Motor cortex 
BA 8 
Premotor cortex 
BA 6 
Primary motor cortex 
BA 4 Primary sensory cortex 
BA 1, 2 and 3  Secondary sensory cortex 
BA 40 and 43  
Visual cortex 
BA 17, 18 and 19  
Auditory cortex 
BA 41 and 42  
Frontal Cortex 
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The Sensory cortex controls sensations such as touch, pressure, vibration, pain, 
temperature, sight, sound, smell and taste. The main sensory cortical areas include primary 
somatosensory cortex (S1) and secondary somatosensory cortex (S2)
7
.   
Primary Sensory Cortex (S1): The surface of the postcentral gyrus contains the S1 (BA 1, 
2 and 3), and is located in the parietal lobe. The neurons in the S1 receive somatic sensory 
information of pain, temperature, touch and pressure from the thalamus.  
Secondary Sensory Cortex (S2): The S2 (BA 40 and 43) cortex lies lateral to the S1 
cortex in the lower parietal lobe. It receives connections from the SI neurons, however, its‘ 
response to sensory stimuli is less precise than the S1.  
 
                              Figure 1.5: Cortical representation of sensory-motor areas 
8
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The cingulate cortex is a part of the frontal cortex and is situated in the medial aspect of 
the cortex. It is shown by BA 23, 24, 29, 30, 31, and 32. It is a component of the limbic 
system. Therefore, it is involved in 
2
: (i) producing and processing emotional responses to 
physical sensation of pain, (ii) linking the conscious function of the cerebral cortex with 
the unconscious functions of the brain stem, and (iii) facilitating learning and memory.  
The insular cortex (IC) is involved in consciousness, perception, motor control, 
cognitive functions and control homeostasis of the body. It is represented by BA 13, 14, 
and 16. 
1.2. Spinal Cord 
The spinal cord is a part of the central nervous system 
4
. It receives sensory information 
from the body, and contains motor neurons responsible for both voluntary and reflex 
movements. It also controls the involuntary activities of the body such as blood pressure, 
body temperature and sweating.  
1.2.1. Spinal Nerves and Tracts 
The spinal nerves carry information or messages from the spinal cord to the rest of the 
body (efferent nerves) and from the body back up to the spinal cord (afferent nerves) 
9
. 
There are 31 spinal nerves grouped into four pairs (Figure 1.6) 
4: eight cervical nerves ―C1-
C8‖, twelve thoracic nerves ―T1-T12‖, five lumbar nerves ―L1-L5‖, five sacral nerves ―S1-
S5‖ and one coccygeal nerve. Each group of spinal nerves control signals of different parts 
of the body (Figure 1.6). 
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The white matter (outer layer) of the spinal cord is made up of tracts that form the 
ascending and descending pathways 
4
. The two types of spinal tracts are ascending and 
descending tracts. The ascending tracts or sensory tracts carry sensory information from 
the body upward to the brain while descending or motor tracts carries information from 
the brain downwards to initiate movement and control body functions. The two common 
ascending tracts are spinothalamic tract (STT) and spinoreticular tract. The STT ascends to 
ventral posterolateral nucleus of the thalamus. The lateral part of the STT is associated 
with pain and temperature, while anterior part of the STT is associated with light touch, 
pressure and itch. The spinoreticular tract, positioned closely to the lateral STT, is 
projected to the reticular formation and the thalamus. It is mainly involved in arousing 
consciousness through cutaneous stimulation and responsible for autonomic response to 
pain. 
 
Figure 1.6: Spinal nerves 10 
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1.2.2. Spinal Horn and Laminae 
The grey matter (inner layer) of the spinal cord contains nerve cells, and it is divided into 
dorsal and ventral horns 
4
. The dorsal horns are generally associated with sensory neurons 
that receive input from the periphery. The ventral horns are associated with motor neurons 
that innervate muscles. 
The dorsal horn of the spinal cord can be subdivided into six distinct layers called laminae 
(lamina I to lamina VI) 
11
 (Figure 1.7). Nociceptive neurons located in the superficial 
dorsal horn, the marginal layer called lamina I, respond only to noxious stimulation, thus 
they are called nociceptive-specific neurons. These nociceptive specific neurons project to 
the higher brain centres. Lamina II contain interneurons which respond either only to 
noxious inputs or only to nonnoxious stimuli. Laminae III and IV are located ventral to the 
lamina II. The neurons in laminae III and IV are more related to the reception of tactile 
information. They receive monosynaptic input from Aβ fibers, and respond to non-
nonxious stimuli. Lamina V neurons project to the brain stem and the thalamus, and they 
receive monosynaptic input from Aβ and Aδ fibers. They also receive input from C fibers, 
either directly or indirectly through excitatory interneurons.  
Figure 1.7: Laminae of the spinal cord 
12
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1.3. Spinal Cord Injury (SCI) 
A lesion to the spinal cord can be a consequence of an accident (traumatic SCI) or by 
disease (non-traumatic SCI) 
13
. The injury may actually tear the spinal cord and/or its nerve 
fibers (spinal nerve).  
1.3.1. Problems Associated with SCI 
The primary consequence of SCI includes loss of motor (efferent) and/or sensory 
(afferent) functions, either completely or partially, below the level of lesion. Depending on 
the level of the lesion and severity of injury, an individual may also lose control of the 
bowel and bladder, breathing, sexual function, and spasms may also occur. Over time, the 
symptoms may be followed by secondary health complications, such as loss of bone 
mineral density, poor blood circulation, reduced control of body temperature, skin 
degradation, heart disease and pain 
13
.  
1.3.2. Classification of SCI 
The classification of SCI is based on a study of Marino 
13
: (i) the level of lesion, and (ii) 
the amount of residual motor activity and sensation below the level of lesion (completeness 
of injury).  
i. Level of Lesion 
The SCI is divided into two types on the basis of the level of lesion: (i) tetraplegia and (ii) 
paraplegia. A lesion of a cervical nerve (above C8) causes paralysis of four limbs (upper 
and lower limbs) referred as ―Quadriplegia‖ or ―Tetraplegia‖. Function of the arms, legs, 
11 
 
trunk and pelvic organs are affected in tetraplegics patients. Injury below the first thoracic 
(T1), lumbar or sacral spinal cord causes paralyses of lower limbs known as ―Paraplegia‖.  
ii. Completeness of Injury 
According to American Spinal Injury Association (ASIA), the SCI is divided into two 
types based on its completeness: (i) complete SCI and (ii) incomplete SCI. The extent to 
which a person‘s sensory and motor functions are affected is described as completeness of 
injury. A complete SCI refers to an injury that results in the complete loss of function 
below the level of injury i.e. no motor and/or sensory functions (ASIA A). An incomplete 
SCI refers to a spinal cord injury in which some sensation or movement is still preserved 
below the level of injury. Hence, motor and/or sensory functions are partially preserved 
below the level of injury.  
The completeness of injury is further classified into five degrees of impairment based on 
neurological level of injury known as ASIA classification 
14
 (Table 1.2 
15
). The ASIA 
classification provides information of motor and sensory function following SCI. The 
sensory level describes `the most caudal segment of the spinal cord with normal sensory 
function on both sides of the body', whilst the motor level is similarly `the most caudal 
segment of the spinal cord with normal motor function on both sides of the body'. A 
standard manual muscle test with muscle force rated on a scale of 0-5 (from total paralysis 
to active movement against full resistance) is used to assess the strength of the muscles for 
each spinal level 
15
. The sensory function in all dermatomes is tested as light touch and 
pinprick sensation at defined key points on both body sides 
15
. The sensitivity is scored as 
0 (absent), 1 (impaired) or 2 (normal).  
12 
 
Table 1.2: ASIA classification of SCI 15 
ASIA type Completeness of injury Motor and sensory functions 
ASIA A complete No motor or sensory function is preserved in the 
sacral segments S4-S5. 
ASIA B incomplete Sensory but not motor function is preserved 
below the neurological level and includes the 
sacral segments S4-S5. 
ASIA C incomplete Motor function is preserved below the 
neurological level and more than half of key 
muscles below the neurological level have a 
muscle grade less than 3. 
ASIA D incomplete Motor function is preserved below the 
neurological level, and at least half of key 
muscles below the neurological level have a 
muscle grade of 3 or more. 
ASIA E normal Motor and sensory functions are normal. 
ASIA: American Spinal Injuries Unit; SCI: Spinal Cord Injury 
 
1.4. Pain 
Pain is defined as ‗an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage, or described in terms of such damage‖ 16. According to 
International Association for the Study of Pain (IASP), in 1986, ―Pain is unquestionably a 
sensation in a part or parts of body but is always unpleasant and therefore also an emotion 
experience‖ 17. Hence, pain involves both pain perception (the subjective experience of 
13 
 
pain) and nociception (the neural mechanisms). Nociception is merely the sensory process 
that includes the activation of a nociceptor (a pain receptor) and transmission of pain 
message to the central nervous system 
18
.  
1.4.1. Pain Pathways  
 Components involved in pain nociception can be split into peripheral afferents, the spinal 
cord, and the supra-spinal level (thalamus and cortex).                            
From the Periphery to the Spinal Cord: Nociceptive information from the periphery, 
through either myelinated A-delta (Aδ) or non-myelinated C-fibers, is transmitted 
primarily at the dorsal horn of the spinal cord (Figure 1.8) 
19
. The fast/ first pain is carried 
by Aδ-fibers, while slow/ second pain is carried by C-fibers 20. The fast pain is 
characterized as a sharp, burning and acute, while slow pain is characterized as a dull and 
annoying pain. Aδ-fibers projects to both superficial layers (laminae I-II) and deeper layers 
(lamina V). The peripheral C-fibers terminate in lamina I and send polysynaptic inputs to 
lamina V.  Therefore, the lamina I receives more nociceptive-specific inputs, whereas the 
lamina V inputs represent integration of many afferent inputs. Nociceptive activity affects 
the processing of neural networks 
21
. 
 
 
 
Figure 1.8: Pain pathway: From periphery 
to the spinal cord. Anatomical basis for the 
nociceptive afferent input via sensory 
nerves (Aδ, Aβ, and C fibers) to the dorsal 
horn (laminae I-V) of the spinal cord. 
14 
 
From the Spinal Cord to the Thalamus: Nociceptive and thermal information is 
transmitted from the second order dorsal horn neurons of the spinal cord to the thalamus 
directly through anterolateral STT or indirectly through spinoreticular tract 
22,23
. The 
anterior part of the STT contains mainly lamina V neurons, and the lateral part contains 
mainly lamina I neurons. The nociceptive specific lamina I pathways are projected to the 
ventral posterior nuclei, posterior part of the ventral medial nucleus and the ventral caudal 
part of the medial dorsal nucleus 
24
 (Figure 1.9). Nociceptive information from lamina I, in 
addition to the thalamus, is also send to the homeostatic sites in the brainstem.  
 
 
 
Figure 1.9: Pain pathway: From the spinal 
cord to the thalamus. Ascending 
projections of the lamina I to the thalamus 
via lateral part of the spinothalamic tract 
(spino-thalamo-cortical system). 
 
  
From the Thalamus to the Cortex: Nociceptive information of the STT is mainly 
conveyed to the S1 and S2 cortices through posterior part of the ventral medial nucleus of 
the thalamus 
25
. Thalamic nuclei project to cortical areas, which in turn send back 
information to different thalamic nuclei, forming thalamo-cortico-thalamic circuits 
26
. The 
somatosensory cortices are responsible for the sensory-discriminative evaluation of pain 
(location and quality)  
27
, whereas anterior cingulate cortex (ACC) and IC are involved in 
15 
 
affective/emotional aspects of pain processing 
28–31
. The posterior cingulate cortex (PCC) 
is involved in sensory vigilance processing 
32
. The S1 neurons stimulate the secondary 
somatosensory cortex (S2) to encode the sensory-discriminative aspect of pain. The S2 
projects to the insula which is thought to be involved in multidimensional experience of 
pain including autonomic aspects of pain processing 
19
 and pain intensity score 
33,34
. 
Chronic pain activates many parts of the brain including the prefrontal cortex, while acute 
pain activates sensory parts of the thalamus projecting to the cortical homunculus 
35
. In 
conclusion, the cortical regions activated in pain include thalamus, primary and secondary 
somatosensory cortices, frontal cortex, and cingular cortex. These cortical areas are known 
as the ‗pain matrix‘.  
1.4.2. Classification of Pain 
Pain is usually classified as nociceptive pain and neuropathic pain 
16
. Both types of pain 
can be either chronic (pain more than 6 months) or acute (<6 months).  
Nociceptive pain is caused by actual or potential damage to tissue e.g. a cut, burn, an 
injury and pressure from inside and/or outside the body 
36
. The activated tiny nerve 
endings send a pain signal to the brain. This type of pain tends to be sharp or aching, and 
responds well to simple analgesics and opioids 
37,38
. 
Neuropathic Pain (NP) is caused by a lesion or disease of somatsosensory system 
39,40
, 
defined by IASP in 2011. There is often no tissue damage that triggers the pain, but the 
affected nerve passes faulty information to the brain that causes NP 
41
. The disturbance in 
homeostatic mechanism (state of balance in the body) may develop pain 
42
. It can generally 
be described as allodynia, hyperalgesia sharp and burning pain 
43,44
. This pain produces 
16 
 
sensations which feels as though it is coming from the body, however, sources of pain can 
be in peripheral nerves, spinal roots or the brain 
45
. The different mechanisms compared to 
nociceptive pain make it difficult to manage this type of pain using traditional pain killers. 
Treatments to this type of pain will be discussed in Chapter 2. NP is classified as Central 
Neuropathic Pain (CNP) which is associated with central nervous system dysfunction or 
Peripheral neuropathic pain which is caused by a damage to the peripheral nerve, plexus, 
dorsal root ganglion, or root 
41
. 
Peripheral neuropathic pain conditions are diabetic neuropathy, post-herpetic neuralgia, 
and post-surgical NP, while CNP conditions are stroke, multiple sclerosis, phantom limb 
pain following amputation, trigeminal neuralgia, and SCI 
46
. The prevalence of CNP is 
highest in patients suffering from amputation (80%) 
47
 followed by patients with SCI 
(40%) 
48,49
, multiple sclerosis (27%) 
50
, parkinson disease (10%) 
51
, and  stroke (8%) 
52
. 
The SCI population experience chronic pain of different pathophysiological mechanisms 
48,53–55
. Therefore, different classifications have been proposed 
36,56,57
. NP is one of the 
most challenging problems that reduces the quality of life 
58–60
. From review 
61
, 11% of 
SCI people give-up their work because of pain, not only from loss of motor functions. 
According to International SCI Pain Classification, NP following SCI is divided into three 
types 
36
: (i) below level NP, (ii) at-level NP, and (iii) above level NP.  
Above level NP is located above the level of injury and is caused by a peripheral nerve 
compression. At-level NP is located within 2 segments above and below the level of injury. 
Therefore, it is caused by a combination of both peripheral and central nervous system 
dysfunction. This type of NP may also be called segmental, transitional zone, or border 
zone NP. NP below the level of lesion is thought to be associated with the damage to the 
17 
 
central nervous system and is termed as CNP 
62
. This pain is perceived as coming from 
three or more dermatomes below the level of injury. 
1.4.3. Mechanisms of NP 
NP is not a single disease, therefore, it is believed to be developed by multiple 
mechanisms 
39
, mainly due to the structural and functional changes in the pain pathways 
63
. 
The mechanisms supposed to contribute to the development of NP include peripheral 
sensitization, long-term potentiation (LTP), central sensitization, central imbalance, central 
disinhibition and thalamo-cortical dysrhythmia (TCD).  
Peripheral Sensitization: The sensitization of nociceptors produces changes in the 
number of sodium ions channels in the injured nerve and their dorsal root ganglia which 
reduces the threshold for depolarization. As a result, the nociceptors response to 
mechanical and thermal stimuli is increased.  
Long-term Potentiation (LTP): It is the process of long-lasting increased synaptic strength 
64,65
. At molecular level, LTP is noticed in pain pathways both in the brain and the spinal 
cord which might cause hyperalgesia in pain patients 
66,67
. LTP in pain pathways might 
cause long-lasting pain amplification under conditions of inflammation, tissue damage or 
nerve injury long after the initial cause of pain has disappeared. 
Central imbalance: The pain could be induced by imbalance of integration between 
spared dorsal column activity and damaged STT 
18,62,68–73
. The damaged STT transmit 
nociceptive impulses from an alternate pathway (multisynaptic paleo STT) to the thalamus 
because Aβ fibers arriving to lamina 111-1V reach outer laminae. Therefore, the central 
18 
 
imbalance may imply that tactile and temperature information is processed abnormally in a 
nociceptive territory, constituting a potential mechanism for allodynia.  
Central sensitization: The Aβ fibers arriving to lamina 111-1V can produce aberrant 
sprouting & reach outer laminae. Therefore, it is suggested that plastic changes taking 
place around the lesion level develops CNP 
74
. The plastic changes to the injured nerve 
cause excessive firing of pain-mediation nerve cells, leading to central sensitisation of 
afferent pathways. Central sensitisation is the expression of an increased excitability of 
neurons in the spinal cord. The hyperexcitability is also caused by either increased 
excitation or reduced inhibition 
43,62
, grey matter loss at the rostral end of the lesion 
70,75
, 
alterations (increased) in N-methyl-D-aspartate, non-N-methyl-D-aspartate receptors, 
reduced g-aminobutyric acid, alterations (increased) in expression of sodium and calcium 
levels 
76,77
. Consequently, the threshold for activation is decreased and response to stimuli 
is increased. The cellular changes, in addition to central sensitisation of afferent pathways 
cause second order dorsal horn neurons in the spinal cord to become hyperexcitable and 
thus develop pain.  
Central Disinhibition: The central disinhibition at the thalamic level is considered as one 
of the important pathophysiological theories for the development of CNP 
78–80
. The 
posterior part of the medial nucleus and ventral caudal part of the medial dorsal nucleus 
plays a role in central integration of temperature and pain sensation 
42
. The central 
disinhibition due to reduced activity of posterior parts of the medial nucleus causes 
thermo-sensory loss and thus develops pain 
76,81
. The phenomena of thermoregulatory 
dysfunction emphasize the concept that pain is not only a feeling but also a behavioural 
drive that signals a homeostatic imbalance. 
19 
 
Thalamo-cortical dysrhythmia (TCD): The damaged nerve fibers lead to a lack of 
excitation in VP nucleus of the thalamus which causes thalamic neurons to fire from high 
frequency to a low frequency bursting regime 
82–84
. This process of abnormal firing of 
neurons by the thalamus is known as TCD. In addition to injury of the nerve fiber, the 
TCD can also be noticed when input from the cortical and sub-cortical regions to the 
thalamus affects the firing process of thalamic neurons 
82
. In TCD, abnormal inputs to the 
thalamus hyperpolarizes thalamic neurons which reduces cortical inhibition or increases 
facilitation 
70,76,81,85
. Hence thalamic integrative circuits behave as generators and 
amplifiers for nociceptive signals and thus induce long-lasting profound cortical and sub-
cortical reorganization which in turn develops NP 
86
. The TCD is characterized by a shift 
of dominant peak towards lower frequency. The formation of  new cortico-cortical 
projections is also considered as a cause of NP 
87
. The cortical reorganization, cortical 
over- and, de-activation and shift of dominant frequency are discussed in Chapter 2.  
1.4.4. Assessment of NP 
The assessment methods for NP are categorized into 
18
: (i) pain questionnaire (verbal 
report), (ii) clinical Examination, and (iii) imaging of the brain.  
Persistent pain is measured subjectively using several pain questionnaires. These include 
‗The Leeds assessment of neuropathic symptoms and signs‘ 88, brief pain inventory 89, ‗the 
neuropathic pain questionnaire‘ 90, McGill Pain Questionnaire 91, and ‗Douleur 
neuropathique en 4 questions‘ 92. These pain questionnaires consist of several factors such 
as location, sign and symptoms of pain, mood, sleep and performance of daily activities. 
Patients also self-reported the pain intensity on 0 to 10 Visual Analog Scale (VAS) 
93
.  
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In a clinical examination, sensory response is tested. According to IASP, there are several 
clinical examination tools for screening NP 
41
. These include: a piece of cotton wool or a 
soft brush for touch sensation, tuning fork (64 or 128 Hz) for vibration, wooden cocktail 
sticks for pinprick and sharp pain, cold object (200C) for cold sensation, and warm object 
(400C) for warmth sensation. The SCI patients are also tested for allodynia (painful 
sensation on a normally non painful stimulus) and hyperalgesia (increased sensitivity of 
pain) based on perceptual threshold in response to stimulation of feet and shank of both 
legs using monofilament 
94,95
. 
Recently, brain imaging techniques have been used to objectively measure pain 
96
. The 
brain imaging techniques will be discussed in next section where as changes in the brain 
activity following pain will be discussed in next chapter. 
Section II. Technologies of the Mind 
1.5. Neuroimaging Techniques 
There are different imaging techniques used by researchers to record the brain activity, 
and to investigate the plasticity in the brain following injury to the nervous system. These 
tools include functional magnetic resonance imaging (fMRI), positron emission 
topography (PET), near infrared spectroscopy, electrocorticogram, 
magnetoencephalography and electroencephalogram (EEG) 
97
.  The summary of 
neuroimaging techniques is shown in Table 1.3. 
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Table 1.3: Summary of neuroimaging methods 97  
Neuroimaging 
Methods 
Activity 
measured 
Direct/ 
Indirect 
Measurement 
Temporal resolution  Spatial 
resolution 
Risk Portability 
EEG Electrical Direct ~0.05s ~10 mm Non-
invasive 
Portable 
MEG Magnetic Direct ~0.05s ~5 mm Non-
invasive 
Non-
portable 
ECoG Electrical Direct ~0.003s ~1 mm Invasive Portable 
Intracortical 
neuron 
recording 
Electrical Direct ~0.003s ~0.5 to 
0.05 mm 
Invasive Portable 
fMRI Metabolic Indirect ~1s ~1 mm Non-
invasive 
Non-
portable 
NIRS Metabolic Indirect ~1s ~5 mm Non-
invasive 
Portable 
PET Metabolic Indirect ~ 30s ~4 mm Non-
invasive 
Non-
portable 
EEG: Electroencephalogram, MEG: Magneto-encephalography, ECoG: 
Electrocorticogram, fMRI: functional Magnetic Resonance Imaging, NIRS: Near Infrared 
Spectroscopy, PET: Positron Emission Topography. 
 
fMRI and PET have been used to measure localized changes in the oxygen content of the 
blood flow. The higher the volume of oxygen in the blood in one area, the more active that 
area 
97
. The temporal resolution for both fMRI and PET is poor, however, fMRI compared 
to PET measures brain activity with much higher precision. The near infrared 
spectroscopy uses infra-red light to record brain activity. It is based on the principle of 
monitoring the changes in blood oxygenation and deoxygenation in the cerebral cortex 
98
. 
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Magnetoencephalography is an imaging technique used to measure the magnetic fields 
produced by electrical activity in the brain 
99
. EEG can directly measure cortical electrical 
functional activity associated with different brain states. In contrast to fMRI and PET, EEG 
has a good temporal resolution but little spatial resolution. Electrocorticogram is an 
invasive procedure to record electrical activity of the cerebral cortex with a higher 
temporal and spatial resolution compared to EEG.  
1.6. Electroencephalogram (EEG)     
EEG is a non-invasive technique used to record brain activity with electrodes placed on 
surface of the scalp 
100
. It cannot be used to analyse dynamics of the deep cortical 
structures, though activation of deeper cortical areas can be estimated using some source 
localisation method 
101
. EEG recorded at the scalp is not the activity of a single neuron but 
made up of summations of billions of individual action potentials 
102
. 
1.6.1.  Electrode Placement 
A standard placement of electrodes that is known as 10-20 International System of 
Electrode placements was established by Jasper in 1958 
103
. The term 10-20 refers to the 
placement of electrode placed 10% or 20% of the total distance between specified skull 
locations. Use of a percentage-based system allows for differences in skull size. The 
extension of 10-20 system are 10-10 and 10-5 systems which allow to use more electrodes 
on the scalp to improve spatial resolution (Figure 1.10) 
100,104,105
. 
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Figure 1.10: EEG electrode placement systems: 10-20 system (only black circles; 21 
electrodes), 10-10 system (black and grey circles; 85 electrodes) and 10-5 system (circles 
and dots; 320 electrodes) 
105
. 
 
1.6.2. EEG Montages 
There are four basic types of EEG montage: (i) linked ears reference or monopolar, (ii) 
bipolar, (iii) common average reference, and (iv) local average reference or laplacian.  
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The monopolar montage provides information of active scalp site by comparing activity 
of active site with a common reference, such as ear lobes or nose tip. The main advantage 
of common referential montage is that common reference allows valid comparisons of 
activity in many different derivations. The disadvantage is that no reference site is ideal.     
The bipolar montages compare activity between two active scalp sites, as shown with 
Eq.(1.1). The difference of two activities reduces noise, however some information is also 
lost.  
               (1.1) 
Where, 
                                                                           
                                                                  
                                                                   
 
In average reference montage, the EEG activity of all channels is averaged and this 
average is used as a common reference for each channel. Equation                                                          
(1.2) is used to calculate the average reference. 
  
       
∑   
 
   
 
 
                                                         (1.2) 
Where, 
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The term local average or laplacian reference represents a unique reference for each 
source. It provides information of active scalp site by comparing activity of active site with 
a weighted average of surrounding electrodes 
106
. Equation                                                          
(1.2) is used to calculate laplacian reference in which n ranges from 2 to 4 depending on 
number of electrodes in surrounding the active electrode. The laplacian is a high-pass 
spatial filter that increases localized activity and attenuates widespread (diffuse) activity 
107
. 
1.6.3. EEG Frequency bands 
Frequency refers to the rate at which a waveform repeats its cycle within 1 sec 
108
. In 
EEG, the frequency range is divided into six frequency bands: delta (less than 4 Hz), theta 
(4-8Hz), alpha (8-13Hz), rolandic mu-rhythm, beta (13-30Hz) and gamma (> 30Hz). The 
description of frequency bands is provided by a Niedermeyer 
109
.    
The delta rhythm refers to EEG activity within a frequency range of 1-4 Hz; the highest 
amplitude compared to other frequency bands. It is dominant in the posterior region of the 
brain in infants, while over the frontal region in adults. The increased power of delta 
rhythm is associated with sleep and neurological pathology such as tumour and brain 
lesion.   
The theta rhythm refers to EEG activity within the 4-8 Hz range, prominently seen 
during sleep. During wakefulness, two different types of theta activity have been 
described: (i) widespread theta rhythm, and (ii) the frontal midline theta rhythm. The 
widespread theta rhythm has been linked to decreased alertness (drowsiness) and impaired 
information processing. This type of theta rhythm is common in infancy and childhood and 
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drowsy or sleepy state, it is less common in waking adult around age of 30 years. The theta 
rhythm is found in large number of brain structures: ACC, hippocampus, hypothalamus 
and medial dorsal nucleus of the thalamus. Furthermore, this wide spread theta rhythmic 
activity is thought to be a sign of maturity to link the cortex, thalamus and hypothalamus. 
The frontal midline theta activity (anterior to the vertex), is characterized by a frontal 
midline distribution and has been associated with focused attention, mental effort and 
mental task such as mathematical calculation, emotion, and effective stimulus processing. 
The ACC (BA 24 and 32) is thought to be a generator of this theta rhythmic activity. 
The frequency range of alpha rhythm is 8-13 Hz. Topographically, the alpha rhythms are 
predominantly found over occipital, parietal, and posterior temporal regions during 
wakeful relaxation in eyes-closed (EC) state. This alpha rhythm can be greatly temporarily 
blocked or reduced during visual stimuli or eyes-open (EO) state. The process of alpha 
suppression is known as ‗alpha blockage‘. The posterior distribution of alpha and its 
attenuation in EO state demonstrate that functionally alpha might be associated with visual 
function system.  
The frequency range of frontal beta is 13 to 30 Hz. Rhythmical beta activity shows 
symmetrical fronto-central distribution. The central beta rhythm is known as ‗Rolandic 
rhythm‘ which will be discussed later on. The amplitude of the frontal beta activity is very 
small, seldom exceeds 30 µV. The beta activity is closely linked to motor behavior and is 
generally attenuated during active movements. Low amplitude beta with multiple and 
varying frequencies is often associated with active, busy or anxious thinking and active 
concentration.  
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There are two types of rolandic rhythms found over the sensorimotor cortex, one has a 
peak around 10 Hz called ‘rolandic alpha rhythm’ or ‘mu’ rhythm and other has a peak 
of around 20 Hz called ‘rolandic beta rhythm’ or ‘central’ rhythm. The frequency range 
for rolandic alpha is similar to posterior or occipital alpha (8-13 Hz), though it has different 
topography. The frequency range for rolandic beta rhythm is around 16-24 Hz. The 
rolandic alpha and beta rhythms are blocked or suppressed during motor tasks, such as 
overt (actual) or covert (imagined) movement. This suppression is bilateral but more 
pronounced on the motor cortical region contralateral to the site of movement. The spatial 
distribution is essentially confined to the precentral-postcentral region; some spread into 
parietal leads is not uncommon. 
The frequency range of gamma activity is above 30 Hz. Gamma oscillations have been 
associated with attention, arousal, object recognition, modulation of sensory processes, and 
binding (the brain‘s ability to integrate various aspects of a stimulus) of different 
populations of neurons together into a network. This purpose being is to carry out a certain 
cognitive or motor function. 
1.7. Biofeedback 
Biofeedback is the process of learning to self-regulate physiological functions 
110
. The 
trainee receives real time information of biological signal recorded via sensors placed on a 
body. The biological signals include breathing, body temperature and heart rate, as well as 
signals coming from muscles and the brain. The online information of biological signal 
may be provided in auditory or visual feedback such as digital or analog displays, or 
computer graphs.  
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1.8. Neurofeedback (NF) 
According to International Society for Neurofeedback and Research, ―NF is a process in 
which sensors are placed on the scalp and electronic devices are used to monitor and 
provide moment-to-moment information to the individual for the purpose of improving 
brain functions‖ 111. NF, a modality of Biofeedback, is a method of acquiring feedback 
from the brain to voluntarily modulate brain activity in real time 
112–114
. It is a non-invasive 
non-pharmacological approach which does not involve either surgery or medication  
112,113
.  
NF is a form of operant conditioning. Operant conditioning is a type of learning in which 
individuals learn to elicit a new response following reinforcement to increase or decrease 
performance. In other words, the individual is required to actively perform an action in 
order to be rewarded or suppressed. Therefore, NF training requires 15-60 sessions, 
depending on application, learning ability and type of feedback 
115
.  
1.8.1. Types of NF and history  
There are three major forms of NF: (i) EEG, (ii) regional Cerebral Blood Flow or 
Homoencephalography (HEG), and (iii) fMRI based.  
NF using HEG trains subjects to voluntarily control cellular activity of a targeted area of 
the brain 
116
. There are two basic forms of HEG based NF 
116–119
: (i) near infrared HEG, 
and (ii) passive infrared HEG. The near infrared HEG system was developed by Hershel 
Toomin in 1995. It involves the use of light in red and near infrared wavelengths (7-14 
µm) and monitors changes in the cerebral blood flow by targeting small areas over the 
ventral lateral frontal sites (F7, F8, Fp1 and Fp2) 
120
. The passive infrared HEG system was 
developed by Jeffrey Carmen. It involves the use of light in far infrared wavelengths (680-
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850 nm) 
116
 and measures changes in the thermal waste products of cellular metabolism by 
targeting a wide variety of skull placements. Both types of HEG NF systems compared to 
EEG NF are less affected by noise 
112
.  
The real-time fMRI feedback provides blood oxygenation-level dependant signal as a 
feedback to allow subjects to self-regulate brain activity 
121–123
. The fMRI feedback 
compared to EEG feedback allows users to self-regulate deeper-cortical and sub-cortical 
structures but the delay is large. The fMRI feedback has a delay of about 1.3-2 s 
121,122,124
. 
EEG based NF was first used in the beginning of 1950s by Dr Joe Kamiya, in which he 
explored that trainees could voluntarily modulate alpha brain activity under EC condition 
121
. At same time, Barry Sterman carried experiments on cats to modulate the activity of 
sensory-motor rhythm (SMR). Later on, in 1970-1980s, the NF was applied in clinical 
studies to treat Attention Deficit Hyperactivity Disorder (ADHD) and through the 1990s to 
psychological and central nervous system disorders. At present, NF is used to improve 
peak performance of sports players, in addition to treating central nervous system disorders 
such as ADHD, pain and epilepsy.  
1.8.2. Division of EEG based NF 
EEG based NF can be divided into two types: (i) deep cortical activity feedback, and (ii) 
scalp EEG feedback.  
The deep cortical feedback is provided by Low Resolution Brain Electromagnetic 
Tomography (LORETA) in which current source density is shown as a feedback signal. 
LORETA-based NF uses approximately 19 electrodes to train deeper cortical structures 
125
. 
The LORETA feedback was first introduced in the 2001 annual meeting of ISNR 
126
, 
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however, it was not until 2004 that it was first validated 
127
. LORETA feedback is more 
cost-effective than fMRI feedback to treat deep cortical structures, and more specific than 
scalp EEG NF 
128. According to Dr Thatcher: ―An advantage of LORETA EEG 
biofeedback is that one can target anatomical regions related to ―loss of function‖ or 
―weak‖ function related to the patients‘ symptoms and complaints‖ 129.    
The scalp EEG-based NF can be divided into four types: (i) Spontaneous EEG NF 
130–134
, 
(ii) ERD-based NF 
135
, (iii) Event related Potential (ERP) based NF 
121,136
, and (iv) slow 
cortical potential feedback 
121,137,138
. The ERD and ERP feedback types are applied for 
brain computer interface (BCI) and are not based on operant conditioning. In spontaneous 
EEG-based NF, a subject is asked to modulate the spectral absolute or relative 
amplitude/power in certain frequency band, ratio of power in two frequency bands over 
single electrode or ratio of power between two sites in single frequency band, coherence 
(NF parameter) between two sites in a given frequency band in both EO and EC modalities 
121,130,131,139–142
. In ERD-based NF, the relative change in EEG power (NF parameter) in a 
given frequency band, in response to either real or imagery motor action, is provided as a 
feedback. In ERP-based NF, the amplitude or latency (NF parameter) of ERP component 
is provided as a feedback to a trainee 
121,136
. In slow cortical potential NF, the trainee 
learns to control negative or positive shifts of slow cortical potentials (NF parameter) in 
response to warning stimuli.  
In spontaneous EEG and ERD based NF training, a term ‗dominant frequency band‘ is 
used when a trainee is asked to increase activity, whereas, ‗inhibit frequency band‘ is used 
when a trainee is asked to decrease the  activity in a particular frequency band 
143–145
.   
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1.8.3. Methods of Providing Audio/Visual Neurofeedback Information to a Trainee 
The feedback information for each types of EEG-based NF (section 1.8.2) can be 
provided either in EO or EC modality in three different ways: (i) NF parameter directly, 
(ii) total time (percentage) patient achieved threshold condition, and (iii)  Z-scores (also 
called classical NF) 
133
. 
NF parameter can be directly shown as a feedback in the form of bars/videos or music 
130–
132
. The greater the amplitude/power, the higher or wider the bar and more intense the 
audio signal. The colour is also changed according to threshold value. In NF training with 
total time as a feedback information rather than NF parameter directly, the score of the 
trainee is increased once threshold condition is achieved. Therefore, the trainee is asked to 
maximize the score, which in general increases the percentage time the threshold is 
achieved 
130,140,141
. In Z-score feedback, a trainee gets positive feedback as long as the 
targeted brain activity remains within a certain range of the standard activity 
133
,
134
. These 
norms are derived from the extensive normative EEG databases. An excellent normative 
database was developed in 1987 for normal controls of all ages 
146
. This database 
determines whether an individual with a head injury or ADHD differs significantly from 
matched normal controls. This database asked questions about power and coherence in 
different frequency bands at different scalp sites. Another database developed in 1999 
stores information about power ratios of theta to beta at the Cz site and is calculated in four 
different conditions: EO state, reading, listening and drawing 
146,147
. The smaller the value 
of the Z-score means a trainee is learning in the desired direction.  
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1.8.4. Frequency of Updating Training Variable 
According to classical conditioning theory, the feedback lag (delay) should be less than 
0.5 s 
146
. The feedback delay depends on spectral analyses method and speed of the 
computer, in addition to the length of the EEG leads. The spectral analysis is performed 
using fast fourier transform (FFT) and filters methods. In contrast to the filter technique, 
the FFT takes more time to make initial calculations which can be resolved by taking small 
length epochs. The small length epochs decreases the frequency resolution which can be 
improved by shifting a window but there is still an initial delay. The delay caused by filters 
is usually less than 0.1 s. The delay in active bans pass filters can be further minimized by 
decreasing the order of the filter but this produced smooth spectrum. On the other hand, 
increased order induced oscillations or ripples which in turn might send wrong feedback.  
1.8.5. Methods to Calculate the Threshold Value of Training Parameters 
The threshold value for training electrode site is set either one of two ways 
108
. (i) 1 to 2 
units or 10-20% lower or higher than the mean spectral amplitude/ power or mean relative 
power, calculated in EO or EC state, for each training day 
130,132,148
, or (ii) spectral 
amplitude/ power or mean relative power at 50-80% of time for the whole baseline 
recording 
131,149
.  
1.8.6. NF experimental procedure and assessment 
NF procedure consists of initial assessment, NF training, and final assessment. The initial 
assessment is always before the first day of NF training and the final assessment is always 
after the last NF training day. The initial and final assessments mainly consist of EEG 
recordings using a large number of electrodes. The initial assessment EEG before NF is 
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also used to compare EEG of a subject with normative database or EEG of a healthy 
population, which also helps to design NF protocols. The final assessment EEG is used to 
find long-term neurological changes. The initial and final assessments also include patient 
history, current symptoms, medical information such as medicine intakes and injuries, 
discussion of diet, sleep and exercise, and goals of training. The behavioural changes are 
also assessed as part of the initial and final assessments, which mainly include 
questionnaires of related applications.  
1.8.7. Placebo for NF Training 
In any medical treatment, the psychological expectation might affect the therapeutic 
outcome. The effect of expectation is called placebo or sham effect 
121
. The placebo effect 
has a real neurophysiological basis that can be revealed by neuroimaging techniques. The 
placebo effect can further prove the efficiency of any therapeutic method. Placebo effect 
can amount up to 30% from the pure effect of a medical drug or real non-pharmacological 
treatment. In NF training, the sham treatment to test the placebo effect can be performed in 
different ways 
121,150
: (i) comparing effect of NF training with medical drug, (ii) showing 
feedback of other subject, (iii) showing feedback of other region of the brain which was 
not previously trained, and (iv) showing pre-recorded EEG as a feedback. 
1.8.8. NF Protocols and Assessments 
In NF,  protocol refers to a selection of NF parameters, montage and electrode position to 
up-regulate NF parameters in ‗dominant frequency band‘ and/or down-regulate in ‗inhibit 
frequency band‘ with the EO or EC modality 151.  
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EEG-based NF is not only used in the optimal performance field but also used for the 
treatment of various neurological and psychological disorders 
152,153
 such as ADHD, 
autism, stroke rehabilitation, depression, anxiety, stress, obsessive compulsive disorders, 
epilepsy, schizophrenia, and pain reduction. However, well-established protocols only 
exist for the treatment of ADHD 
154
.  
The SMR protocol along with theta and beta inhibition protocol have been used to 
successfully treat ADHD. In the field of NF, the range of SMR is 12-15Hz which was first 
studied by Barry Sterman on cats in 1960. The SMR protocol on ADHD patients was first 
tested by Lubar in 1970s. This protocol aims at increasing SMR activity, mainly over 
frontal (F3 and F4), central (Cz, C3 and C4), and parietal (P3 and P4) sites 
120,121,149,155–159
. 
The feedback was provided both in visual and audio forms and a threshold condition was 
set to 80% of time or 1 to 2 units below/above the spectral amplitude/power 
149,155
. Other 
applications of SMR reward protocol, though not standardized, include treatment of 
depression 
160,161
, improvement of sleep 
162,163
, obsessive compulsive disorder 
108,164
, 
Parkinson‘s disease 165. The frontal leads were chosen for the treatment of depression and 
anxiety, and sensory-motor cortex was chosen for improving sleep.   
The SMR reward and theta-beta inhibit protocol over sensory-motor cortex has been used 
also to manage pain 
140,166–168
. The application of NF protocol for the management of pain 
will be discussed in Chapter 2.  
The alpha-theta EC protocol from the occipital site was first used by Green Elmer 
169
 in 
1975, but Peniston, later on, added temperature biofeedback and a protocol is known to be 
Peniston alpha-theta protocol 
170
. The alpha-theta (Peniston) protocol aims at raising both 
theta (4-8Hz) and alpha (8-12Hz) bands activity from the occipital lobe following 
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temperature biofeedback. The alpha-theta biofeedback over the occipital site has been 
reported to be of clinical benefit in the treatment of addiction and posttraumatic stress 
disorder 
121,171,172
. The alpha frequency range was 8-13 Hz and theta range was 4-8 Hz.  
The alpha asymmetry protocol uses the ratio (F4-F3)/ (F4+F3) as a feedback parameter to 
reduce left alpha activity 
108,173
. This protocol aims to normalize alpha asymmetry in the 
lateral frontal areas. The alpha asymmetry protocol has been used for the treatment of 
mood disorders and depression. 
The connectivity based protocol is based on coherence between two brain sites 
174
. The 
connectivity based protocol has been used for the treatment of autism disorder 
174–176
. The 
electrode location and frequency bands were individualized. 
The self-regulation of slow cortical potential has been used to establish communication in 
severely paralyzed people 
121
, to reduce seizure rate in patients with epilepsy 
137
, to treat 
psychiatric patients (schizophrenia) 
138,177,178
, and to reduce alcohol dependency 
179
. The 
feedback was provided from Cz, C3 and C4 sites. 
The ten sessions of Z-score LORETA NF, together with scalp EEG NF, improves speech, 
cognitive score and grades followed by reduction in theta and delta band activity in a 
single patient with autism spectrum disorder 
180
. Other studies also reported improvement 
in cognitive functions and reduction in delta and beta band activity following 15 to 33 
sessions of scalp EEG and 19-channel LORETA Z-score NF training 
181,182
. The feedback 
was provided both in audio and visual forms from BA 32.  
Currently, real-time fMRI NF is mostly applied on healthy subjects, showing that self-
regulation of brain activity of different cortical and sub-cortical regions can be useful to 
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explore cognitive neuroscience and to improve various psychological disorders 
124
. The 
feedback is mainly provided from areas including sensory-motor cortex 
183
, ACC 
184
, IC 
185–187
, subgenual ACC 
188
, auditory cortex 
189
 and inferior frontal gyrus 
190
. The real-time 
fMRI NF study on healthy population suggested that upregulation of brain activity in the 
left amygdala can help to treat patients with neuropsychiatric disorders 
191
. The 
downregulation of BOLD activity in ACC, IC, and sensory-motor cortices demonstrate 
that real-time fMRI can be used to manage pain 
192
. The upregulation of brain activity of 
the SMC, IC, PFC and PMC has shown improvement in patients with parkinson‘s disease, 
schizophrenia, depression and stroke 
186,193–195
. The down-regulation of brain activity in 
auditory cortex and ACC can reduce tinnitus symptoms, nicotine addiction, and pain 
intensity 
150,196–198
.  
In the field of cognitive neuroscience, different protocols have been used to provide 
feedback with EEG-based NF. These protocols include upper-alpha, theta, gamma, alpha 
desynchronization, SMR/ theta, alpha/ theta, SMR and low beta protocols along with theta 
and beta inhibit, and peak alpha frequency 
148,152,199,200
. The field or application of NF to 
improve cognitive performance of healthy participants is commonly called ‗optimal‘ or 
‗peak performance‘ field 152. In this area of cognitive neuroscience, NF has been used to 
improve peak performance of sports player, musicians, actors, and dancers, and to improve 
communication/ presentation skills 
143,201,202
. The outcomes of NF training include 
improved memory, reaction time, large event-related P300b amplitude, and enhance visuo-
motor skills. The details of each protocol and its application can be found from Gruzelier 
reviews paper 
152,153
. 
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Section III.Methods of Quantitative EEG Analysis 
1.9. Spectral Analysis Methods of EEG  
The spectral analysis provides information of a signal x(t) in frequency domain. The 
spectral analysis is often performed using fast fourier transform (FFT). The FFT describes 
a signal x(t) as a linear superposition of sines and cosines characterized by a frequency ‗f‘.  
| ( )|  ∫  ( )       
  
  
   
(1.3) 
 
Equation (1.3) is the continuous fourier transform (X(F)) of the signal x(t) over each 
frequency point ‗f‘. Based on Eulers formula Eq. (1.4), the exponential function in Eq. 
(1.3) can be represented with sine and cosine function. 
                (1.4) 
 
The discrete FFT of a signal x(n) consists of N discrete samples is shown in Eq. (1.5). 
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Where, 
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The frequency of FFT is calculated using Eq. (1.6). It shows that the frequency resolution 
is based on length of data epoch extracted for FFT. 
38 
 
  
  
 
 
                   (1.6) 
Where, 
                                    ( )                              (   )  
                       
                           
 
Power of a signal: The power of a signal represents amount of energy or activity at 
different frequencies. Equation (1.7) shows that the power of a signal x(n) can be 
calculated by squaring the amplitude of the FFT output X(F) calculated in Eq. (1.5).  
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The absolute power is varied with many factors such as neurophysiological, anatomical 
and physical properties of the brain and surrounding tissues. The relative power for a 
frequency range of f1 to f2 Hz can be calculated using Eq. (1.8). 
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Cross Power of two signals: The cross power is a measure of energy at different 
frequencies that is in common to the two different raw data time-series. Assume that x(n) 
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and y(n) are two different signals then the cross power between them is the product of the 
power of one signal with the conjugate of power of other signal Eq. (1.9).  
   ( )  ( ( ))  ( 
 ( )) (1.9) 
Where, 
   ( )                                  
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  ( )                                ( )  
 
Coherence between two signals: The coherence measures the linear relationship between 
two signals in frequency domain. Coherence provides information whether the same 
frequency components of two signals preserve their phase shift from one state to another. It 
can be represented as the ratio of the square of cross-spectrum of two signals to the product 
of the two auto-spectra Eq. (1.10). 
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1.10. Time-Frequency Methods of EEG  
The time-frequency analysis provides information of a signal both in time domain and in 
frequency domain simultaneously. Due to the trade-off between time localization and 
frequency resolution, the resolutions in time and frequency domains cannot reach their 
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highest levels concurrently. However, it is better to have a smaller time resolution of higher 
frequencies and larger on lower frequencies. The two most widely used time-frequency 
methods are short time FFT and wavelet transform. 
In short time FFT method, the signal of length N is first divided into K segments of 
length L using Eq. (1.11). Each segment is multiplied with a window prior to estimate the 
FFT using Eq. (1.12), then FFT output is averaged over all epochs.   
  
 
 
 
(1.11) 
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Where, w(n) is a window function.  
There are different window functions 
203
, such as Bartlett, Hanning, Blackman, Kaiser-
Bessel, Flat top, Tukey, and Hamming (Eq. (1.13)). In Eq. (1.13), ‗n‘ is length of the 
window and ‗N‘ is length of whole signal. 
        ( )               (    
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The short time FFT method has disadvantage of same width of time-frequency windows 
for all frequencies (Figure 1.11 (a)), therefore the wavelet analysis is mostly used to study 
the time frequency dynamics of task-related EEG.  
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(a) short time FFT                                                  (b) Wavelet Transform 
Figure 1.11: Short time FFT and wavelet transform breakdown of a signal. (a) The time-
frequency window has fixed window length for all frequencies in short time FFT. (b) The 
time-frequency window length is large for lower frequencies and small for higher 
frequencies 
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The wavelet analysis decomposes a signal into wavelets, instead of sinusoidal functions. 
The wavelet is shifted and scaled to match the input signal using Eq. (1.14). The process of 
shifting and scaling is shown in Figure 1.12. A figure shows that the length of the time-
slice window is according to the frequency of the component extracted. The varying time-
frequency window length allows smaller time resolution for higher frequencies and larger 
time resolution for lower frequencies (Figure 1.11 (b)). There are different wavelets 
families such as morlet, meyer, demyer, Gaussian and daubechies. The disadvantage of 
wavelet time-frequency method is an increased computational time and memory 
requirement.   
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Figure 1.12: The scaling (dilated) and shifting (translated) process of wavelet 
204
. 
 
The most widely used parameter to quantify task-related EEG activity is Event Related 
Spectral Perturbation (ERSP). The ERSP measures average dynamic changes in amplitude 
of the narrow band EEG frequency spectrum as a function of time relative to an 
experimental event. The ERSP is calculated using Eq (1.15) 
205
.  
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Where,  
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The two terms used to describe this phenomenon are Event Related Desynchronization 
(ERD) and Event Related Synchronization (ERS). The ERD/ ERS represent decrease 
Upper wavelets are twice 
narrower to ‗catch‘ higher 
frequencies 
Lower wavelets are twice 
wider to ‗catch‘ lower 
frequencies 
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(negative ERSP)/ increase (positive ERSP) in energy during active or task related state 
compared to resting or baseline state. The ERD/ ERS are noticed in the alpha and beta 
bands. ERD can be interpreted as an increased cortical excitability in the cortical areas 
involved in processing of sensory or cognitive information or production of motor 
behavior. In other words, ERD is associated with enhanced processing of information in 
the brain i.e. active brain. The large negative ERD value represents strong 
desynchronization or more active brain. The strong ERD is based on many factors such as, 
complexity of the task, and tasks require more effort and tension.  ERD over the sensory-
motor cortex can be noticed during motor task and over the occipital cortex when 
processing visual information. ERS can be interpreted as a decreased cortical excitability 
which is associated with reduced information processing i.e. deactivated brain.    
1.11. Independent Component Analysis and its Application to EEG  
Independent Component Analysis (ICA) is a computational method for separating a 
multivariate signal into spatially fixed and temporally independent components 
206
. The 
ICA represented with Eq. (1.16) shows that only a single variable    is known, therefore, 
few assumptions are taken to estimate the unknown mixing variable    and unknown 
sources/ ICs (  ): (i) The ICs are statistically independent, (ii) the ICs must have non-
Gaussian distribution, and (iii) the unknown mixing matrix is square.  
                         (1.16) 
Where, 
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              (                             )  
 
The EEG signal recorded at the scalp is a weighted sum of different rhythms produced at 
different frequencies by generators located at different cortical and subcortical areas. 
Furthermore, the scalp EEG is also affected with several types of non-brain artifacts which 
include eye movements, eye blinks, muscle activity and line noise. To extract real EEG 
sources or to remove non-EEG sources, source separation methods are applied. These 
methods include dipole fitting method, LOERTA, standardized LORETA (sLORETA), 
principal component analysis, common spatial pattern, and ICA. ICA has been widely used 
method to remove artifacts from EEG signals recoded at the scalp 
207–210
. EEG signal 
recorded at each electrode can be described with ICA using Eq. (1.16) 
211,212
. In case of 
EEG both weights (   ) and sources (generators and/ or noise,   ) are unknown 
208
. It is 
important to note that in terms of EEG    is the source generated by deep cortices and/ or 
sub-cortices or artifact,     is the weightage matrix, j is the numbers of electrodes placed 
on the scalp, and    is the potential recorded at the scalp using EEG electrodes.  
The whole process of ICA rejection and back-projection is shown in Figure 1.13 
213
. In 
terms of EEG, Eq. (1.16) can be rewritten as Eq. (1.17). 
                 (1.17) 
Where, EEGM*N and UM*N are EEG recorded with ‗N‘ electrodes and unknown ‗N‘ sources 
for time M. AN*N is a mixing square matrix (electrodes * components).  
The unknown sources ‗U‘ in Eq. (1.17) are obtained by multiplying the observed EEG 
signal ‗EEGM*N‘ with the inverse of a mixing matrix ‗A‘ using Eq. (1.18). 
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                 (1.18) 
Where, WN*N is inverse of mixing matrix ‗A‘ or W=A
-1
.  
The bad components are set to zero before back projected the components to the corrected 
EEG. The corrected or artefact free EEG is obtained by multiplying the sources ‗U‘ with 
inverse matrix ‗W-1‘ using Eq. (1.19). 
                 
  
         (1.19) 
 
 
Figure 1.13: General block diagram for ICA rejection and back-projection to artefact-free 
corrected EEG 
213
. 
 
Figure 1.14 shows application of ICA to remove noise from 3 sec EEG. The EEG was 
recorded in our lab using 61 channels but only ten channels are shown for simplicity 
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(subfigure ‗a‘). The electroocculogram (EOG) artefact can be noticed on frontal leads 
while muscle artefact at electrode AF8. The subfigure ‗b‘ shows derived independent 
components. The EOG artefacts and muscle artefacts in the EEG data are isolated in 
components 1 and 2 respectively. The bad components (non-EEG) are determined based 
on their temporal and spatial information, and frequency characteristics. In subfigure ‗c‘ 
only 3 scalp components are shown in which first two components are EOG and muscle 
artefacts while last component is occipital alpha. The scalp components representing EOG 
and muscle artefacts in subfigure ‗c‘ are set to zero before inverting the data to EEG 
domain shown in subfigure‗d‘.  
Actual EEG 
EEG=A*S 
Components 
S=W*EEG 
Scalp Trajectories 
W
-1
 
Corrected EEG 
EEGcorrected=W
-1
*S 
(a) 
 
 
 
 
 
 
 
 
 
 
 
 
(b)  
 
 
 
 
 
 
 
 
 
 
 
 
        (c)  (d) 
Figure 1.14: Example of ICA procedure on EEG data recorded with 61 channels in our 
lab, only 10 channels are shown for simplicity. (a) 3-sec portion of the recorded EEG time 
series. (b) ICA component activations for EEG, (c) the scalp topographies of three selected 
components (first two components are noise), (d) the artifact-corrected EEG signals 
obtained by removing two selected EOG and muscle noise components from the data. 
 
 
EOG 
Muscle 
Alpha 
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Chapter 2. Cortical Plasticity and Pain Management 
This chapter begins by discussing neuroimaging studies that describe the effect of spinal 
cord injury (SCI) on the brain. Following this, studies that considered the effect of pain in 
SCI patients, while analysing brain activity, are discussed. From the literature review of 
neuroimaging studies on SCI patients with and without pain, the limitations in existing 
studies are presented. Solutions are proposed to fill the lack in current knowledge about 
changes in the brain in patients with central neuropathic pain (CNP) following SCI. 
Secondly, the effect of pharmacological and non-pharmacological treatments on pain in 
general population and patients with SCI are discussed. This chapter will focus on non-
pharmacological interventions because in this thesis a non-invasive non-pharmacological 
approach was chosen to treat pain. From the literature review of studies describing effect 
of non-pharmacological treatments on pain in patients with SCI, the limitations in existing 
literature are highlighted and an alternative approach to treat CNP in patients with SCI 
proposed.  
2.1. Brain Plasticity 
Brain plasticity describes structural and functional changes in the cortices and sub-
cortices in response to new tasks, normal development, lesions to the peripheral and central 
nervous systems, and neurorehabilitation (motor / sensory training either through external 
stimuli or mental practise) training following lesion 
214
. It is caused by either physical 
wiring of new cortical circuits known as structural plasticity, or by change in strength of 
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existing connection known as physiological plasticity. In general, injury or paralysis of the 
body parts affects the sensory and motor functions that cause functional reorganization of 
the cortical region deprived of sensory input (deafferentation). The cortical/ subcortical 
plasticity can be described as shrinking/reduced and shifting of cortical representation of 
affected body part, and invasion by adjacent cortical representation. In this chapter, we will 
discuss cortical and subcortical plasticity following SCI and pain. 
2.1.1. Brain Plasticity following SCI 
It has been well documented that cortical and sub-cortical areas showed plasticity 
following SCI, due to disruption of the motor and sensory pathways between the brain and 
the periphery 
215–231
. In few studies SCI patients either showed over- activation 
215–219,232,233
 
or reduced activation of the cortex 
220–223
. In addition to over- and reduced- activation, SCI 
patients have also displayed somatotopical reorganization 
219,224–229,234
. On the contrary, 
few studies have not found  differences in brain motor activation patterns between SCI 
patients and able-bodied people 
235,236
.  
A Positron Emission Topography (PET) study comparing cortical activity of SCI 
population (paraplegics and tetraplegics) and able-bodied during hand movement 
(attempted movement by tetraplegics and actual movement by paraplegics) found strong 
activation in SCI group over supplementary motor cortex (SMC), insular cortex (IC), 
parietal cortex and thalamus 
215
. The functional Magnetic Resonance Imaging (fMRI) 
studies also reported over-activation of affected and unaffected cortical and sub-cortical 
areas during motor imagery (MI) of paralyzed lower limbs and during motor execution of 
non-paralyzed upper limbs in chronic complete and incomplete paraplegics 
216,217
. Another 
study also reported over-activation of primary motor cortex (M1), primary sensory cortex 
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(S1), premotor cortex (PMC) and SMC in chronic complete paraplegics during motor 
execution and MI of paralyzed toes 
218
. The over-activation of primary and secondary 
motor cortical areas has also been reported in sub-acute tetraplegics (complete and 
incomplete) during extension of paralyzed wrist 
233
. Also, electroencephalogram (EEG) 
studies reported strong beta frequency band (13-30 Hz) activation or high event related 
desynchronization (ERD) in SCI patients (complete and incomplete) during actual plantar-
flex movement of toes 
219
.  
Contrary to over-activation of cortical and sub-cortical areas in SCI population compared 
to able-bodied, reduced activation in sensory-motor areas and thalamus has been observed 
in both paraplegics and tetraplegics during motor execution of paralyzed and non-
paralyzed parts of the body (wrist, foot and tongue) 
221
. Similar to motor execution task, 
MI of paralyzed lower limb also reduced activity at the sensory-motor cortical region in 
SCI patients having complete injury based on American Spinal Injuries Association 
(ASIA) 
220
. Spontaneous EEG studies have shown reduced alpha activity in relaxed eyes-
closed (EC) state in SCI population compared to able-bodied 
222,223
. 
The somatotopical reorganization in complete and incomplete paraplegics has been seen 
in the form of midline (towards paralyzed limb; Cz site) and posterior shift of cortical 
representation of non-paralyzed hands, thumbs and little finger 
225,226
. Similar to fMRI 
studies, EEG studies also showed posterior shift of cortical representation of unaffected 
hands during movement of non-paralyzed hand 
227,237
.  
The varying and conflicted findings are due to large variety in inclusion criteria, such as 
level of injury (Cervical 
224,233,235
; cervical to thoracic 
220,221,227,237,238
; thoracic to Lumbar 
216–218,226
; cervical to lumbar 
215
) completeness of injury (complete injury 
216,220,226,236
; both 
50 
 
complete and incomplete injury 
217,218,233,235,237
), motor and sensory functions (ASIA-A 
216,220,236
; ASIA A-D 
227,233,237
, ASIA A-B 
217,218
, ASIA A-C 
235
), type of SCI patients 
(paraplegic, tetraplegic), subjects characteristics (number of individuals; 4 to 44, age; 17-
67 years, gender and time since injury; 0.25 months to 33 years), neuro-imaging 
techniques, motor tasks (attempted, actual and/or imagined movement of upper limb, lower 
limb and/or facial tasks), and frequency of motor tasks. In addition to the above mentioned 
variability, researchers did not actually consider the effect of presence of chronic 
Neuropathic Pain (NP).  
2.1.2. Brain Plasticity following NP 
Brain neuroimaging has been widely used to investigate the structural and functional 
changes in the brain associated with chronic pain 
35,239
. A number of studies found that 
cortical and subcortical plasticity or reorganization were increased with chronicity and 
intensity of pain 
239,240
 in different chronic pain states, such as Complex Regional Pain 
Syndrome (CRPS) 
241
, fibromyalgia 
240
, trigeminal neuralgia 
242
, pain following amputees 
243
, and pain following SCI 
87,244
. Also, the over- and reduced- activation of several brain 
regions, painful and non-painful cortical presentations, has been reported in chronic pain 
87,245–247
. 
Cortical plasticity has been observed as a shift 
248,249
, invasion 
243
, expansion 
250
 and 
contraction 
248,249,251,252
 of cortical representation of affected body parts on the homunculus. 
The S1 and S2 representations of the affected arm shrinks in CRPS 
249,253
, and in patients 
with trigeminal neuralgia 
242
. The invasion of cortical representation of the affected body 
part by the unaffected body part has been observed following phantom limb pain 
243
. Also, 
the cortical shift of the painful body part towards intact body part has been observed in 
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chronic pain 
248,249
. A shift of cortical representation of non-paralyzed little finger and 
thumb towards paralyzed painful leg cortical representation has also been observed in SCI 
patients with NP 
244
.  
Numerous imaging studies also showed that regions of the brain such as the thalamus, S1 
and S2, M1, SMC, IC, and anterior cingulate cortex (ACC) are overactivated in chronic 
pain 
245,246
; other studies showed reduced activation and grey matter loss in rostral parts of 
the ACC and frontal cortex 
35,248,254–256
. The fMRI studies found over- activation of 
thalamus, M1, SMC, S1, S2, Prefrontal cortex (PFC), ACC, IC and parietal cortex in 
patients with chronic CRPS and chronic back pain 
245,246
. Similar to fMRI studies, 
spontaneous EEG studies reported overactivation (enhanced spectral power) of cortical and 
subcortical areas, mainly in the theta and beta frequency bands 
257,258
, which was not 
restricted to the cortical representation of the body part perceived as being painful 
84,257–259
. 
A PET study on SCI patients reported that increased blood flow in the thalamus is related 
to NP 
247
. A single fMRI study on complete paraplegics and a single scalp EEG study on 
SCI population (complete and incomplete) with below level chronic NP have found over-
activation in the pain related cortical and subcortical areas in SCI patients with pain 
compared to SCI patients without pain 
46,87
. Another EEG study found over-activation in 
the theta band in SCI population with chronic pain 
260
. However, another fMRI study has 
not shown differences in cortical activity between two SCI groups (pain versus no-pain 
group) during imagination of brushing little finger, thumb and lips 
261
. 
 In addition to over- and reduced- activation, EEG studies provide information about peak 
theta-alpha frequency. The shift of peak frequency towards low frequency in neurogenic 
pain was reported in three studies 
84,258,259
, except a single study showing no change in 
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peak frequency 
257
. This shift of peak frequency in relaxed state has also been reported in 
SCI patients with chronic pain, while this shift of peak frequency was not reported in SCI 
patients without pain and able-bodied 
46,262
. Furthermore, it has been mentioned that 
reduced activity in EC state compared to eyes-open (EO) state shown by the pain group 
compared to able-bodied and SCI patients with no pain groups is associated with thalamo-
cortical dysrhythmia (TCD) 
262
. 
In conclusion, some studies showed reduced- 
34,239,247
  or over- 
245,246
 activation of the 
surface and deep cortical structures, others reported shift 
248,249
, invasion 
243
, expansion 
250
, 
and contraction 
248,249,251,252
 of the cortical representation of the affected limb. The varying 
and conflicting findings might be due to different reasons, such as patient selection criteria 
and types of pain (fibromyalgia, CRPS, trigeminal neuralgia, back pain, phantom limb 
pain, and pain after SCI), number of patients and neuroimaging technique (EEG, fMRI and 
PET).  
2.2. Management of NP 
Treatment of NP can be classified as pharmacological or non-pharmacological, both of 
which can be applied either by invasive or by non-invasive way. Some studies showed 
higher use of non-pharmacological than pharmacological treatments 
263,264
, while others 
reported opposite 
265–267
. Here, pharmacological treatments will be described first followed 
by non-pharmacological treatments. The main focus will be on non-pharmacological 
treatments.  
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2.2.1. Pharmacological Treatments for Neuropathic Pain 
The pharmacologic treatments include oral medicines, pumps for drug delivery and direct 
delivery of steroids invasively (using syringe) to alleviate pain. The two main categories of 
pharmacological treatment include anticonvulsants and antidepressants. The 
anticonvulsants and antidepressants  decrease neuronal activity via many different 
mechanisms, such as blocking sodium channel, and enhancing modulatory systems 
18,268–
270
. The anticonvulsants decrease the peak alpha frequency and antidepressants increases 
activity of theta and beta activities along with slowed alpha frequency 
271–274
. Past research 
275,276
 suggests tricyclic antidepressants and anticonvulsants as a first-line treatment, and 
opioids as a second-line treatment. A recent study suggested pregabalin (anticonvulsant) as 
a first choice for patients with anxiety, and antidepressants for the patients with depression 
277
. The side effects and application of pharmacological treatment on different types of pain 
is shown in Table 2.1. 
Anticonvulsants, such as gabapentin and pregabalin have shown efficacy in 54%  patients 
for the treatment of postherpetic neuralgia 
278–282
 and diabetic neuropathy 
283,284
. 
Carbamazepine has been used for the treatment of trigeminal neuralgia 
285
. In patients with 
SCI, a single study supports the use of gabapentin for the treatment of NP (62% patients 
showed clinically significant i.e. >30%  reduction of pain) 
286
, but other studies failed to 
show the efficacy of gabapentin 
277,287,288
. Pregabalin is effective in reducing 25-40% pain 
intensity but with strong side effects 
289–291
. Other anticonvulsants, such as duloxetine, 
were also not efficient for the treatment of chronic pain in patients with SCI 
292–294
. In 
patients having chronic NP of mixed types, anticonvulsants reduce pain larger than 50% in 
21% patients and larger than 30% in 61% 
295,296
. In patients with CNP, the reduction of 
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pain larger than 30% was noticed in 42% patients only 
297
. Common side effects of 
anticonvulsants include dizziness (19%), somnolence (14%), sedation, constipation, a dry 
mouth and drowsiness 
298
. Due to these side effects, 10% patients stop taking 
anticonvulsants 
296
. 
Table 2.1: Pharmacological treatment for pain and side effects 
Types Name Pain Type Side effects 
Anticonvulsants 
Pregabalin, 
gabapentin, 
carbamazepine, and 
duloxetine 
Postherpetic 
neuralgia, diabetic 
neuropathy, 
trigeminal neuralgia, 
post stroke pain, 
phantom limb pain, 
and pain following 
SCI 
Dizziness, 
sedation, 
constipation, dry 
mouth, and 
drowsiness. 
Antidepressants Amitriptyline, 
nortriptyline 
postherpetic 
neuralgia, 
painful diabetic 
neuropathy, central 
pain, and SCI 
Drowsiness, dry 
mouth, 
constipation, and 
increased spasticity 
 
Antidepressants, such as amitriptyline  has been effective for few patients 
277
 but did not 
show its efficacy for mixed NP and nociceptive pain in SCI patients 
299
. It has also been 
used for postherpetic neuralgia and diabetic neuropathy 
300
. Common side effects of 
tricyclic antidepressants include drowsiness (17%), dry mouth (17%), constipation (14%) 
and increased spasticity (11%) 
301
. 
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Analgesics, such as, nonsteroidal anti-inflammatory drugs, acetaminophen, tramadol and 
opioids did not relieve NP, especially in SCI population 
302–304
. However, a study supports 
use of opiods 
305
. 
In conclusion, patients having chronic NP do not report sufficient pain relief with 
pharmacological treatments 
264,266,306
. Moreover, it is difficult for patients to continue 
treatment because of strong side-effects. These shortcomings in pharmacological 
treatments call for the need of non-pharmacological treatments for NP. 
2.2.2. Non-Pharmacological Treatments for Neuropathic Pain 
It was mentioned previously in sections 2.1.1 and 2.1.2, multiple cortical and sub-cortical 
areas are over-activated and showed plasticity in chronic pain 
307
. Therefore, it was 
hypothesized that interventions that directly or indirectly modulate the cortical and/or sub-
cortical activity and reduces plastic changes can help to manage pain 
307
.    
Brain modulation techniques reduce pain by altering the brain activity of the pain-related 
areas 
307
. Non-pharmacological interventions that directly targets the brain either 
invasively or non-invasively to achieve neuro-modulation include transcranial direct 
current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), invasive 
motor cortex stimulation (MCS), and deep brain stimulation. The invasive MCS and deep 
brain stimulation are invasive procedure which requires surgery. The non-invasive brain 
stimulation techniques do not require surgery but work with defined protocols (frequency 
and current of stimulation, number of training sessions and duration of training) to achieve 
neuro-modulation.  The non-pharmacological and non-invasive techniques in which 
neuromodulation is achieved using peripheral stimulation include cranial electrical\ 
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electrotherapy stimulation (CES), acupuncture, transcutaneous electrical nerve stimulation 
(TENS) and percutaneous electrical nerve stimulation (PENS). These neuromodulation 
techniques also work with defined protocols (frequency and current of stimulation, number 
of training sessions and duration of training). The non-pharmacological approaches in 
which brain is not physically stimulated from external stimuli rather trained/ teach to 
achieve neuro-modulation include NF, visual illusion (VI), hypnosis, cognitive behaviour 
therapy, and meditation training and practise.   
Invasive stimulation of motor cortex has shown significant improvement in chronic 
central pain 
308
, refractory NP 
309
, central deafferentation pain 
310
, CRPS 
311
, central pain 
312
, neuropathic facial pain 
312
, neuralgia 
313
 and phantom limb pain 
314
. Evidence showed 
that invasive procedure for motor cortex stimulation (MCS) relieves trigeminal NP, but 
CNP was not reduced 
315
. There was a study which proposed somatosensory cortex 
stimulation apart from motor cortex to treat deafferentation pain 
316
. Invasive MCS has 
shown promising results (75% response rate) 
312
, however, less invasive or pure non-
invasive stimulation techniques are required to provide cost effective pain treatment 
without surgical procedure.  
rTMS, a noninvasive brain stimulation technique involves stimulation of the cortex by a 
stimulating coil applied to the scalp to cause depolarization or hyperpolarization in the 
neurons of the cortex 
317–320
. Changing magnetic fields induces electric currents in the 
neurons of the targeted region 
321
. Low-frequency rTMS (< 1Hz) decreases cortical 
excitability at the site of stimulation, whereas high-frequency stimulation (> 5 Hz) 
increases cortical excitability or causes synchronization 
320
. In rTMS studies, cortical areas 
such as M1 
78,312,322–324
, S1 
325
, frontal cortex 
325,326
  and parietal cortex 
327
  are mainly 
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targeted, though  stimulation over primary motor cortex is more effective in reducing pain 
324,328–330
. The frequency of stimulation is varied from 0.2-20 Hz 
322,324
. It is believed that 
stimulation with frequencies in a range 10-20 Hz, that has the largest effect on reducing 
pain, restores the intracortical inhibition and causes increase in EEG power 
324
. Through 
lateral cortical connections between the stimulated and other cortical sites, rTMS affects 
not only the stimulation site but also other cortical areas involved in pain matrix, such as 
PFC, S1, and S2 cortical areas 
324,330
, possibly activating inhibitory circuits involved with 
pain reduction 
326
. Evidence supports the clinical efficacy of rTMS (1 Hz – 20 Hz) in 
patients with trigeminal neuralgia and post-stroke pain syndrome 
331
, CRPS 
332
, and 
fibromyalgia 
333
. Compared to placebo, active 20Hz stimulation over the M1 representing 
contralateral painful zone induced significant reduction in pain  
320,323,334
. There are three 
crossover rTMS studies (both active and sham groups) for the management of NP in SCI 
population 
335–337
. All studies reported clinically non-significant reduction of pain. 
However, in addition to improvement in quality of life, statistically significant reduction in 
average pain and worst pain has been noticed. The stimulation was applied with a 
frequency of 5-10 Hz over the cortical representation of paralyzed and painful lower limb 
in a study having only paraplegics while over the hand and leg cortical representations in 
studies with mixed SCI population (paraplegics and tetraplegics, complete and incomplete 
injury). In two other rTMS studies with heterogeneous group of pain patients 
334,338
, only a 
single SCI patient was enrolled but authors did not discuss the individual response. In 
summary, rTMS induced 25-30% reduction in pain in non-SCI patients 
319
 and 15-21% in 
SCI population 
335–337
.       
tDCS, a noninvasive brain stimulation technique, uses constant low current (<2 mA) via 
small electrodes applied to the scalp for the modulation of the brain activity 
339–342
. The 
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current induced from anodal stimulation causes a depolarization of the resting membrane 
potential, thus increases the neuronal/ cortical excitability of the area being stimulated, 
while cathodal stimulation causes hyperpolarization which decreases the neuronal 
excitability analogous to mechanisms supporting long-term potentiation (LTP) and 
depression 
343
. Increased neuronal excitability increases synchronization. The dorsolateral 
prefrontal cortex (DLPFC) and M1 have been stimulated at 1-2 mA for pain treatment 
using tDCS 
344–349
. The anodal tDCS (1 mA – 2 mA for about 20 min) compared with sham 
over the M1 corresponding to painful zone showed efficacy in patients with chronic NP 
following multiple sclerosis 
350
, refractory chronic pelvic pain 
346
, fibromyalgia pain 
351
 
344
 
347
 and other chronic pain syndromes (trigeminal neuralgia, poststroke pain syndrome, 
back pain) 
352
. There were two tDCS studies on NP in SCI population 
345,353
.  In one study, 
five sessions of active anodal tDCS (2mA) over M1 compared to sham tDCS induced 
statistically significant reduction in pain 
345
. However, the clinically significant reduction 
in pain in active group was noticed in 63% subjects (7/11) only. This reduction in pain was 
negatively correlated with the duration of pain. The other study did not find reduction in 
pain following a single session of both active anodal tDCS and sham tDCS 
353
. However, 
theta and alpha amplitude increases and gamma amplitude decreases significantly.  
Reduction in level of NP in five paraplegics has been evaluated using visual illusion in 
three modes (virtual walking, motor imagery and watching movie) in which greater and 
longer time pain reduction was observed with virtual walking mode in four out of five 
patients 
354
. Contrary to Moseley 
354
, noticeable improvement of NP was not observed in 
visual illusion group 
355
. Studies showing increased activation of ACC and right DLPFC in 
patients with NP prevents using MI for the treatment of NP 
261,356,357
.  
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The combined effect of both tDCS and visual illusion on NP in SCI population has been 
assessed in two studies 
355,358
, where reduction in pain was high in combined therapy 
compared with a single intervention. The study provided evidence that combinational 
treatment group (tDCS + visual illusion) than other three groups (tDCS alone, visual 
illusion alone and sham/placebo) reported largest and longer lasting (12 week follow-up) 
reduction in pain intensity and quality of life 
355
. In other study with combinational 
therapy, 72% (13 out of 18) patients reported clinically significant reduction in NP 
358
.  
The mechanisms of NF is not completely known, but is believed that it facilitates global 
connectivity and after a prolonged practice induces neuroplasticity 
359
. It has been 
suggested that NF can provide benefit to both NP and nociceptive pain by affecting the 
pain experience indirectly through enhanced central nervous system stability and improved 
homeostatic control 
360
. Since, the goal of NF is either to activate or suppress EEG activity; 
the mechanism is also based on selection of protocol. NF treatment of chronic pain is 
typically based on increasing dominant activity (e.g. alpha) and decreasing theta and beta 
frequency activity 
361
. It is believed that sensory-motor rhythm (SMR) enhancement 
facilitate thalamocortical inhibitory mechanisms and reduce hyperactivity 
362
. Alpha and 
theta suppression are associated with increased corticospinal excitability, increased 
excitation of sensory cortex, decreased intra cortical inhibition, cortical metabolism, 
attention, behavioural and increased neural activation of the cortex 
363–365
. Further, the 
suppression in alpha amplitude induced up-regulation of functional connectivity within the 
ACC 
366
.  
It has been reported that scalp EEG-based NF showed positive results in 95% patients 
with 19 or more NF sessions and in only 12 % (3 out of 25) patients with 11-19 NF 
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sessions 
167
. NF training has shown promising results in treating individuals with chronic 
pain of different origins but there is no single recommended protocol (frequency bands and 
scalp locations) 
353,360,361,367–369
. The early NF study on pain management found that 
occipital alpha enhancement did not reduce pain, though alpha activity was increased in 
both EC and EO modalities 
168
. SMR reinforcement, and theta and beta suppression at Cz 
and C4 following few (more than 20) sessions of NF reduced fibromyalgia pain syndrome 
140,141,370,371
. It has been reported that tailored protocols, such as enhancement of SMR and 
theta using bipolar T3-T4 and P3-P4 respectively reduced CRPS 
367
, whereas alpha reward 
reduced trigeminal neuralgia 
368
. Other protocols include alpha-theta training, bipolar Cz-
Fz, F3-F4 and F7-F8, and theta (2-7Hz) and beta inhibits training at C3, C4 and T4 sites. In 
addition to reduction in pain intensity, improvement in other symptoms, such as physical 
and psychological functioning, sleep quality, depression, anxiety and muscle tenderness 
has been reported 
140,141,367,371
. To the best of our knowledge, there is only a single scalp 
EEG NF study comparing the effect of scalp EEG feedback with the control group 
141
. The 
control group were given escitalopram and NF group received 20 sessions of SMR 
enhancement training from the C4 site for a period of four weeks. Compared to control 
group, the NF group showed largest reduction in pain and improvement in depression and 
anxiety.  
NF studies uses fMRI to provide real time feedback showed that chronic pain can be 
controlled by controlling rostral ACC activation 
150,198
. In these studies, the control groups 
compared to active group did not report reduction in pain intensity. The control groups in 
these studies either did not receive feedback, received feedback from a different brain 
region, or feedback from other person brain activity. There are two groups working on 
LORETA feedback for the management of pain. A group at University of Alberta has been 
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working on LORETA based feedback since 2006 for the treatment of chronic pain but we 
found only one news article and one magazine article 
372,373
. In these articles it was 
reported that down-regulation of activity of ACC (BA24) and PFC (BA9) reduced pain 
intensity. Another group at ―Tallahassee Neurobalance Center, Florida, USA‖ reported 
positive effects of LORETA Z-score feedback in four case studies 
374
. In that study patients 
achieved clinically significant reduction in chronic pain accompanying reduction of EEG 
power and reduced activity in IC and ACC in theta and beta frequency bands.   
Table 2.2 shows list of protocols tested for the treatment of pain with NF. The table also 
provides information about sample size and total number of sessions. 
Table 2.2: Details of NF studies for management of pain 
Feedback 
Type 
 
Protocols 
Sample 
Size 
Total 
sessions 
Reference 
Electrode/ 
Brain region 
Frequency 
bandwidth 
 Reward Inhibit 
S
ca
lp
 E
E
G
 
Oz (EO, EC) A  1 67 Gannon 1971
168
 
C4 SMR T 3 10 Kayiran 2007 
371
 
Cz, C3, C4, T3-
T4, P3-P4, Cz-Fz, 
F3-F4, F7-F8 
SMR, T, 
A/ T 
B 18 30 Jensen 2007 
367
 
C4 SMR  18 20 Kayiran 2010 
141
 
C3, C4, P3, P4, 
T3-T4 
A T, B 13 12 Jensen 2013 
142
 
T3, T4 A T 30 1 Jensen 2013
353
 
Cz SMR T, B 67 40 Caro 
140
 
fMRI ACC   4 3 Decharms 2005 150
 
LORETA BA: 9, 13, 24  T, B 4 4 
Koberda 2013 
374
 
EO: eyes open, EC: eyes closed, A: alpha, B: beta, T: theta, SMR: sensory-motor rhythm, A/T: 
alpha over theta ratio, BA: broadmann area.  
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Recently, the effect of scalp EEG NF on SCI patients with chronic pain (either 
nociceptive or NP or both) has been assessed in two studies 
142,353
. In both studies, patients 
reported clinically non-significant reduction in pain. The non-significant reduction in pain 
might be due to small number of NF sessions (12 sessions 
142
 and only 1 session 
353
) 
167
. 
However, in addition to improvement in pain symptoms, significant decrease in theta and 
significant increase in alpha amplitude has been reported 
142
. The three different protocols 
were tested: reinforce alpha and inhibit beta at T3-T4 bipolar; reinforce 10-15 Hz and 
suppress beta and theta at C3 and C4; and reinforce 10-15 Hz and suppress beta and theta 
at P3 and P4. 
Hypnosis is usually induced by a procedure known as hypnotic induction involving a 
series of preliminary instructions and suggestions, defined by ‗The Society of 
Psychological Hypnosis‘375. Hypnotic treatment for chronic pain mainly includes 
suggestions to create a comfort and relaxation by changing the pain experience or pain 
related thoughts and behaviours 
376,377
. A number of studies show that hypnosis can reduce 
the pain experience 
376–378
. Evidence supports the clinical efficacy of hypnosis in treating 
individuals having chronic pain following SCI, however, it has not been mentioned 
whether individuals had NP or other type of pain 
379–381
. In a study with four SCI patients 
receiving hypnotic treatment, two patients reported short term while two patients reported 
a long-term (1 year follow-up) positive effect 
379
. In another study using hypnosis with 
large number of population with chronic pain (13 SCI subjects), significant improvement 
in average pain intensity has been reported by a subset of patients 
380
. SCI participants 
receiving hypnosis compared to participants receiving biofeedback reported significant 
decrease in pain intensity that was maintained at 3 month follow-up 
381
. A recent hypnosis 
study (only single session) on SCI population also showed significant reduction in pain 
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following significant increase in theta and alpha amplitude and decrease in gamma 
amplitude 
353
.  
Meditation is a technique that involves internal effort (practise) to self-regulate the mind 
to promote relaxation 
382
. Meditation has shown positive outcomes on patients with chronic 
pain of different origins 
34,383,384
. It has been reported that meditation reduces pain by 
modulating brain activity in the pain-related areas (S1, S2, ACC, IC and PPC), in addition 
to, brain areas not related to pain 
34
. Recently, it has been shown that a single session of 
meditation could significantly reduce chronic pain in SCI patients 
353
. The patients also 
showed significant increase in alpha and beta bands amplitude.   
The electrical current in CES is applied as a pulse (100 µA) via clip electrodes attached to 
the earlobes. It is suggested that CES reduced pain by modulating activity of the 
hypothalamus and limbic system 
385
. CES significantly reduced pain of mixed types (NP, 
nerve root entrapment, visceral and musculoskeletal) associated with SCI (paraplegic and 
tetraplegic) 
386,387
. The short-term statistically significant reduction in pain, though 
clinically significant only in 14%, has been reported in a sham double-blinded study with 
large number of SCI population (128 subjects) with NP 
388
.  
In acupuncture, 6-12 needles are inserted at different acupoints (body location) 
389
. Also, 
electro acupuncture technique is used in which a small amount current is applied at 
acupoint or at the needle. Recently, it has been suggested acupuncture is effective for some 
but not all kinds of pain 
390
. Acupuncture has been used with good results to reduce NP 
following SCI 
391–393
. In studies 
391,393
 46% patients reported reduction in pain following 
treatment, however, 27% also reported increased pain 
393
. Moreover, Norrbrink 
391
 
compared the effect of massage therapy with acupuncture therapy and found it less 
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effective. Of the 36 SCI participants with below level NP, 24 patients reported reduction in 
pain 
392
.  
The mechanism of TENS is based on Gate theory in which large diameter afferent fibers 
are activated that overlap the area of injury and pain 
11
. There are two variants of TENS: 1) 
low-intensity (1–2 mA), high-frequency (50–100 Hz) TENS; and 2) high-intensity (15–20 
mA), low-frequency (1–5 Hz) 394. PENS is a technique involving insertion of an ultra-fine 
acupuncture needle probes into the soft tissues or muscles to electrically stimulate 
peripheral nerve fibers 
395,396
. PENS is related to both electro acupuncture and TENS 
396
. 
NP of different origins have been treated using PENS and TENS in patients with diabetes 
395
, 
397
. In SCI patients with NP, the significant reduction in pain has been reported in 38% 
patients with low frequency TENS (2-4 Hz pulse frequency) and in 29% patients received 
high frequency TENS (80 Hz pulse frequency) 
398,399
.     
The outcomes of above studies varied from patient to patient because of using different 
techniques in a heterogeneous population of patients with different origins and duration of 
NP. Some subjects achieved short term relief while others did not benefit. In the context of 
cortex stimulation techniques, the variability of results could be related to inaccurate 
positioning of stimulation electrode, stimulation parameters (frequency and site of 
stimulation), active or sham stimulation. Further, most studies did not discuss neurological 
outcomes of treatment.  
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2.3. Limitations in the Literature 
Previous brain imaging studies with SCI patients did not show a consistent change in 
brain activation patterns during motor tasks (see Section 2.1.1). The inconsistency in these 
findings may be due to the large variety of inclusion criteria, including ignorance of pain. 
Current knowledge of changes in brain activity following chronic pain in patients with SCI 
is mainly derived from fMRI studies. These studies do not provide information about 
dynamic changes in brain activity. EEG studies with SCI patients who have CNP have so 
far been limited to the analysis of relaxed states (EO and EC states). Additionally, it has 
been mentioned that  different pharmacological and non-pharmacological treatments have 
been used to manage chronic pain (see Section 2.2). These studies found that non-
pharmacological treatments compared to pharmacological treatments reduces pain with 
less side effect. NF is a non-pharmacological treatment approach that has the potential to 
reduce pain. However, there is no standard NF protocol and effect of large numbers of 
training sessions was not assessed. Furthermore, previous NF studies did not show the 
immediate global effects of NF training. Most non-invasive non-pharmacological 
treatments showed behavioural changes and few studies discussed the effects of long-term 
changes in brain activity following treatment.  
2.4. Objectives of the Study/ Research Problem 
The aim of this thesis is to address the limitations described above. This will be 
accomplished using four main objectives: (1) to detect frequency dependant CNP 
signatures in paraplegics with CNP by recording EEG in relaxed and during MI states, (2) 
to test different NF protocols for the treatment of CNP in paraplegic patients, (3) to find 
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the immediate global effect of NF training on power and coherence, and (4) to find long-
term neurological changes in pain related cortical and sub-cortical areas following long-
term NF training.  
The study outlined in this thesis is divided into three phases to achieve the four main 
objectives.  
Phase 1 (Diagnostic phase): Phase 1 of the study is intended to achieve objective 1. Here, 
scalp EEG will be used to compare frequency dependent dynamic changes in the brain 
activity of three groups: (i) paraplegic patients with CNP, (ii) paraplegics without pain, and 
(iii) able-bodied subjects.  
Phase 2 (Treatment Phase): Phase 2 of the study is intended to achieve objectives 2 and 
3. Here, NF training will be provided to seven patients, selected from the patients recruited 
for phase 1 of the study, to assess the effect of NF on CNP in paraplegics. The NF 
protocols will be designed based on the results of phase 1 in combination with 
neurostimulation techniques that mainly target the cortex to achieve neuromodulation. 
Furthermore, whole head EEG with 16 channels was also assessed during NF to find the 
immediate global effects of NF training.  
Phase 3 (Neurological Outcomes): Phase 3 of the study is intended to achieve objective 4. 
Here, whole head EEG analysis with 61 channels will be performed after the last training 
session to compare cortical and deep cortical changes before and after NF.  
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Chapter 3. Dynamic Oscillatory Signatures of Central 
Neuropathic Pain in Spinal Cord Injury 
3.1. Abstract 
Objective: To define electroencephalogram (EEG) signatures of Central Neuropathic Pain 
(CNP) in paraplegic patients.  
Methods: Three groups of ten participants took part in the study: Able bodied (AB), 
paraplegic patients with no pain (PNP) and paraplegic patients with CNP (PWP). EEG was 
recorded in the eyes open (EO) and eyes closed (EC) relaxed state and during cue-based 
motor imagery (MI) of upper and lower limbs. Power and event-related desynchronization/ 
synchronization (ERD/ERS) were analysed. 
Results: In the relaxed state, CNP is characterised by the increased power in the theta (4-8 
Hz) and alpha (8-12 Hz) band and shift of the dominant alpha frequency towards lower 
values. During motor imagery (MI), CNP is characterised with dynamic, frequency 
dependant increase of ERD over the sensory-motor and parietal cortices, not 
somatotopically restricted to painful parts of the body. 
Conclusion: Increased ERD, not restricted to MI of painful body parts, might be a 
signature of CNP. 
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3.2. Introduction 
CNP is believed to be accompanied by functional and structural changes in several 
cortical and sub-cortical structures 
239,307,400
. The cortical and sub-cortical areas show 
plastic changes include primary and secondary sensory-motor cortices, anterior cingulate 
and insular cortices, and dorsal lateral part of the frontal cortex 
261,400
. It has been 
mentioned in section 2.1.2 that the plastic changes can be observed in the form of either 
increased or decreased activation of the cortical representation of the painful and non-
painful parts of the body during motor task. The cortical plasticity can also be noticed in 
the form of expansion, invasion, and shift of the cortical representation of the body part 
perceived as being painful. Our knowledge on this interaction is mainly based on 
functional magnetic resonance imaging (fMRI) studies which can provide information 
about sub-cortical structures but could not provide frequency-dependant dynamic changes 
in the brain activity 
27,401
. Previous studies also suggested that chronic pain may be related 
to changes in brain activity measured with EEG 
46,257–260,262
.  Limitation of these studies 
was that they provided information about brain activity in a relaxed state only. However, a 
study demonstrates that dynamic oscillations of EEG are associated with empathy for pain 
402
. 
The objective of this study was to detect frequency-dependant dynamic oscillatory 
signatures of chronic pain in the brain. The objective was achieved by comparing task-
related and task-unrelated EEG activity of paraplegic patients having CNP with the EEG 
activity of able-bodied and paraplegic patients without CNP. The methods, results and 
discussion presented in this chapter are based on our published study in the journal of pain 
403
. 
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3.3. Methods 
3.3.1. Participants  
A total of 30 age-matched adult (between 18 and 55 years old) volunteers were recruited 
in three groups of 10. The three groups were: 
1. Paraplegic patients, with diagnosed below level CNP (PWP) (3F, 7M age 45.29.1) 
2. Paraplegic patients with no chronic pain (PNP) (2F, 8M age 44.48.1)  
3. Able-bodied (AB) volunteers with no chronic pain (3F, 7M age 39.110.1) 
 
Informed consent was obtained from all participants and the ethical approval was 
obtained from the University Ethical Committee for the able bodied group and from 
National Health Service ethical committee for patients‘ groups. Information of both 
patients‘ groups is shown in Table 3.1. The location on the body perceived as being painful 
is shown in Figure A.1 (Appendix). 
The neurological level of SCI was determined using the American Spinal Injury 
Association (ASIA) Impairment Classification 
14
 . All SCI patients were at least 1 year 
post injury and had a spinal lesion at or below T1 level. Inclusion criteria for patients with 
CNP was a positive diagnosis of CNP, reported a pain level ≥ 5 on the visual analog scale 
(VAS) and a treatment history of CNP for at least 6 months The general exclusion criteria 
for all three groups were a presence of any chronic (non CNP) or acute pain at the time of 
the experiment; brain injury or other known neurological impairment that would affect 
EEG interpretation or would prevent patients understanding the experimental task. 
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Table 3.1: Information about both patients groups 
 
 
Nr 
Injury 
Level ASIA 
Injury time 
(years) 
Pain 
VAS 
Pain time 
(years) Medications 
Patients with pain group (PWP) 
1 T5 A 7 7 7 Baclofen Carbamazepine Gabapentin  
2 T5/6 A 11 6 11 / 
3 T5 A 7 8 7 Pregabalin  Gabapentin 
4 L1 B 15 7 15 Gabapentin 
5 T6/T7 D 4 7 3 Pregabalin 
6 T7 B 6 8 5 / 
7 T6/7 B 25 10 24 Gabapentin 
8 T1 A 25 5 10 Pregabalin 
9 T5 A 14 5 13 Amitriptyline, Baclofen, Diazepams 
10 L1 B 5 5 4 / 
Patients with no pain group (PNP) 
1 T7 A 7    
2 T7 B 7    
3 T12 A 7    
4 L1 A 6    
5 T2 A 2    
6 T5 B 15    
7 T11 A 11    
8 T4 A 9    
9 T7 A 15    
10 T7 B 22    
ASIA: American Spinal Injuries Association, CNP: Central Neuropathic Pain, PWP: Patient 
with pain group, PNP: Patient with no pain group, VAS: Visual Analog Scale.  
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3.3.2. Recording Equipment  
A 61 channel EEG (Synamp 2, Neuroscan, USA) was used to record with electrodes 
placed according to standard 10-10 locations 
100
 using an ear-linked reference and AFz 
ground. Electrooculagram (EOG) was recorded from 3 channels around the right eye. All 
channels were sampled at 1000 Hz. Individual electrode impedance was below 5kΩ. In 
addition, electromyogram was recorded from the right and the left wrist extensor muscles 
and right shank using the bipolar inputs to the Synamp device. The purpose of 
electromyogram recording was to check for the absence of any evidence of voluntary 
movements when subjects performed MI.  
3.3.3. Experimental Study Design 
Participants were instructed not to drink coffee or alcohol on the day of the experiment. 
EEG was recorded in two paradigms: spontaneous activity and induced activity during cue-
based motor imagery. Before starting the experiment participants with pain were asked to 
fill out ‗brief pain inventory‘ 89 to establish the level and location of pain. 
3.3.4. Spontaneous EEG Recording 
Spontaneous resting EEG was recorded under the EO and EC condition in a quiet room. 
During the EO state, participants were asked to visually fixate on a small cross presented 
on a computer screen, while in EC state they had to close their eyes and relax. EEG was 
recorded for 2 min for each condition repeated 3 times, alternating between the conditions.  
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3.3.5. Cue Based Motor Imagery 
An experimental protocol that instructed participants to imagine hand or lower limb 
movements was devised using visual cues. Participants were seated at a desk, 
approximately 1.5 m in front of a computer monitor. Participants were instructed to look at 
the centre of the monitor and were instructed to respond to a sequence of visual cues. The 
cues comprised at t= -1s a readiness cue (a cross +) which remained on for 4s (Figure 3.1). 
At t=0s an initiation cue, presented as an arrow was displayed for 1.25s, pointing to the left 
←, to the right → or down ↓ and corresponding to imagination of the left hand waving 
(LH), right hand waving (RH) and tapping with both feet (F). Participants were asked to 
continue to perform real or imaginary movements until the cross disappeared from the 
screen (3s after the initiation cue appeared). In total 60 trials of each movement type were 
presented to subjects and cues were collected in randomised sequences comprising 10 trials 
with rest periods between. 
3.3.6. Data Pre-processing 
For pre-processing of spontaneous EEG, a high pass filter (IIR, 12db cut off frequency) 
was set to 1 Hz and a notch filter was applied between 48-52 Hz, to remove line noise at 50 
Hz. Filtering was applied forwards and then backwards to avoid phase shift. Signals were 
then down-sampled to 250 Hz.  EEG was visually inspected and sequences containing 
EOG artefact and other types of noise (amplitude exceeding approximately 100 V over all 
channels) were manually removed. For EO and EC state for each volunteer after noise 
removal a minimum of 3 min of data was required for data inclusion. For pre-processing 
EEG data during MI, signals were pre-processed as explained above and were then 
exported to EEGLab 
208
. Independent Component Analysis (ICA) was performed using the 
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Infomax algorithm 
210
 implemented in EEGLab for advanced noise removing purposes to 
avoid excessive EEG removal from a limited number of trials. In this way no more than 2 
(out of 60) trials had to be removed per dataset. 
Figure 3.1: Experimental setup for cue based motor imagery (MI) tasks: At t=-1 s a 
readiness cue (a cross) appeared on a computer screen, followed by a cue (an arrow) at t=0 
s. The cue stayed on the screen till t=1.25 s while the warning stayed until t=3 s. A 
volunteer was asked to perform repetitive imagination of movement from t=0 s till 
readiness cue disappeared at t=3s. Different arrows indicate motor imagery of different 
limbs. 
 
3.3.7. Analysis of Spontaneous EEG 
Data were re-referenced to an average reference. For each volunteer, a power spectral 
density (PSD) was calculated over 2 s windows overlapped for 1s using Hamming 
windows. Logarithmic PSD was calculated as 10∙log10PSD for normalisation purposes. 
The location of the dominant alpha peak was determined based on PSD. Location of a peak 
frequency was additionally confirmed by a visual inspection. A dominant peak frequency 
for each volunteer was normalised and averaged over all electrodes.  
A ‗Study‘ structure was created in EEGLab to compare on a group level between 
different conditions. ‗Groups‘ were three groups of volunteers (AB, PWP, and PNP) while 
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‗conditions‘ were EO and EC state. PSD was averaged over different frequency bands and 
compared for each electrode location between Groups and between Conditions. To 
compare between means of two variables a non-parametric permutation test 
404
 based on 
resampling was implemented in EEGLab with a significance level set to p=0.05.  A non-
parametric two-way ANOVA based on permutation analysis was also applied to compare 
between Groups and Conditions and to check for their interaction. A correction for 
multiple comparisons was performed using the False Discovery Rate (FDR) 
405
. All 
procedures were implemented in EEGlab. 
3.3.8. EEG Analysis of Motor Imagery 
Before performing the analysis, EEG data were re-referenced to the average reference.  A 
‗Study‘ structure was designed in EEGLab to allow EEG analysis on a group level. 
‗Groups‘ were PWP, PNP and AB groups and ‗Conditions‘ were motor imagery of LH, 
RH and F.   Data analysis was based on ERD/ERS phenomena 
406
.  
For calculating the ERD/ERS of each single volunteer a reference period from -1.9 to -
1.1s (before the cross) was adopted, time-frequency decomposition was performed in a 
frequency range 3-55 Hz using a sinusoidal wavelet with minimum 3 wavelet cycles per 
data window at lowest frequencies. Overlapping Hanning tappers windows were applied.  
In order to find regions of significant ERD/ERS for each condition (on a single electrode 
site), a significance level was set to p=0.05 and nonparametric bootstrapping procedure 
(N=2000 trials) 
407
 was performed, comparing ERD/ERS maps between groups. A FDR 
correction was applied to correct for multiple comparison from multiple time-frequency 
windows.  
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Scalp maps were created based on ERD/ERS averaged over certain frequency bands and 
short time windows (0.2 s). Comparison between scalp maps of different groups or 
conditions was performed based on a permutation statistics (p=0.05) as previously 
described and FDR was applied to account for comparison from multiple electrode sites.  
3.4. Results 
3.4.1. Spontaneous EEG Activity of Three Groups 
To assess the dynamic response of the motor cortex to CNP in an imagined movement 
task, we first characterised the relaxed states, using EO and EC states. The power spectral 
density in the theta and the alpha band was compared amongst each of two groups (AB 
versus PNP, AB versus PWP, PWP versus PNP) over all 61 electrode locations (Figure 
3.2). The subfigure ‗a‘ and subfigure ‗b‘ shows difference in the theta band (4-8 Hz) and 
alpha (8-12Hz) band separately in EO and in EC state. Because of multiple comparisons 
across 61 electrodes, a FDR method was used to avoid Type II error. These may lead to 
more conservative results than in previous studies which haven‘t used FDR. PNP group 
had lowest theta and alpha power in EO state, significantly lower than PWP and AB. 
Results confirmed that in EO state PWP patients had increased theta PSD compared to 
PNP group 
257,259,260,262 
(Figure 3.2a) and comparable theta PSD to AB group.  No 
difference among groups was found between theta PSDs in the EC state (Figure 3.2a). The 
intensity of the alpha PSD in PWP was comparable with the alpha PSD in AB group in 
both EO and EC state (Figure 3.2b). PWP had larger alpha PSD in EO state than in PNP 
group over most of recording sites (Figure 3.2b). However in the EC state there was no 
difference between PWP and PNP group in the parieto-occipital region (Figure 3.2b), 
76 
 
which is normally an area of largest alpha activity in the EC state. This effectively means 
that PWP group had a reduced EC/EO ratio in the parieto-occipital region. Reduced 
EC/EO ratio has already been reported in paraplegic patients with CNP and is believed to 
be an indicator of the thalamocortical network involved in CNP processing 
262
. There was 
no significant difference between groups in the beta range. In PWP, the dominant 
frequency 9.1±0.8 Hz was significantly lower compared to 10.1±0.6 Hz in the AB 
(Wilcoxson p= 0.008) and 10.4±0.9 Hz in PNP (Wilcoxson p= 0.0085). 
(a) (b) 
Figure 3.2: Comparison of PSD in relaxed state between each two groups (p=0.05) with 
FDR correction for multiple comparison. Large black dots mark electrode locations with 
statistically significant differences between groups (AB: able bodied, PWP patients with 
pain, PNP patients with no pain) in eyes open (EO) and eyes closed (EC) states. (a) Theta 
band 4-8 Hz; (b) Alpha band 8-12 Hz.  
 
3.4.2. Dynamic Activation of Sensory-Motor Cortex during Motor Imagery 
Figure 3.3 shows ERD/ERS at electrode location Cz, being of pimary somatotopic 
relevance to the leg area. PWP patients showed the most significant ERD, spreading over 
all frequency bands (being most pronounced for the movements of the feet), being 
EO 
EC 
AB vs PNP PNP vs PWP AB vs PWP 
EO 
EC 
AB vs PNP PNP vs PWP AB vs PWP 
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statistically significant larger than ERD in the other groups. This strong ERD persisted 
during motor imagery of both painful and non-painful limbs.  
 
 
Figure 3.3: ERD/ERS time frequency map at Cz site for all three groups  (AB: able 
bodied, PWP patients with pain, PNP patients with no pain) and for all three motor 
imagery (MI) tasks (RH: right hand MI, F: feet MI, LH: left hand MI. Figures far right 
show areas of statistically significant differences among three MI tasks, while figures at the 
bottom row show areas of statistically significant differences among three groups (p=0.05) 
with FDR correction for multiple comparison. At t=-1 s (dashed line), a warning cross was 
appeared. Participants were asked to start with motor imagery when a cue appeared at t=0s 
(solid line) and to continue with motor imagination until t=3 s. ERD/ERS map shows a 
time period starting at t=-2 s before the cue and ending at t=2.5 s after the cue in a 
frequency range 3-55 Hz. 
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The comparison of ERD/ ERS between each two group (AB versus PNP, AB versus 
PWP, PWP versus PNP) corresponding to Figure 3.3 is shown in Figure A.2 (Appendix). 
Also, the ERD/ ERS time-frequency maps for all three groups for all three MI tasks at C3 
(Figure A.3) and C4 (Figure A.4) sites are shown in the Appendix.  
3.4.3. CNP Leads to a Distinctive Cortical Activation 
Cortical activation during imagined movements in patients with CNP was stronger and 
spatially different from that of the other groups (AB, PNP). Figure 3.4a show ERD/ERS 
scalp maps averaged over the SMR1 band (8-12 Hz) and over a period 0.4-0.6 s after 
presentation of a cue on the computer screen, for all groups and all three tasks. As this 
latency period exceeds what would be a normal reaction time to a movement we believe 
that this period, 0.4-0.6 s after MI cue corresponds to the covert i.e. ‗mental‘ execution of 
the MI task. This period is also the time point where intensity of ERD is maximal (Figure 
3.3).   
In PWP ERD was not limited to the cortical presentations of the painful legs. They had a 
wide-spread ERD, strongest for MI of the right hand and weakest for MI of the left hand, 
with no ERS in ‗the surrounding‘ areas, (Figure 3.4a). Although shifted posteriorly, the 
ERD spatial distribution in PWP still follows the somatotopic presentation, where the 
movement of the right hand causes a strongest ERD at electrode locations placed over the 
left hemisphere, over the centro-parietal area for the feet and over the right hemisphere for 
the left hand. In contrast, AB participants and PNP both exhibited similar spatial 
distributions, central ERD accompanied with weak ERS in the areas surrounding the 
central area (a phenomenon known as ‗central ERD with surrounding ERS‘) 408 . 
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(a) 
(b) 
Figure 3.4: Comparison of ERD/ERS over whole scalp among groups and conditions. (a) 
Scalp maps of ERD/ERS in SMR1 band at 0.4-0.6 s post cue for all three groups and all 
three tasks. ERD shows areas of increased cortical activity, as compared to the period 
before motor imagery. Column far right shows areas of statistically significant differences 
(p=0.05) with FDR correction for multiple comparison among three tasks AB: able bodied, 
PWP patients with pain, PNP patients with no pain; RH: right hand, F: feet, LH: feet. (b) 
Areas of statistically significant difference between groups and tasks shown in Figure 4a 
(p=0.05) with FDR correction for multiple comparison. 
 
In contrast to relaxed state, where AB and PNP alpha PSD showed statistically significant 
difference over all cortical areas (Figure 3.2a), during MI AB had stronger responses than 
PNP for MI of the LH only (Figure 3.4). The largest difference between PWP and PNP 
patients was found for MI of the RH although areas of statistically significant difference 
existed for motor imagery of both hands and feet (Figure 3.4b column PWP versus PNP). 
While there was no statistically significant difference in the normalised alpha power in EO 
state between AB and PWP (Figure 3.2), there was a statistically significant difference in 
the SMR1 ERD during MI (Figure 3.4). Statistically significant differences between AB 
participants and PWP were found for MI of F, RH, and LH - again indicating that CNP 
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produces a widespread increased activity in the sensory-motor cortex. In AB group 
strongest ERD could be noticed in the frontal and in the occipital areas. This might be 
attributed to visual processing of the target and movement planning. Similar but weaker 
tendency can be noticed in the PNP group. In the PWP group however, ERD can be 
noticed over almost all cortical regions from which EEG was measured. A relatively 
conservative correction for multiple comparisons, which does not take into account spatial 
correlation of measured values, might explain why relatively few EEG locations show 
statistically significant difference between the groups. 
3.4.4. EEG of Patients with CNP Reveals Frequency-Specific Temporal Signatures 
MI induces dynamic cortical responses that cannot be captured using fRMI. In addition to 
showing that CNP causes a frequency specific activation pattern over several cortical 
areas, we show that this activation has a specific temporal pattern.  As an example of this, a 
response to imagined movement of the feet is shown for all three groups for theta (Figure 
3.5) SMR1 (Figure 3.6) and SMR2 (16-24 Hz) (Figure 3.7) band activities. Although 
participants repetitively imagined movement for 3s, we show first 2 s only as this captures 
the important initiation of the task.  
In the theta band (Figure 3.5) and in the period 0.2-0.4 s, all three groups exhibited ERS. 
Following this, in a period from 0.4 to 0.6 s, PWP group showed widespread ERD from the 
occipital to the frontal area until 0.8 s. In the period 0.8-1.2 s, weak ERD was noted over 
the parietal (sensory) area. In the other two groups theta ERD could not be noticed in the 
central area of the cortex. Thus theta ERD over sensory-motor cortex appears to be an 
observation only seen in patients with CNP. 
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In the SMR1 band, Figure 3.6, strongest ERD in PWP group was in a period t=0.2-0.8 s 
dominantly located posteriorly but for t>0.8 s SMR1 ERD can be noticed at the lateral 
areas of the central region only. In other two groups, distinctive ERD in the central area of 
the cortex could be noticed until t=0.8 s. In AB group ERD can also be noticed in the 
frontal and occipital area until the end of the analysed period.  PNP group had weaker ERD 
in the frontal and occipital areas compared to the other two groups, and almost no visible 
ERD after t=0.8 s. 
Finally, in the SMR2 band, (Figure 3.7) all three groups had strongest ERD in a period 
t=0.2 to 0.4 s. In a period t=0.2 to 0.6 s, ERD in PWP group can be noticed over the 
central, parietal and occipital areas but for t>0.6 s remained only at the central areas 
(Figure 3.7). ERD in the AB and PNP group is wide spread. No visible ERD can be 
noticed in the AB group after t=0.8 s while some ERD over the central area could be 
noticed for both PNP and PWP groups till the end of the analysed period. 
 
Figure 3.5: Spatio-temporal changes in ERD/ ERS of three groups in the theta band. AB: 
able-bodied, PNP: patients with no pain, PWP: patients with pain. The motor imagination 
task was a repetitive tapping of F from t=0s till t=0.3 s. 
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Figure 3.6: Spatio-temporal changes in ERD/ ERS of three groups in the SMR1 band. AB: 
able-bodied, PNP: patients with no pain, PWP: patients with pain. The motor imagination 
task was a repetitive tapping of F from t=0s till t=0.3 s. 
 
 
Figure 3.7: Spatio-temporal changes in ERD/ ERS of three groups in the SMR2 band. AB: 
able-bodied, PNP: patients with no pain, PWP: patients with pain. The motor imagination 
task was a repetitive tapping of F from t=0s till t=0.3 s. 
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3.5. Discussion  
The study provides evidence of altered spontaneous and evoked cortical activations in 
patients with CNP in the absence of peripheral nociceptive stimulation as a way to identify 
what aspect of the EEG might reflect a long lasting alteration in brain behaviour associated 
with chronic pain, thus further expanding on indicative results from fMRI studies 
87,244
. 
Spontaneous EEG Activity of Three Groups: In the relaxed EO state, PWP had higher 
alpha and theta power than PNP group. The occipital alpha power in EC state was 
comparable between PWP and PNP groups. PWP and AB group showed similar EEG 
energy levels in both the EO and EC state. PWP group also had a significantly lower 
dominant frequency in the alpha band than both AB and PNP groups. Increase in the theta 
power in presence of CNP is in accordance with previous studies 
257,259,260,262
, while 
increase in the alpha power mirrors the observation of Sarnthein et al. 
259
 on a mixed 
patient group, but disagrees with  study by Jensen et al. 
260
 who reported a decrease in the 
alpha power. PWP group had a reduced reactivity in the occipital alpha between EO and 
EC state, which in this patient group has been attributed to a thalamo-cortical dysrhythmia 
262
. The low alpha power in the PNP group confirms results of previous studies on this 
patient group 
222
. 
EEG of Three Groups during MI: During MI, PNP group had weaker ERD than the AB 
group while PWP had distinctive strong EEG signatures. PWP group had significantly 
stronger alpha ERD over multiple electrode locations compared to both AB and PNP 
group; this contrasts between group analysis of spontaneous alpha power in EO state where 
no difference was found between AB and PWP group. Taken together, this indicates that 
strong ERD in PWP group was not a simple consequence of a high alpha power in the 
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reference period but can rather be attributed to the more intensive activation of the sensory 
and motor cortex. Of interest is that PNP group had weakest alpha ERD not only over 
central cortical areas but also over the frontal, parietal and occipital areas which are 
involved in higher order cue-based movement planning. Beta band ERD in PWP group 
also had a distinctive parietal location and was of a stronger intensity than in the other two 
groups at equivalent sites. From all three groups, AB group had the shortest lasting beta 
ERD. 
 A striking characteristic of PWP group was a wide spread ERD in the theta band. Theta  
is not a EEG frequency band commonly associated with movement related ERS/ERD and 
it‘s ERSP is likely to reflect the underlying CNP condition and may therefore be a putative 
signature of this disorder in both the relaxed 
259
 and active state.  
Although in this study we were not able to separate the influence of sensory loss and pain 
in PWP group, EEG analysis between PNP and PWP group showed statistically significant 
difference in both relaxed state and during MI. This supports a novel theory of distinctive 
effect of sensory loss and of pain initiated by trauma leading to sensory loss 
409
.  
Noteworthy finding of this study is that increased ERD over the sensory-motor cortex in 
PWP group is wide spread, indicating a possibility that MI in presence of CNP equally 
affects cortical presentation of painful and non-painful limbs.  This wide spread affect 
indirectly supports the results of neuromodulation/ neurostimulation studies, which showed 
that although it is important to modulate activity of the motor cortex, it is not necessary to 
target cortical areas corresponding to the painful part of the body 
142,324,410
. 
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It should be mentioned that while this EEG study demonstrated distinctive brain activity 
in patients with CNP it could not confirm any related anatomical or functional changes. 
Therefore it is possible that different factors such medication, disuse reorganisation, 
anxiety or depression influenced brain activity recorded by EEG. A disuse reorganisation 
unrelated to CNP should be present in both PWP with PNP groups but these two groups 
had distinctive EEG responses in both relaxed state and during MI. Anxiety and depression 
might have contributed to EEG signatures of PWP group 
411
, though these patients showed 
no statistically significant difference in EEG power in a relaxed state compared to AB 
group. Antiepileptic drugs and antidepressants which were used by patients for treatment 
of CNP might have affected their relaxed state EEG, in particular in the theta band 
274,412
. 
Antidepressants increase EEG amplitude in the theta and the higher beta (>20 Hz) 
274
, 
while antiepileptic drugs are known to slow down the dominant frequency and increase the 
energy in the theta and the delta band 
412
. The antispastic drug taken by two patients 
targeted GABA receptors, and could potentially also increase energy level in the theta and 
delta band 
413
.  However evidence from the literature show that theta band power is 
reduced in patients undergoing surgery for CNP 
259
, suggesting that increased power in 
theta band is most likely related to pain, not to medications alone.  
3.6. Conclusion 
The results showed that the presence of CNP itself leads to frequency-specific EEG 
signatures that could be used to monitor CNP and inform neuromodulatory treatments of 
this type of pain.
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Chapter 4. Experimental Evaluation of Neurofeedback 
Protocols for Treatment of Central Neuropathic Pain 
following SCI 
4.1. Abstract 
Objective: This study had two main objectives: To develop and test a neurofeedback (NF) 
protocol for the treatment of central neuropathic pain (CNP) based on 
electroencephalogram (EEG) signatures of CNP and to assess the global effect of NF 
training on modulation of EEG activity and connectivity of wider cortical structures.  
Methods: Seven paraplegic patients with chronic CNP were asked to voluntarily modulate 
their brain activity provided feedback from one EEG electrode at a time. The electrode was 
located over the sensory-motor cortex. The task was to simultaneously regulate relative 
power spectral density (PSD) in three frequency bands: inhibit theta (4-8 Hz), inhibit beta 
(20-30 Hz), and reward alpha (9-12 Hz) or reward sensory-motor rhythm (SMR: 12-15 Hz) 
band. Patients were also tested for placebo effect: a) by showing a pre-recorded session 
with a feedback, and b) by providing NF from electrode location which had not previously 
been used for training. Patients learning ability to modulate the EEG PSD was analysed by 
comparing change in EEG PSD during NF with EEG PSD while practising NF without 
feedback information i.e. no GUI.   
Results: Five out of seven patients completed the study. All five patients showed a 
statistically significant reduction of pain while four patients reported a clinically significant 
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reduction of pain (>30%). NF from one electrode site was accompanied by a widespread 
modulation of PSD. The effect of training on pain intensity was strongest when patients 
modulated PSD from C4 site, reducing the power of the theta and beta band and increasing 
power of the alpha band. Patients also learned to modulate PSD without graphical user 
interface (GUI). 
Conclusion: Although NF therapy has been shown to have a potential to reduce chronic 
CNP in paraplegics, study on a larger number of patients is needed to further confirm the 
effectiveness of NF on CNP and to introduce this protocol in clinical practice. 
4.2. Introduction 
Chronic CNP in patients with spinal cord injury (SCI) is resistant to treatment 
60,414
. 
Neuroimaging studies (section 2.1.1) and results found in Chapter 3 provided evidence that 
chronic pain is associated with the plasticity in the cortex. The insufficient reduction of 
pain and intolerable side-effects with pharmacological treatments suggests to test non-
pharmacological treatments 
264
 (see section 2.2.2). The effectiveness of various non-
pharmacological treatments were discussed in a review paper; reducing pain for some 
group of patients 
264
. The inconclusive results for non-pharmacological treatments of NP 
might be due applying it with varied protocols on heterogeneous group of patients (see 
section 2.2.2). Recently, Jensen et al.
142
 found inconsistent effect of different protocols of 
NF training, but suggested to test the effect of large number of training sessions with 
different protocols.   
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NF training is based on voluntarily modulation of brain activity (discussed in section 1.8). 
There are no standard protocols (electrode sites and frequency bands) for the treatment of 
chronic pain with NF (discussed in section 2.2.2). However, the feedback is mainly 
provided from the sensory-motor cortex to decrease the activity of theta and beta frequency 
bands 
140–142
 and to increase the activity of alpha and SMR frequency bands 
140–142,367,368,371
. 
Furthermore, the immediate global effect of training on power and connectivity was not 
presented in previous NF studies. Also, past NF studies did not focus on changes in full 
spectrum PSD, changes in baseline PSD and pain intensity, patients learning ability to 
modulate brain activity without feedback, comparison of modulation of local versus distant 
sources, and suggestions for placebo training 
415
.  
The two main objectives of this study were: (1) to test the effect of different protocols on 
pain reduction in paraplegic patients with large number of training sessions, and (2) to test 
the immediate global effect of NF training on power and connectivity among different 
electrode site. Moreover, this study addresses the mentioned limitations of previous NF 
studies of pain management. 
4.3. Methods 
4.3.1. Participants 
Seven out of the 10 paraplegic patients with CNP (PWP: patients with pain) who 
participated in the diagnostic phase of the study (Phase 1) also received NF training 
(Training Phase or Phase 2) in a single-blinded manner. The numbers of NF sessions were 
set to 40 based on recommendation of past NF studies on pain management 
167
. CNP 
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produces long term changes in cortical activity and therefore long term training is required 
to potentially reverse the effect. The demographics for the seven patients are shown in 
Table 4.1. Each patient had chronic CNP rated 5 or more on Visual Analog Scale (VAS). 
Three patients had a complete injury (ASIA A) and four had an incomplete injury (ASIA 
B). During the study patients were not treated using other non-pharmacological treatments, 
however, they continued their pharmacological treatment with anticonvulsant drugs 
gabapentin or pregabalin. Four patients completed all 40 training sessions, one patient 
received only 20 training sessions (greater than minimum recommendation of 19 sessions 
167
). This patient who received 20 sessions lived outside of Glasgow and had to live in the 
hospital for the purpose of training for three weeks. This patient received NF training every 
day, while others received NF training 2 to 3 times per week. Therefore, total numbers of 
week each patient received training was depend on total number of times per week they 
received training. Patients six and seven left training after three sessions due to transport 
and family problems, though one of them reported reduction of pain. 
Table 4.1: Demographics of PWP who received NF training 
No Level of 
Injury 
Completeness 
of Injury 
ASIA 
Level 
Years 
with 
Injury/ 
Pain 
Pain 
on 
VAS 
Total  
sessions 
Total 
weeks 
Description of 
pain 
Medicaions 
1 T8 cSCI A 7/ 7 6 40 19 pricking/ es G 
2 T7 cSCI A 7/ 7 7 40 16 burning P 
3 T6/T7 iSCI B 3/ 3 6 40 19 pricking/ es P 
4 T6/T7 iSCI B 25/ 24 9/10 40 20 squeezing/ es P 
5 T8 iSCI B 11/ 11 9 20 3 burning/ es P 
6 T5/6 cSCI A 11/ 11 6 3 2 burning G 
7 T12/L1 iSCI B 33/ 4 6 3 1 tingling  P 
cSCI= complete SCI, iSCI= incomplete SCI, VAS= visual Analog Scale, ASIA= American 
Spinal Injuries Association, es= electrical sensation, G= gabapentin, P= pregabalin. 
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The exact location of perceived pain for each patient is shown in Figure 4.1. It can be 
noticed that except PWP7, all patients had pain on legs, buttocks and shank. PWP7 had 
pain on feet only. 
PWP1 PWP2 PWP3 PWP4 
PWP5 PWP6 PWP7 
Figure 4.1: Locations on the body perceived as being painful 
 
The ethical permission to conduct this study was granted by the NHS for the Greater 
Glasgow and Clyde, and NF experiments were performed at the Queens Elizabeth National 
Spinal Injuries Unit, Southern General Hospital, Glasgow, Scotland. 
4.3.2. Assessment/ Clinical Evaluation 
The self-reported pain and EEG parameters were assessed and evaluated on every training 
day under three conditions: (i) immediately before a training (Pre NF or baseline EEG) 
(used to set thresholds for the training), (ii) during each sub-session of NF training (during 
NF), and (iii) three to four minutes after the last sub-session of training (Post NF) (used to 
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assess a short-term carry-over effect). The EEG parameters that were analysed post-hoc 
included full spectrum PSD, coherence and dominant EEG frequency.  
4.3.3. Experimental Procedure 
Each daily training session lasted approximately 45 min and was split into three steps: (i) 
two min EEG recordings in both eyes open (EO) and eyes closed (EC) relaxed state (Pre 
NF) (ii) two, 3 min long sub-sessions of EC audio feedback followed by six or seven 5 min 
long sub-sessions of EO visual feedback, and (iii) two min EEG recordings in EO and EC 
relaxed state (Post NF). The purpose of EC training on every training day was to provide 
relaxation 
169
 before starting NF sessions for the treatment of CNP. 
4.3.4. Experimental Paradigm  
The experimental paradigm for a whole NF study is shown in Figure 4.2. There were four 
different experimental paradigms: (i) actual NF training, (ii) placebo test, (iii) mental Task, 
and (iv) practising NF strategy without feedback.  
 
 
Figure 4.2: Experimental Paradigm for NF training 
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i. NF Training 
There were three different experimental setups that were used to provide NF training. 
These setups are based on different numbers of EEG recording electrodes (five and sixteen 
channels) and different referencing montage (monopolar and Laplacian). These include: (i) 
monopolar five channels, (ii) monopolar sixteen channels, and (iii) laplacian five channels.  
Five EEG Channels Setup: The five channel EEG setup was tested on each day of 
training. The commonly used locations were over the primary motor cortex (C3, Cz and 
C4), visual cortex (Oz), and over the area of sensory cortex (P4 or CP4).  
Sixteen EEG Channels Setup: We have chosen location of the following 16 EEG 
channels: F3, Fz, F4, C7, C3, Cz, C4, C8, CP3, CP4, P3, Pz, P4, O1, Oz, and O2) to cover 
most of the cortex. In this way it was possible to assess the global effect of NF training on 
the other areas of the surface cortex. Scalp maps PSD and coherence between each 
electrode pair were measured. The sixteen EEG channels used for recording are shown in 
Figure 4.3. 
Laplacian Derivation: To test whether patients modulated the widespread or local EEG 
sources, we provided a feedback from laplacian derivation. The laplacian for C4 site was 
calculated from four channels (C2, C6, CP4, and FC4) using Eq (4.1). In studies which 
analyse motor control for the purpose of BCI, this derivation is often used to extract local 
‗mu‘ rhythm and to separate it from the wide-spread alpha rhythm which can be present at 
the same frequency range and at the same location as the mu rhythm 
106,107
. 
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(4.1) 
 
 
Figure 4.3: Electrode locations for sixteen channels experimental setup 
 
 
ii. Testing for a Placebo Effect of NF Training 
In this study, two different tests for a placebo effect were applied: (i) feedback from a pre-
recorded EEG, and (ii) feedback from a cortical area which is not a part of the pain matrix.  
A single-blinded placebo which was administered by showing pre-recorded PSD as a 
feedback was used to confirm whether modulation of EEG PSD during NF was an effect of 
NF training. This feedback placebo was tested only on PWP5 on the last day of training.     
The occipital region is not a part of the pain matrix. Therefore, we chose the occipital 
region for providing a NF in EO state to test  whether reduction of pain was a consequence 
of a particular NF protocol. The modulation of occipital 7-10 Hz activity with EC that was 
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a part of everyday training for the purpose of relaxation was also used to test whether 
reduction of pain was consequence of a particular NF protocol. 
iii. Mental Tasks 
A reduction of the alpha power during an active mental task (reading and mental 
arithmetic) is a well-documented phenomena 
416,417
 . The effect of these tasks should be 
opposite to the effect of the NF protocol on the alpha rhythm. Therefore, the purpose of 
comparing modulation of EEG PSD during NF with EEG PSD during mental tasks 
(reading and mathematics) was to confirm whether changes in EEG were a consequence of 
a particular NF protocol or is caused simply by a distraction. In the mental arithmetic task, 
patients were asked to subtract seven starting from 100 until reaching a minimum number 
greater than zero. This task usually took one to two min. In the reading task, patients read 
an article of their interest from a magazine for three min. Patients were tested for mental 
task on the following dates (PWP1: date36, PWP2: date25, PWP3: date09, PWP4: date09, 
PWP5: date16). 
iv. Mental NF Practise 
One of the purposes of long term NF training was to enable patients to learn the strategy 
to modulate their EEG activity in a direction that reduces pain without using feedback 
information (no GUI). Patients‘ EEG was recorded during mental practise (without 
feedback) and was compared with their EEG during actual NF to test whether patients 
modulated the PSD in same direction in both conditions.  
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4.3.5. Creating NF Protocols 
i. Electrode Positions and Frequency Bands for EC Training 
For a successful NF therapy it is necessary that trainees are relaxed. To assure that 
patients were relaxed before starting NF treatment of pain, at the beginning of each daily 
training session, patients received audio feedback training. The occipital alpha is an 
indicator of a relaxed state 
109
. Therefore, reward 7-10 Hz frequency band over the 
occipital region was chosen to achieve relaxation.  
ii. Electrode Positions and Frequency Bands for EO Training 
There is no widely accepted recommendation for selecting a brain site and a frequency 
band for pain management, therefore, consistent with other studies 
367,368
 tailored protocols 
were tested. Four different protocols were tested based on results of Chapter 3 and past 
neuroimaging studies defining the cortical areas involved in pain, past neurostimulation 
(tDCS and TMS) studies, NF studies on pain management, and correspondence with Mark 
P Jensen (Department of Rehabilitation medicine, University of Washington) 
418
, who was 
running a study on treatment of chronic pain in SCI patients 
142,419
. However, the reason for 
each frequency band and electrode location is discussed in detail in discussion (section 4.5 
under heading ‗Design of NF Protocols‘). Four frequency bands were considered, that 
corresponded to parts of the standard EEG rhythms:  theta (4-8 Hz), alpha (9-12 Hz), SMR 
(12-15 Hz) and beta (20-30 Hz). The four different protocols are listed below: 
Protocol 1: Reward SMR, inhibit theta and inhibit beta from the Cz site. 
Protocol 2: Reward alpha, inhibit theta and inhibit beta from the CP4/ P4 site. 
Protocol 3: Reward alpha, inhibit theta and inhibit beta from the C3 site. 
Protocol 4: Reward alpha, inhibit theta and inhibit beta from the C4 site. 
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Figure 4.4 shows total number of training days and sequence of training with each 
protocol. It can be noticed that apart from PWP1, other patients received feedback with 
Protocol 4 for most of training days. PWP1 received feedback with Protocol 1 for first 28 
days followed by feedback with Protocol 4 for last 12 training days. However, Protocol 3 
was also tested within session with Protocol 4 for two training days (Day 37 and Day 38). 
PWP2 initially received feedback with Protocol 1 for first 4 training days than practised to 
modulate the EEG with Protocol 3 for next three days (Day 5 to Day 7). Also, Protocol 4 
was used within session for three training days (Day3 to Day5). Following this, Protocol 4 
was used for most training days. However, Protocol 3 was again tested for two training 
days (Day 13 and Day 36) and within session with Protocol 4 for four training days. 
Protocol 2 was tested only in two training days (Day 24 and Day 25). In total, feedback 
with Protocol 4 was provided for 31 training days. PWP3 was initially tested with all four 
protocols for first 11 training days (Day 1 to Day 11); 2 to 4 training days with each 
protocol. Following 11 days, Protocol 4 was used to provide feedback for most training 
days and Protocol 3 was tested again for two training days (Day 26 and Day 35). Protocol 
2 was tested again within sessions with Protocol 4 for four training days (Day 17 to Day 
20). In total, Protocol 4 was used for 31 training days. Similar to PWP3, PWP4 was also 
tested with all four protocols for first 13 days. For the remaining training days, Protocol 3 
was used for five days and Protocol 2 was used for a single day. Altogether, PWP4 
received feedback with Protocol 4 for 31 training days. In PWP5, feedback with Protocol 4 
was provided for 14 training days out of 20 days and other protocols were used for 
remaining training days. 
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Figure 4.4: The number of sessions and sequence of training with each protocol. 
 
iii. Choosing a Feedback Parameter and Threshold Value  
As previously mentioned, a relative PSD was chosen as a feedback parameter 
121,131
. It is 
shown in Eqs (4.2) and (4.3) that the training threshold for NF was set 10% above the 
mean baseline PSD value for the reward bands, while 10% below the mean baseline PSD 
value for the inhibit bands 
121
. The threshold value was calculated for every NF training 
day due to the natural variation in the baseline EEG. Attempts were made to perform all 
NF training sessions at the same time of day, with patients were instructed not to have food 
or tea/coffee 1-2 hours prior to training. 
              (4.2) 
 
                  (4.3) 
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Where, 
Pd and Pi are mean PSD value for dominant and inhibit bands respectively 
P‘dom and P‘inhibit are threshold values for dominant and inhibit bands respectively 
 
4.3.6. Design of NF system and GUI 
A biosignal amplifier (usbamp, Guger technologies Austria), Simulink/MATLAB 2009 
(USA), and Labview 9 (USA) were used for NF training. A real-time communication 
between Simulink and Labview was achieved by using ‗Simulation interface toolkit‘ (V 
5.0).  
 EEG was processed in Simulink using purpose made software package g.RTanalyzer 
(Guger technologies, Austria). The EEG feedback parameter (relative PSD) for EO visual 
training were displayed in Labview GUI.  
EEG was recorded with 256 Hz sampling rate using a fifth order finite impulse response 
(moving average) filter. A notch filtered at 50 Hz was applied to remove the artefact 
coming for the mains. Filtering was provided within the device. The power and relative 
power was calculated for each recorded channel in five frequency bands (theta, alpha, 
SMR, beta and 2-30 Hz) with respect to 2-30 Hz band. The initial delay was 19.5ms 
(model order/ sampling frequency; 5/256) but later-on sliding window of 128 samples (0.5 
s) was updated (shifted) for every sample. For EC training system, the same NF system 
was used but the relative power was calculated only for 7-10 Hz. 
i. NF Task for Audio (EC) NF training 
For EC training, the intensity of instrumental music during NF was inversely proportional 
to the relative power of the occipital alpha. The volume of the music was lower when 
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patients‘ alpha power was above the threshold value and increased when patients‘ alpha 
was below the threshold value. Patients were instructed to relax to increase the occipital 
alpha and to decrease the volume of music. 
ii. GUI and NF Task for Visual (EO) NF Training 
Figure 4.5 shows the GUI used to provide visual NF. There were two screens, one for that 
provided feedback to the trainee (right screen) and the other that allowed the operator to set 
the feedback parameters i.e. thresholds and electrode site (left screen).  
 
Figure 4.5: Graphical User Interface for EEG real-time feedback. The left side window is 
for the operator and the right side window is for a patient.  
 
Four different protocols were tested (section 4.3.5) in which electrode locations and 
dominant bands (either alpha or SMR) were varied but inhibit bands (theta and beta) were 
the same in all protocols. Therefore, on the left screen the operator was asked to insert 
‗electrode position‘ and ‗frequency band to train‘. Furthermore, the threshold value for 
dominant and inhibit bands was inserted into the boxes ‗dominant threshold‘, ‗theta 
threshold‘ and ‗beta threshold‘ on the left screen. The LEDs were green only when 
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threshold conditions were satisfied. On the right screen, there were three bars; two lateral 
bars representing inhibit bands (left bar: theta, right bar: beta) and one central bar 
representing the reward band (centre: alpha or SMR). The height of the bar represents the 
total relative PSD, and colour (either red or green) represents the status of a trainee‘s PSD 
with respect to the threshold value. The colour of the bars was green when the threshold 
condition was satisfied and red when the threshold condition was not satisfied. Therefore, 
patients were informed that in order to achieve successful training (all three bars green) the 
level of the dominant band bar should be increased, whereas the level of the inhibit bands 
bars should be decreased. There was no special instruction provided as to how to make 
bars green, however, patients were suggested to relax as increased concentration would 
decrease the alpha and increase the beta power 
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. The patients were always presented 
with the same GUI irrespective of the experimental paradigm and training protocol. 
4.3.7. Data Processing 
i. PSD Processing for a Single Training Session 
The PSD was calculated using the Welch modified periodogram method (4 s epochs, 50% 
overlapping). For statistical analysis to compare between PSD of different conditions (Pre 
NF vs during NF, Post NF vs during NF), the following procedure is applied: the whole 
EEG recording of the chosen condition was divided into 4 s long epochs and a full 
spectrum PSD was calculated for each epoch separately. For each 1 Hz of the full spectrum 
PSD, a parametric unpaired t-test was applied between two different conditions to find 
statistically significant differences over the whole frequency spectrum. A p<0.05 was 
regarded as statistically significant. 
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For a particular frequency band, the PSD was averaged over that frequency band then a 
parametric unpaired ttest was applied between two different conditions to find statistically 
significant differences. 
ii. Baseline Pain Intensity and EEG Parameters Processing 
The linear regression analysis was performed to estimate the trend of change in baseline 
values for pain intensity and EEG parameters over all training days in Pre NF state only. 
The EEG parameters include PSD and dominant frequency at Cz, C3 and C4 sites.  
iii. Analysis of Pain Intensity During NF Training Over all Training Days  
For each patient, self-reported pain intensity was averaged during each sub-session of NF 
for each training day. A non-parametric Wilcoxon paired two tailed test was applied to find 
a statistically significant change in pain intensity between two conditions (Pre NF versus 
during NF) over all training days. Following this, the pain intensity over all training days 
was averaged separately for both Pre NF and during NF states. 
iv. Relative PSD Processing 
The relative change of PSD represents change in EEG PSD during NF compared to EEG 
PSD in Pre NF state. For each patient, PSD was averaged during each sub-session of NF 
for each training day. Following this, a relative change in PSD was calculated using Eq 
(4.4) for each training day. This relative change in PSD was calculated for all three 
frequency bands (inhibit theta, reward alpha, and inhibit beta). A Wilcoxon paired two 
tailed non-parametric test was applied to find a statistically significant change in PSD 
during NF compared to PSD in Pre NF state. Therelative change in PSD was averaged in 
two ways: (i) over consecutive ten days, and (ii) over all training days. Averaging ten days 
102 
 
means average from Day1 to Day10, Day11 to Day20 Day21 to Day30 and Day31 to 
Day40.  
 
      
              
       
     
(4.4) 
 
Where,  
i= 1, 2, 3… n (n= total number of training days) 
     = Percentage change in PSD for i
th
 training day 
      = Average PSD during all sub-sessions of NF training for i
th
 training day 
       = PSD in Pre NF training for i
th
 training day 
 
v. Dominant Frequency Processing During NF Over All Training Days 
The dominant frequency was analysed in 7-13 Hz. The reason for selecting 7-13 Hz came 
from EEG studies showing shift of dominant peak frequency towards low frequencies in 
patients with pain 
46,257–259,262
. The change in dominant frequency over all training days 
was processed in a similar way to the change in pain intensity over all training days 
(section 4.3.7, Part iii). 
vi. Processing of a Total Time Patients Followed Training Rules 
The progressive learning of patients with NF training was also assessed by calculating 
total time (percentage) each patient followed the training rules. In this study, a post-hoc 
analysis was performed to find total time patients followed training rules. Analysis was 
performed, similar to relative change in PSD (section 4.3.7, Part iv), for all three frequency 
bands of EEG over all training days. The higher the value of time percentage means more 
time a person achieved threshold condition. 
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vii. PSD and Coherence Processing for a Sixteen Channels Experimental Setup  
In a sixteen channel setup, PSD at training site during NF is first calculated for five time 
periods of two min length overlapping for one min rather than whole five min training 
period to choose the period in which each patient best followed the NF training protocols. 
The reason for choosing an optimum period was to provide a representative EEG for 
analysis of PSD spectral scalp maps.  
For coherence analysis, a representative two min period EEG was further split into four s 
long epochs. Following this, coherence among each electrode pairs (16*16) was calculated 
using Welch‘s method (0.5 s hamming window, 50% overlapping) both in Pre NF and 
during NF states. A parametric unpaired ttest was applied over each four s epoch to find 
significant change in coherence during NF compared to Pre NF for theta, alpha and beta 
frequency bands. Also, Holms-Bonnifernoi correction was applied to reduce Type II error 
dues to multiple comparisons. Following this, a difference of coherence (NF-Pre) over all 
epochs was calculated for electrode pairs showing significant change (p<0.05). 
4.4. Results 
First, the influence of each single protocol (Protocol 1 to Protocol 4) on the full PSD 
spectrum and the intensity of pain is shown for a single representative day. Following this, 
the longitudinal effect of Protocol 4, used on majority of training days, is demonstrated on: 
(a) Pain intensity, (b) PSD over the training site (C4) and adjacent central sites (Cz and 
C3), (c) dominant alpha frequency, and (d) post-hoc analysis of the time-percentage during 
which NF training rules were followed. Finally, the following phenomena were analysed: 
(a) the global effect of NF training on other sites, (b) the effect of placebo training, (c) the 
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effect of NF modulation of local versus wide-spread sources, and (d) the effect of mental 
practise effect without feedback on pain and full spectrum PSD. 
4.4.1. Immediate and Short-term Effects of Each Protocol  
The immediate and short-term effect represents the effect of NF training on full spectrum 
PSD and on self-reported pain intensity during NF (immediate) and two to four min Post 
NF (short-term) for a representative training day.  
The full PSD spectrum for a single training day was analysed: (i) to find the most 
effective training protocol for reducing pain by modulating a PSD, and (ii) to assess the 
effect of NF training in one frequency band on the rest of the PSD spectrum.  
Protocol 1: Reward SMR, and Inhibit Theta and Beta from Cz Site: This protocol was 
practised by each patient. Four patients (PWP1, PWP2, PWP3 and PWP5) did not show 
short-term change in PSD in the desired direction in any training frequency band. Patient 
PWP4 was able to modulate the PSD in the desired direction but did not report a reduction 
in pain.  
Figure 4.6 shows the ‗immediate‘ and ‗short-term‘ effects of Protocol 1 on PSD of PWP4 
on fourth training day. A statistically significant immediate increase in PSD in the reward 
SMR and inhibit beta bands is noticed, while the short-term increase of PSD is not noticed 
in either band. In the inhibit theta band, only a short-term statistically significant decrease 
in PSD is noticed. 
The effect of increase in SMR band PSD during NF is widespread to higher beta range, 
up to 22 Hz, though PSD returns back to the baseline beyond the training (Post NF).    
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Figure 4.6: ‗Immediate‘ and 
‗Short-term‘ effect of Protocol 1 
on PSD of PWP4 at Cz site.  Pre 
NF (dotted line), during NF (solid 
line) and Post NF (dashed line). 
The immediate significant change 
is shown with thick black line and 
short-term significant change is 
shown with thick grey line above 
x-axis. 
Protocol 2: Reward Alpha, and Inhibit Theta and Beta from CP4/ P4 Sites: Four of five 
patients, except PWP1, practised Protocol 2. Two patients (PWP3 and PWP4) failed to 
modulate PSD while two patients (PWP2 and PWP5) modulated the PSD in the desired 
direction and reported a reduction in pain (PWP2: 6 to 5, PWP5; 8 to 7 on VAS). The 
modulation of PSD by PWP2 was not significant while PWP5 showed significant change 
in PSD in the desired direction.  
Figure 4.7 shows ‗immediate‘ and ‗short-term‘ effects of Protocol 2 on PSD of PWP5 on 
the eighth training day. A statistically significant immediate and short-term increase in 
PSD is noticed in the reward alpha band, while this significant increase in PSD in the 
inhibit beta band is noticed in short-term only. In the inhibit theta band, a statistically 
significant decrease in PSD is noticed both in immediate and short-term. 
In Post NF state, a statistically significant increase of PSD can be noticed in smaller 
frequency bands over delta, alpha, and beta bands. 
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Figure 4.7: ‗Immediate‘ and ‗Short-
term‘ effect of Protocol 2 on PSD of 
PWP5 at P4 site. Pre NF (dotted 
line), during NF (solid line) and Post 
NF (dashed line). The immediate 
significant change is shown with a 
black thick line and short-term 
significant change is shown with 
gray thick line above the x-axis. 
 
Protocol 3: Reward Alpha, and Inhibit Theta and Inhibit Beta from C3 Site: Each patient 
practised Protocol 3 to modulate PSD in order to control pain. Two patients (PWP1 and 
PWP2) failed to modulate PSD in the desired direction in any frequency band. Although 
three patients modulated the PSD and reported a reduction in pain, the increased spasms 
did not allow patients to continue training with this protocol.  
Figure 4.8 shows ‗immediate‘ and ‗short-term‘ effects of Protocol 3 on PSD of PWP5 on 
12
th
 training day. A statistically significant increase in PSD is noticed in the inhibit theta 
and reward alpha frequency bands both in immediate and short-term, while statistically 
significant decrease in PSD is found in the inhibit beta frequency band. The increase in 
PSD can also be noticed in 2-9 Hz both in Post NF and during NF states. 
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Figure 4.8: ‗Immediate‘ and 
‗Short-term‘ effect of Protocol 3 
on PSD of PWP5 at C3 site. Pre 
NF (dotted line), during NF (solid 
line) and Post NF (dashed line). 
The immediate significant change 
is shown with a black thick line 
and short-term significant change 
is shown with gray thick line 
above the x-axis. 
 
Protocol 4: Reward alpha, and inhibit theta and beta from C4 site: Each patient practised 
this protocol to modulate the PSD in order to control pain. The reduction of pain was 
accompanied by a pleasant warm sensation over the body parts that were previously 
perceived as being painful. As each patient reported reduction of pain with this protocol, 
this protocol was used to provide feedback for the majority of training days. The PWP1 
first received training with this protocol after 25 training sessions because of testing with 
different protocols (Protocol 1 to Protocol 3) in the early stages of training. Three (PWP2, 
PWP3 and PWP4) out of five patients reported both immediate and delayed reduction of 
pain. PWP1 reported only immediate reduction of pain while PWP5 reported delayed 
reduction of pain. Figure 4.9 shows ‗immediate‘ and ‗short-term‘ effects of Protocol 4 on 
PSD of each  patient (PWP1: date28, PWP2: date30, PWP3: date27, PWP4: date10, 
PWP5: date18). 
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Figure 4.9: ‗Immediate‘ and ‗Short-term‘ effect of Protocol 4 feedback on PSD at C4 site 
of each patient (PWP1: ‗subfigure (a); PWP2: ‗subfigure (b); PWP3: ‗subfigure (c); PWP4: 
‗subfigure (d); PWP5: ‗subfigure (d)). Pre NF (dotted line), during NF (solid line) and Post 
NF (dashed line). The immediate significant change is shown with black thick line and 
short-term significant change is shown with grey thick line above the x-axis. 
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In the inhibit theta band, a statistically significant increase of PSD both in immediate and 
in short-term is noticed in two patients (PWP3 and PWP5) and only an immediate increase 
of PSD is noticed in two patients (PWP2 and PWP4), while both immediate and short-term 
decrease of PSD is noticed in PWP1 only. 
In the reward alpha band, a statistically significant increase of PSD is noticed in four 
patients (except PWP1) both in immediate and short-term, while no change of PSD is 
noticed in PWP1.  
In the inhibit beta band, both immediate and short-term change of PSD is noticed in each 
patient. Three patients (PWP1, PWP2 and PWP4) showed statistically significant increase 
of PSD, while two patients (PWP3 and PWP5) showed statistically significant decrease of 
PSD. 
In conclusion, PWP1 followed rule in the inhibit theta band only, PWP2 and PWP4 
followed rule in the reward alpha band only, and PWP3 and PWP5 followed rule in the 
reward alpha and inhibit beta bands.  
The effect of modulating PSD in a single frequency band over other frequency bands was 
patient specific. In three patients (PWP1, PWP3, PWP5) the spreading effect of increased/ 
decreased PSD in the alpha band was noticed over 2 to15 Hz band, while other two 
patients showed global increase (over all frequencies) in PSD. Furthermore, the change in 
PSD during NF was sustained beyond the training (Post NF). 
In addition to reduction of pain with Protocol 4; patients with incomplete injury often 
reported being spasm-free for the rest of the training day. A single patient (PWP3) reported 
improved dorsi-flexion of the foot, spasm-free while stretching a body at bed time, and a 
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pleasant warm sensation that lasted for some hours after training. Some patients had a 
complete SCI and could not possibly feel real changes in temperature, therefore this 
sensation was most likely been generated in the brain. As these results were mostly 
subjective, they were not investigated in a systematic way. 
4.4.2. Effect of Training on Pain intensity  
The effect of training with Protocol 4 on pain intensity is presented as: (i) change in 
baseline pain intensity, and (ii) cumulative change in pain intensity over all training days. 
i. Change in Baseline Pain Intensity  
Table 4.2 shows the clinical change in pain intensity and a linear trend in baseline pain 
intensity (slope, r and p values) for each patient when Protocol 4 was used for NF training. 
Each patient, except PWP1, shows clinically significant reduction (> 30%) in pain. 
Furthermore, the significant negative slope (from regression analysis) supports the 
observation that the baseline pain intensity is significantly reduced over the period of 
training. 
Table 4.2: Pain Intensity and trend in baseline pain intensity. The significant reduction in 
pain is shown in bold with italic. 
 Clinical Change in Pain intensity  Trend in baseline Pain Intensity 
Code First Day Last Day  Percentage Change 
in pain 
Slope 
Direction 
r-value p-value 
PWP1 6 4/5 -25 - 0.74 0.023 
PWP2 7 5 -30 - 0.66 2.5e-5 
PWP3 6 2 -67 - 0.61 0.001 
PWP4 9/10 5/6 -55 - 0.83 6.85e-8 
PWP5 9 5 -40 - 0.64 0.005 
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ii. Change in Pain Intensity Averaged over all Training days 
Table 4.3 shows the value for pain intensity in Pre NF and during NF states averaged over 
all training days. The significant value is set to p<0.05. Each patient shows statistically 
significant reduction in pain intensity. 
 
Table 4.3: Cumulative Change in Pain Intensity. A significant change is shown in bold 
with italic. A non-parametric Wilcoxon paired test was applied. 
 
Pre NF  
Mean ± SD 
NF  
Mean ± SD 
p-value  
PWP1 5.3±1.2 4.3±1.1 0.05 
PWP2 6±0.83 5±1.3 0.0004 
PWP3 5±1.6 2.4±2.8 0.0001 
PWP4 6.4±1.1 5.4±1 0.0002 
PWP5 7.9±0.7 7±1.6 0.006 
 
4.4.3. Effect of Training on PSD Modulation 
The effect of training on PSD at training site (C4), contralateral (C3) and adjacent sites 
(Cz) to the training site is presented in two ways: (i) relative change in PSD over ten 
consecutive days and over all training days, and (ii) change in baseline PSD on each day 
before NF training.  
i. Relative Change in PSD  
Averaging Over Ten Training Days: The relative change in PSD averaged over ten 
consecutive days for each patient in three frequency bands is shown in Figure 4.10. The 
positive bars represent increased PSD and negative bars showed decrease PSD during NF 
compared to Pre NF.  
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Figure 4.10: Relative change in PSD at C4 site over ten days (day1-day10; vertical lines bar, 
day11-day20; filled grey bars, 21-30; dotted bars, day 31-day40; white bars) in: (a) theta band, 
(b) alpha band, and (c) beta band for each patient. The Protocol 4 was used for training. 
Significant increase in PSD is shown with *, while significant decrease in PSD is shown with +. 
The results for PWP1 for first twenty training days are not shown because this PWP1 received 
training with Protocol 4 for last 15 training days. PWP5 received twenty training sessions only. 
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In the theta band (subfigure ‗a‘), only PWP1 showed decrease in PSD, while other 
patients showed increase in PSD over all training days. This decrease in PSD is significant 
only for last training days, while the increase in PSD is significant in two patients (PWP2 
and PWP3) for 50 % training days. 
In the alpha band (subfigure ‗b‘), only PWP1 showed decrease in PSD, while other 
patients showed increase in PSD over all training days. This increased alpha PSD is 
significant for 75% days in PWP2 and PWP3 (last thirty days) and for only 50% of days in 
PWP4 (first ten and last ten days) and PWP5 (first ten days).  
In the beta band (subfigure ‗c‘), two patients (PWP1 and PWP2) showed increase in PSD, 
while two patients (PWP3 and PWP5) showed decrease in PSD. PWP4 showed increased 
PSD for first 50% of training days, while decrease in PSD for last 50% of training days. 
The increase in PSD is significant in PWP1 and PWP4 for first ten training days, while 
decrease in PSD is significant in PWP3 for all training days. 
Averaging PSD over all training days: The relative change in PSD over all training days 
is shown for Cz, C3, and C4 sites in theta, alpha, and beta frequency bands.   
Table 4.4 shows the effect of training on a relative change in PSD (during NF - Pre NF) at 
C4 site in three frequency bands averaged over all training days. The positive numbers 
shows increase in PSD during NF, while negative numbers shows a decrease in PSD. In 
the theta band, three patients (PWP2, PWP3 and PWP4) show a statistically significant 
increase in PSD, while only PWP1 shows a significant decrease in PSD. In the alpha band, 
three patients (PWP2, PWP3 and PWP4) show a statistically significant increase in PSD. 
In the beta band, two patients (PWP1 and PWP2) show a statistically significant increase 
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in PSD, while PWP3 shows a significant decrease in PSD. In conclusion, only PWP1 
followed training rule in the theta band, two patients (PWP2 and PWP4) followed training 
rule in the alpha band, and PWP3 followed training rule in the alpha and beta bands. PWP5 
non-significantly followed training rule in the alpha and beta bands.  
Table 4.4: Relative change in PSD at training site (C4) in three frequency bands. A 
significant decrease in PSD is shown in bold and italic, while significant increase in PSD 
direction is shown in bold only. A Wilcoxon paired two tailed non-parametric test was 
applied. 
Code theta alpha beta 
 Change in PSD (%) 
Mean ± SD 
P-value Change in PSD (%) 
Mean ± SD 
P-value Change in PSD (%) 
Mean ± SD 
P-value 
PWP1 -9.3±4.9 0.02 -9±12.8 0.16 116±82 0.02 
PWP2 9±9.8 0.9e-4 9.4±15 0.4e-4 6.5±16.6 0.05 
PWP3 22±19 0.4e-3 12±13 0.8e-3 -27±19 0.1e-3 
PWP4 6.8±11 0.01 10±17 0.03 17.6±34 0.06 
PWP5 18.6±33.6 0.07 12.5±21.5 0.08 -9.5±19 0.5 
 
Table 4.5 shows the relative change in PSD (during NF - Pre NF) at C3 site in three 
frequency bands averaged over all training days. The results for PWP1 at C3 are not 
presented because C3 location was measured for three training days only. A significant 
decrease in PSD is shown by a single patient (PWP4) in the theta band and a single patient 
(PWP3) in the beta band, while a significant increase in PSD in the alpha band can be seen 
in three patients (PWP2, PWP3 and PWP4). PWP5 shows a non-significant change in PSD 
in all three frequency bands. 
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Table 4.5: Relative change in PSD at C3 site in three frequency bands. A significant 
decrease in PSD is shown in bold and italic while significant increase in PSD shown in 
bold only (Wilcoxon paired two tailed non-parametric test). 
 theta alpha beta 
Code Change in PSD (%) 
Mean ± SD 
P-value Change in PSD (%) 
Mean ± SD 
P-value Change in PSD (%) 
Mean ± SD 
P-value 
PWP1 NA NA NA NA NA NA 
PWP2 -18±19.8 0.09 79.6±60.4 0.03 10±16.6 0.22 
PWP3 -2.3±28 0.85 116±47.7 0.5e-3 -28.2±21 0.003 
PWP4 -28.8±9.5 0.2e-3 30.4±9.5 0.2e-3 1.9±18.5 0.74 
PWP5 -13.9±48.4 0.11 5.6±26.9 0.62 -13.4±26.8 0.18 
 
Table 4.6 shows the relative change in PSD (during NF - Pre NF) at Cz site averaged over 
all training days. A significant decrease in PSD is shown in bold and italic while 
significant increase in PSD shown in bold only. A significant increase in PSD is shown by 
two patients (PWP2 and PWP3) in the theta band and a single patient in the alpha (PWP4) 
and beta (PWP1) bands, while a significant decrease in PSD is observed in PWP3 in the 
beta band. PWP5 shows a non-significant change in PSD in all three frequency bands. 
Table 4.6: Relative change in PSD at Cz site in three frequency bands. A significant 
decrease in PSD is shown in bold and italic while significant increase in PSD shown in 
bold only (Wilcoxon paired two tailed non-parametric test). 
 
theta alpha beta 
Code  Change in PSD (%) 
Mean ± SD 
P-value Change in PSD (%) 
Mean ± SD 
P-value Change in PSD (%) 
Mean ± SD 
P-value 
PWP1 -2.8±4.2 0.08 -2.7±9.2 0.7 59±44 0.02 
PWP2 10.6±10 0.4e-4 0.9±12.5 0.7 7.2±16.7 0.06 
PWP3 20.4±24 0.2e-3 6.2±13.8 0.7 -23.4±19 0.9e-4 
PWP4 6.8±11 0.01 12.5±21 0.03 9.3±26 0.12 
PWP5 25±58 0.07 -1±21 0.7 -1.7±28 0.76 
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ii. Change in Baseline PSD before NF Training 
Table 4.7 shows slope direction, r and p values for change in baseline PSD at C4 site in 
Pre NF state only. A statistically significant decrease in baseline PSD is observed only in 
PWP1 in the theta band, while statistically increase in baseline PSD is noticed in two 
patients (PWP1: beta band, PWP2: alpha band). In conclusion, a statistically significant 
change in baseline PSD in the direction of training protocol (expected direction) is noticed 
in two patients (PWP1: theta decreased, PWP2: alpha increased), while a significant 
change in unexpected direction is noticed in PWP1 in the band only.   
Table 4.8 shows slope direction, r and p values for change in baseline PSD at C3 site in 
Pre NF state only. Neither patient shows statistically significant change in slope direction. 
Table 4.9 shows slope direction, r and p values for change in baseline PSD at Cz site in Pre 
NF state only. A statistically significant increase in baseline PSD is noticed in three 
patients (PWP1: beta, PWP2: alpha, PWP4: alpha), while significant decrease in baseline 
PSD is noticed in PWP1 only in the theta band. 
Table 4.7: Shift in baseline PSD at C4 site. A statistically significant decrease in slope 
direction is shown in bold and italic, while a significant increase in slope direction is 
shown in bold only. 
 theta alpha beta 
Code slope r p slope r p slope r p 
PWP1 - 0.64 0.009 - 0.15 0.3 + 0.55 0.02 
PWP2 - 0.01 0.56 + 0.16 0.02 + 0.014 0.57 
PWP3 + 0.003 0.78 - 0.2 0.12 - 0.14 0.27 
PWP4 + 0.02 0.46 + 0.13 0.06 + 0.216 0.15 
PWP5 + 0.06 0.36 - 0.009 0.71 - 0.083 0.26 
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Table 4.8: Shift in baseline PSD at C3 site.  
 theta alpha beta 
Code slope r p slope r p slope r p 
PWP1 NA NA NA NA NA NA NA NA NA 
PWP2 - 0.43 0.28 - 0.34 0.4 + 0.02 0.76 
PWP3 - 0.05 0.86 - 0.27 0.3 + 0.0002 0.92 
PWP4 + 0.2 0.4 + 0.06 0.28 + 0.004 0.99 
PWP5 + 0.2 0.4 - 0.28 0.3 - 0.02 0.95 
 
Table 4.9: Shift in baseline PSD at Cz site. A statistically significant decrease in slope 
direction is shown in bold and italic while significant increase in slope direction is shown 
in bold only. 
 theta alpha beta 
Code slope r p slope r p slope r p 
PWP1 - 0.7 0.03 - 0.09 0.8 + 0.8 0.01 
PWP2 - 0.13 0.5 + 0.4 0.03 + 0.12 0.5 
PWP3 + 0.05 0.8 - 0.2 0.1 + 0.0004 0.9 
PWP4 + 0.08 0.6 + 0.79 0.009 + 0.42 0.13 
PWP5 + 0.37 0.2 - 0.5 0.07 - 0.04 0.86 
 
4.4.4. Effect of Training on Dominant Frequency  
The effect of training on dominant frequency at training site (C4), contralateral (C3) and 
adjacent to the training sites (Cz) is presented in three ways: (i) change in dominant 
frequency over all training days, (ii) immediate and short-term effect of training on 
dominant frequency, and (iii) changes in baseline dominant frequency on each day before 
NF training. 
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i. Change in Dominant Frequency over all Training Days 
Table 4.10 shows change in dominant frequency over all training days. Only PWP5 
shows significant increase in dominant frequency at C3 and C4 sites. Three patients 
(PWP1, PWP2 and PWP4) show non-significant increase in dominant peak frequency. 
PWP3 shows non-significant decrease in dominant frequency. 
ii. Immediate and Short-Term Effect of Training on Dominant Frequency 
Figure 4.11 shows immediate and short-term change in dominant frequency of PWP5 at 
training (C4) site. The figure represents PSD in three states (Pre NF, During NF and Post 
NF). The patient shows shift in dominant frequency towards higher frequency during NF 
(immediate effect) which was sustained in Post NF state (short-term effect), though not to 
the same level as during NF. 
Table 4.10: Change in dominant frequency over all training days at Cz, C3 and C4 sites. A 
significant decrease in dominant frequency is shown in bold and italic, while significant 
increase is shown in bold only (Wilcoxon paired non-parametric test). 
Code C3 Cz C4 
 Dominant Frequency (Hz)  Dominant Frequency (Hz)  Dominant Frequency (Hz)  
 Pre NF 
mean ± SD 
NF     
mean ± SD 
p-value Pre NF 
mean±SD 
NF 
mean±SD 
p-value Pre NF 
mean±SD 
NF 
mean±SD 
p-value 
PWP1 NA NA NA 8.2±0.76 8.5±0.45 0.12 8.7±0.24 8.82±0.13 0.26 
PWP2 7.5±0.4 7.6±0.4 0.44 7.64±0.59 7.47±0.29 0.14 7.6±0.15 7.6±0.32 0.78 
PWP3 8.19±0.5 8±0.32 0.06 8±0.67 7.6±0.37 0.061 8.3±0.94 7.8±0.43 0.13 
PWP4 9.64±1.08 9.63±0.54 0.71 9.24±1.12 9.4±0.5 0.21 9.57±1.14 9.83±0.44 0.13 
PWP5 9.42±0.58 10±0.3 0.0008 9.4±0.35 9.3±0.71 0.75 9.65±0.62 10.13±0.3 0.004 
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Figure 4.11: Full spectrum PSD 
showing change in dominant 
frequency in three states: Pre NF 
(Dashed line), During NF (solid line) 
and Post NF (Dotted line). This PSD 
spectrum is of PWP5. 
iii. Change in baseline dominant frequency  
Table 4.11 shows slope direction, r and p values for change in baseline dominant 
frequency at three sites in Pre NF state only. Each patient shows non-significant positive 
slope for dominant frequency calculated at C4 site. 
Table 4.11: Shift in baseline dominant frequency at Cz, C3 and C4 sites. 
 C3 Cz C4 
Code slope r p slope r p slope r p 
PWP1    - 0.01 0.8 + 0.03 0.63 
PWP2 + 0.01 0.84 + 0.1 0.21 + 0.001 0.97 
PWP3 - 0.05 0.41 - 0.02 0.53 + 0.003 0.93 
PWP4 - 0.04 0.43 + 0.11 0.86 + 0.04 0.33 
PWP5 + 0.01 0.79 + 0.07 0.29 + 0.003 0.95 
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4.4.5. Effect of Training on Total Time Patients Achieved Threshold   
Table 4.12 shows percentage of time patients followed the rule (during NF - Pre NF) over 
all training days.  A significant increase in time-percentage can be seen for all patients 
except PWP5. Patients showed a significant increase in time following training rules is in 
the same frequency band in which PSD was significantly modulated in the desired 
direction. 
Table 4.12: Relative change in total time (percentage) patients‘ followed the training rules. 
A significant decrease in percentage of time patients following the rules is shown in bold 
and italic, while significant increase is shown in bold only (Wilcoxon paired two tailed 
non-parametric test).    
 theta alpha beta 
 Change in time-
percentage (%) 
Mean ± SD 
P-value Change in time-
percentage (%) 
Mean ± SD 
P-value Change in time-
percentage (%) 
Mean ± SD 
P-value 
PWP1 10±7.8 0.03 -10±15.3 0.11 -44.5±23.3 0.03 
PWP2 -9.6±15.8 0.5e-3 16.3±28.6 0.3e-3 -5.6±18.2 0.1 
PWP3 -23.5±17 0.1e-3 4±26 0.2 45±24.5 0.5e-4 
PWP4 -6.5±11.6 0.01 12.5±22.8 0.052 -16.6±20.6 0.002 
PWP5 -17.3±29 0.07 12.8±26 0.2 15.1±28 0.13 
 
4.4.6. Global Effect of Training  
The global effect represents the effect of training with Protocol 4 on PSD and coherence 
over whole head when a sixteen channels experimental protocol was used for NF training. 
i. Global Change in PSD 
The PSD scalp maps in Pre NF and during NF states for each patient in three frequency 
bands are shown in Figure 4.12.  
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The global effect of training on PSD in the inhibit theta band is shown in Figure 4.12 (a). 
It can be noticed that apart from PWP1 and PWP3, other patients did not regulate theta 
band PSD in the desired direction (reduce theta) at C4 site. However, a global reduction in 
frontal theta PSD can be seen for all patients. 
The global effect of training on PSD in the reward alpha band is shown in Figure 4.12 (b). 
The alpha power is increased in four out of the five patients at the C4 site but the global 
increase in power is noticed in all patients including PWP1 who showed reduced alpha 
power at training site. Furthermore, the increased alpha power is more prominent at the 
adjacent sites of the training site. In two patients, the maximum power is shifted to the 
central region from the frontal (PWP5) and parietal (PWP3) cortices. 
The global effect of training on PSD in the inhibit beta band is shown in Figure 4.12 (c). 
The PSD in beta band at C4 site is increased in PWP1 and PWP3, while decreased in other 
patients. The increased beta band PSD in PWP1 is global; mainly in the frontal region 
which might be due to increased concentration 
109
. For the other four patients, the frontal 
beta ipsilateral to the training site is decreased. 
ii. Global Change in Coherence among Each Pair of Channels 
For each patient, electrode pairs showing statistically significant difference of coherence 
between two states (NF-Pre NF) in three frequency bands (theta, alpha, and beta bands) are 
presented in Figure 4.13.  
The global effect of training on coherence in the inhibit theta band is shown in Figure 
4.13 (a). A statistically significant decrease in coherence is noticed in three patients 
(PWP3, PWP4 and PWP5), while increase in coherence is found in PWP1 only. The 
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decrease in coherence is global in PWP3. For PWP4, a reduced coherence is noticed 
between temporal and frontal region. For PWP5 reduced coherence is noticed among 
occipital sites. In PWP1, Pz and P3 sites show increased coherence with Fz site. 
The global effect of training on coherence in the reward alpha band is shown in Figure 
4.13 (b). Increased coherence is noticed between the occipital and other regions of the 
brain for PWP1 and PWP4. For PWP5 decreased coherence is noticed between the 
occipital and parietal region and increased coherence between Cz site and the frontal 
region of the brain. 
The global effect of training on coherence in the inhibit beta band is shown in (Figure 
4.13 (c)). The coherence between the central and frontal regions is increased in three 
patients (PWP1, PWP3 and PWP5), and decreased in other two patients (PWP2 and 
PWP4). The coherence among posterior region, and between posterior and frontal regions 
is decreased in three patients (PWP2, PWP4 and PWP5), while increased in PWP1. 
In conclusion, the frontal and occipital areas showed the largest change in coherence with 
other regions of the brain in all frequency bands; mainly in the beta band. The direction of 
change in coherence was not consistent in each patient for each frequency band. 
Furthermore, the change in coherence was independent of change in PSD. This global 
change in coherence may cause reduction of pain intensity. 
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Figure 4.12: Immediate global effect of NF training on PSD (16 channels). PSD scalp 
maps in in three frequency bands: (a) theta, (b) alpha, and (c) beta bands. For each 
subfigure, first row represents PSD scalp maps in Pre NF and second row represents PSD 
scalp maps during NF state for each patient (PWP1; column 1, PWP2; column 2, PWP3; 
column 3, PWP4; column 4, PWP5; column 5). For each patient, a scale bar is shown on 
the right side of the scalp map for each frequency band. 
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(a) Theta band 
 
(b) Alpha band 
 
(c) Beta band 
 
Figure 4.13: Immediate global effect of NF training on coherence. Scalp maps showing 
statistically significant (corrected for multiple comparison) change in coherence among 16 
scalp sites during NF compared to Pre NF (NF-Pre) for each patient in three frequency 
bands. Solid lines show increase in coherence value and dotted lines show decrease 
coherence during NF compared to Pre NF. The thickness of line shows strength of change 
in coherence (thin line: 0 to 0.1, medium line: 0.1 to 0.2, thick line: 0.2 to onwards). 
4.4.7. NF Modulation of Wide Spread and/ or Local Sources 
To find whether patients modulate local activity or widespread sources, EEG PSD with 
Protocol 4 (monopolar derivation) feedback was compared with EEG PSD of laplacian 
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derivation feedback. Figure 4.14 shows PSD of each patient at C4 site in Pre NF and 
during NF states for both Protocol 4 and laplacian montage feedback performed on the 
same training day.   
It can be noticed from Figure 4.14 that four patients modulated both widespread and local 
alpha activity while PWP3 modulated only widespread alpha. In the theta band, three 
patients (PWP2, PWP4 and PWP5) modulated only local theta, PWP1 modulated only 
widespread theta, and PWP3 modulated both local and widespread theta activity. Each 
patient, except PWP2, modulated both local and widespread beta sources. 
4.4.8. Comparing PSD between NF and Mental Task 
Table 4.13 compares change in PSD in alpha band during three states (NF, reading and 
math tasks) with respect to Pre NF state on the same training day.  
Each patient shows increased PSD during NF and decreased PSD during the mental task 
compared to PSD in Pre NF state. The increased PSD during NF is significant in four 
patients (except PWP1), while the decreased PSD during the mental tasks is significant in 
three patients (PWP2, PWP3 and PWP4). 
Figure 4.15 compares the effect of actual NF training with mental task in PWP3 (reading 
task; subfigure ‗a‘) and PWP4 (math task; subfigure ‗b‘). Compared to Pre NF, the PSD 
during NF in the alpha band is increased while PSD during the mental tasks (reading/ 
maths) reading is decreased. The decreased PSD during mental tasks in the alpha band 
indicates that increased PSD during NF is not by chance but an effect of voluntarily 
modulation of brain waves. 
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Figure 4.14: Comparison of PSD modulation in laplacian and monopolar derivatives  with 
feedback from the C4 site. PSDs during NF is shown with solid lines (black line: 
monopolar, grey line: laplacian) and PSD in Pre NF is shown with dotted lines (black line: 
monopolar, grey line: laplacian). The subfigure ‗a‘ is for PWP1, subfigure ‗b‘ is for PWP2, 
subfigure ‗c‘ is for PWP3, subfigure‗d‘ is for PWP4 and subfigure ‗e‘ is for PWP5. The 
significant change in PSD with Protocol 4 is shown with thick black line and significant 
change in PSD with Laplacian feedback is shown with grey thick line above x-axis. 
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Table 4.13: Percentage change in PSD during NF, reading and math tasks compared to 
PSD in Pre NF. A statistically significant decrease in PSD is shown in bold and italic, 
while increase in PSD is shown in bold only. A parametric unpaired ttest was applied. 
 Actual NF  
(Change in PSD) 
Reading Task  
(Change in PSD) 
Math Task 
 (Change in PSD) 
 Mean (%) P-value Mean (%) P-value Mean (%) P-value 
PWP1 12 0.3 -10 0.3 -15 0.2 
PWP2 18 0.05 -11 0.2 -34 0.02 
PWP3 32 0.02 -16 0.03 -36 0.001 
PWP4 23 0.01 -13 0.5 -61 1e
-9
 
PWP5 37 0.03 -5 0.8 14 0.3 
 
  
Figure 4.15: Comparison of modulation of PSD during NF and in mental tasks with 
respect to PSD in Pre NF state at C4 site. PSD during NF is shown with solid line, PSD in 
Pre NF is shown with dotted line, and PSD during mental task is shown with dashed line. 
(a) PSD of PWP3 during reading, (b) PSD of PWP4 during math task.  
 
4.4.9. Effect of Placebo NF on Pain and EEG  
Pre-recorded EEG Placebo: Figure 4.16 shows PSD of PWP5 in Pre NF (dotted line), 
during NF (solid line) and during feedback from Pre-recorded EEG or placebo (dashed 
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line).  The PSD in the reward alpha and inhibit beta band is significantly changed in 
opposite direction during NF and placebo. 
 Figure 4.16: Change in EEG PSD 
during placebo feedback of pre-
recorded EEG. PSD of PWP5 in Pre 
NF (dotted line), during NF (solid 
line) and placebo (dashed line). A 
significant change in PSD between 
NF and Pre NF states is shown with 
thick black line and significant 
change in PSD between placebo and 
Pre NF states is shown with thick 
grey thick line above x-axis. 
 
Feedback from Occipital site in EO state: Figure 4.17 (a) shows PSD of PWP4 at 
electrode location Oz and C4 while receiving a visual feedback from Oz site as a placebo. 
It was mentioned in sections 4.4.1 and 4.4.3 that the main NF strategy of PWP4 was  to 
modulate reward alpha, therefore, we will discuss only reward alpha band. During placebo 
training, PSD at C4 site in the alpha band was not changed while PSD at Oz (placebo 
feedback site) site was significantly decreased. This shows that feedback from the 
untrained site i.e. Oz site makes it hard for a patient to modulate the PSD in the desired 
direction. 
Figure 4.17 (b) shows PSD at C4 site while using Protocol 4 as a feedback immediately 
after the placebo feedback from Oz site. The PSD is globally increased during NF 
compared to PSD in Pre NF. This shows that that change in EEG during NF is a 
consequence of patients learning strategy to modify or modulate brainwaves from C4 site. 
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Figure 4.17: Placebo effect with feedback in EO state from the occipital site. For subfigure 
(a): solid lines show PSD during NF (gray line: C4 PSD, black line: Oz PSD) and dotted 
lines show PSD in Pre NF (gray line: C4 PSD, black line: Oz PSD). The significant change 
between Oz PSD is shown with black rectangle and significant change in C4 PSD is shown 
with grey rectangle. For subfigure (b): dotted line shows PSD in Pre NF and solid line 
shows PSD during NF with Protocol 4 immediately after placebo test. 
 
Effect of Feedback in EC state from Occipital site: Figure 4.18 shows PSD scalp maps in 
Pre NF and during NF for sixteen channels experimental setup when patients received 
occipital 7-10 Hz activity as a feedback in EC state. During NF PSD is increased both at 
training site (occipital) and at C4 site, patient did not report reduction in pain. 
 
Figure 4.18: PSD scalp maps 
showing effect of placebo with 
feedback in EC state from 
occipital site in 7-10 Hz frequency 
band.  
Effect of Protocol 1 on EEG PSD and Pain: As stated in section 4.4.1, a single patient 
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not report reduction in pain. This supports the finding that the reduction of pain following 
modulation of PSD with Protocol 4 might be an effect of training. 
4.4.10. Learned Mental Strategy to Control Pain  
Figure 4.19 shows PSD in Pre NF, during NF and during mental practise of NF (no 
feedback) for four patients at C4 site.  
  
  
Figure 4.19: Comparison of modulation of PSD during NF and without feedback with 
PSD in Pre NF state at C4 site. PSD is shown in three states: Pre NF (dotted line), during 
NF (solid line) and during mental practise (dashed line). (a) PWP2, (b) PWP3, (c) PWP4 
and (d) PWP5. The significant change in PSD between NF and Pre NF states is shown with 
black thick line while significant change in PSD between mental practise and Pre NF is 
shown with grey thick line above the x-axis on each subfigure. 
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The analysis of whole PSD spectrum (Figure 4.19) shows that modulation of PSD without 
feedback is in the same direction and in the same frequency as during NF. The 
accompanying change in pain intensity in three states (Pre NF/ during NF/ Practising NF) 
is: (PWP2: 5/4/5, PWP3: 6/3/3, PWP4: 5/5/4, PWP5: 7/6/6). However, after several weeks 
patients self-reported a loss of this ability, indicating that they would benefit from 
occasional repeated NF treatment. 
4.4.11. Learning Curve of NF Training 
Figure 4.20 shows time-course of Power in Post NF state for all training days with 
Protocol 4 starting with a baseline power recorded on the first session when Protocol 4 was 
used. A non-parametric Wilcoxon unpaired test was used to compare EEG PSD in Post NF 
with the baseline EEG PSD, recorded on the first session. 
In the theta band, the reduction in EEG PSD in Post NF state with respect to the baseline 
PSD was noticed in PWP1 only for all sessions but this reduction in PSD was non-
significant. In other patients, the change in PSD was not consistent (increased for some 
sessions while decreased for other sessions). 
In the alpha band, PSD in Post NF state as compared to the baseline PSD (First sessions 
with Protocol 4) was non-significantly increased in all patients except PWP1. 
In the beta band, two patients (PWP3 and PWP5) showed decreased PSD in Post NF 
states compared to PSD in baseline, while other patients showed increase in PSD. This 
increases/ decreases in PSD were non-significant. 
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Figure 4.20: Time-course of Post NF power together with resting baseline for theta, alpha, 
and beta bands with Protocol 4 feedback. 
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4.4.12. Subjective Response of Each Patient with Each Protocol 
PWP1 had complete injury (ASIA A) and pain in the lower limbs. Pain was developed in 
the same year when patient was injured; 7 years before receiving NF training. While 
receiving feedback with Protocol 1, this patient failed to modulate the EEG PSD, hence did 
not report reduction of pain. However, improved sleep was reported by this patient. With 
feedback from Protocol 4, this patient reported clinically non-significant reduction of pain 
(Table 4.3) following reduction of theta power. No side effect of the training was reported 
with any training protocol. This patient was tested neither for the placebo nor for the 
mental practising NF (without GUI). However, modulation of EEG PSD in EC state at the 
training site (Oz) and over the primary motor cortex (Cz, C3, and C4 sites) without 
reduction of pain demonstrate that reduction of pain with Protocol 4 might be real..      
PWP2, similar to PWP1, had a complete injury and pain for seven years before receiving 
first NF training. This patient did not follow training rule while receiving feedback with 
Protocol 1 and Protocol 3, while reported reduction of pain following modulation of EEG 
with feedback using Protocol 2 and Protocol 4. However, large reduction of pain was 
reported with Protocol 4. In addition to reduction of pain, pleasant warmth sensation was 
reported over the body parts perceived as being painful; mainly on the feet. This patient 
was not tested for the placebo effect but reported smaller reduction of pain with Protocol 2 
compared to Protocol 4. Also, modulation of EEG PSD in EC state at the training site (Oz) 
and over the primary motor cortex (Cz, C3, and C4 sites) without reduction of pain 
demonstrate that reduction of pain with Protocol 4 might be real. The patient modulated 
the PSD in the similar direction during NF and while practising NF (without GUI). This 
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demonstrates that patient learned the mental strategy to modulate the EEG PSD to control 
pain.  
PWP3 had incomplete injury (ASIA B) and pain over the last three years. This patient did 
not follow training rule with Protocols 1 and 2, while modulated the EEG PSD with 
Protocols 3 and 4. The reduction of pain was reported with both protocols but strong 
spasms with Protocol 3 did not allow the patient to continue training with this protocol. 
With Protocol 4, patient reported improved dorsi-flexion of the foot, spasm-free while 
stretching a body at bed time, and pleasant warmth sensation that lasted for some hours 
after training. This patient was also not tested for placebo effect but modulation of EEG 
PSD in EC state at the training site (Oz) and over the primary motor cortex (Cz, C3, and 
C4 sites) without reduction of pain demonstrate that reduction of pain with Protocol 4 
might be real.  
PWP4 had incomplete injury (ASIA B) and pain over the past 24 years. This patient did 
not follow training rule with feedback from Protocol 2, while modulated the EEG PSD 
with Protocols 1, 3 and 4. The pain was not reduced with Protocol 1 but patient reported 
improved sleep. Pain intensity was reduced with Protocol 3 but strong spasm was noticed. 
However, pleasant warmth sensation was reported followed by reduction of pain with 
Protocol 4. Furthermore, patient reported being spasms-free for the rest of the training day. 
This patient was tested for the placebo effect in which feedback was provided in EO state 
from the occipital site. It was noticed that patient failed to modulate the EEG PSD in the 
desired direction at the training site (Oz) and at the C4 site. However, immediately after 
the placebo test patient successfully modulated the EEG in the required direction with 
feedback from Protocol 4. This demonstrates that patient learned the strategy to modulate 
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the EEG PSD with Protocol 4 (C4 site). This was further confirmed while patient was 
asked to modulate the EEG PSD without feedback information (no GUI). Furthermore, 
modulation of EEG PSD in EC state at the training site (Oz) and over the primary motor 
cortex (Cz, C3, and C4 sites) without reduction of pain demonstrate that reduction of pain 
with Protocol 4 might be real. 
PWP5 had incomplete injury (ASIA B) and pain over the past 11 years. This patient did 
not follow training rule with feedback from Protocol 1, while modulated the EEG PSD 
with Protocols 2, 3 and 4. The reduction of pain was reported with each protocol but strong 
spasms were also noticed with Protocol 3. The reduction of pain was largest with Protocol 
4. Also, patient reported spasm-free and pleasant warmth sensation over the body parts 
perceived as being painful. During pre-recorded EEG placebo, EEG of this patient was 
changed in the opposite direction as compared to EEG during NF. Patient learned the 
mental strategy to modulate the EEG PSD in the desired direction without feedback 
information (no GUI). Furthermore, modulation of EEG PSD in EC state at the training 
site (Oz) and over the primary motor cortex (Cz, C3, and C4 sites) without reduction of 
pain demonstrate that reduction of pain with Protocol 4 might be real. 
4.5. Discussion  
The two main objectives of the Phase 2 of the study were to test different NF protocols 
for the treatment of CNP in paraplegics, and to find the immediate global (topographically) 
effect of a NF training on PSD and coherence among each channel. The NF protocols were 
created based on the results of the study reported in Chapter 3, past neuroimaging studies 
defining the cortical areas involved in pain, and NF and neurostimulation studies for the 
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management of pain 
243,248,249,346,368
. The modulation of PSD followed by a clinically and 
statistically significant reduction in pain showed that frequency dependent EEG based 
CNP signatures can be used to develop NF protocols (section 4.4.2, Table 4.2, and Table 
4.3), although a study on the larger number of patients is required to further confirm the 
efficacy of NF training for the treatment of CNP. 
Design of NF Protocols (section 4.3.5 Part ii): The rationale for both inhibit bands (theta 
and beta) came from results of Chapter 3 and from results of past neuroimaging studies 
showing theta and beta band overactivation in patients with chronic pain 
257–260
. The theta 
and beta bands were also chosen as inhibit bands in previous NF studies on pain 
management 
140–142
. The SMR reinforcement was chosen on the basis of pain management 
studies using NF 
140,141,367,371
. The neuroimaging studies and results of Chapter 3 showed 
that a dominant alpha peak is shifted towards lower frequencies in patients with pain 
compared to those of able-bodied and SCI patients without pain 
46,257–259,262
. Therefore, for 
the reward band we chose a slightly narrower the alpha band (9-12 Hz) without lowest 
frequencies, in order to shift the dominant alpha peak frequency towards the higher 
frequencies. The alpha reward band was chosen in two published NF studies for chronic 
pain management 
142,368
.  
A NF in this study was provided from the central (C3, Cz and C4), parietal (P4) and 
centro-parietal (CP4) areas, though C4 site was used for most of training days. These 
electrodes are located over the primary sensory and the primary motor cortex. Sensory 
cortex is a part of a pain matrix recognised in the literature 
27
. The primary sensory-motor 
cortex was chosen based on: (i) neuroimaging studies showing the overactivation of M1 in 
CNP
17,18
, (ii) results of Chapter 3 showing stronger ERD during MI in PWP over the 
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sensory-motor cortex, and (iii) results of neurostimulation studies for treatment of CNP 
based in rTMS and tDCS achieving the best reduction of pain when targeting M1
19-21
. A 
single rTMS study in SCI-related NP suggested stimulation of cortical area corresponding 
to painful body area 
336
, and two NF studies 
140,141
 on fibromyalgia suggested Cz site. 
Patients in our study had paralyzed and painful lower limbs, therefore, feedback was first 
provided from the Cz site located over the primary motor cortex of the paralyzed painful 
limbs. Due to the nature of EEG recording reflecting the mixed activity of local and distant 
sources, electrode location Cz probably records the  activity of both sensory and motor 
cortex. 
The selection of C3 and C4 sites was based on rTMS and tDCS studies stimulating motor 
cortex areas adjacent to the somatotopic representation of the painful body part 
334,344,345,349,420
. The rTMS study for pain management on SCI patients also suggested 
stimulation of cortical representation of the upper limbs because, unlike the lower limb, it 
is not expected to shrink due to disuse reorganisation and is closer to the scalp 
335
. A case 
study of NF 
368
 and a tDCS study for treatment of CNP pain 
347
 also proposed targeting the 
left hemisphere (C3). Another tDCS study proposed stimulation of the ipsilateral 
hemisphere of the dominant hand 
346
 (C4 in our case). Therefore, feedback in this study 
was also provided from C3 and C4 sites.  
The selection of CP4/ P4 was based on rTMS studies stimulating primary sensory cortex 
325
 and parietal cortex 
327
, and studies showing lateral effect of stimulation on non-
stimulated cortices 
324,330
. Another reason of selecting the primary sensory and parietal 
cortices came from a neuroimaging study showing parietal and centro-parietal cortices 
138 
 
projection towards DLPFC and thalamus regions in patients with pain following SCI 
compared to SCI patients without pain 
87
. 
Effectiveness of Protocol 4: Although four different protocols (scalp locations on sensory-
motor and parietal cortices) were tested, Protocol 4 (C4 site, inhibit theta 4-8 Hz and 
inhibit beta 20-30 Hz, and reward alpha 9-12 Hz) was most effective in reducing pain 
following significant modulation of PSD in a desired direction (section4.4.1). The strong 
training effect from C4 site (which corresponds to cortical representation of the left 
hand/arm) is in accordance with a tDCS study in which the stimulation was applied at the 
cortical presentation of the non-painful limb rather than painful limb 
346
. Patients reported 
spasms while receiving a feedback from the cortical presentation of another non-painful 
limb i.e. C3 site (dominant hand). There is no certain reason for strong spasm.  
Band Specificity During NF Training: To date only few studies have shown full spectrum 
PSD during NF training to find the effect of training a single frequency band on the rest of 
the spectum
363,366,421
. These studies found that alpha desynchronization was positively 
correlated with theta and beta desynchronization. In our study (section 4.4.1), the full 
spectrum analysis also revealed that modulation of PSD in specific frequency band induced 
effect on full spectrum PSD. The global change in whole spectrum from theta band to beta 
band while modulating a PSD in specific frequency band was also reported in past NF 
studies 
363,421
. 
The immediate change in PSD during NF, analysed for a single training day, was 
sustained for several minutes beyond the training (Post NF, short-term) with each protocol, 
except with Protocol 1. This indicates that short-term plasticity might cause long-term 
plasticity effect of NF training over the number of training days. 
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Relative Change of PSD During NF and Shift in Baseline PSD: The temporal change in 
baseline value has been reported in two NF studies 
200,422
. The relative change in PSD at 
training site (Table 4.4) and shift in baseline PSD (Table 4.7 and Table 4.9) found in our 
study is in accordance with neuroimaging studies showing decrease of alpha and increase 
of theta and beta band power/ amplitude in patients with pain 
257–260
. This shift in baseline 
PSD demonstrates that training might have a successful long-term effect. 
Bilateral Effect of NF Training: The bilateral or lateralized effect of NF training has been 
reported in past NF studies 
366,423–425
. It is worth noting that although patients in our study 
modulated relative EEG power at C4 the effect was more pronounced at C3 site (Table 4.5 
and Table 4.6). The strong modulation of brain activity over the contra-lateral hemisphere 
was also reported by Barnea et al 
424
 while comparing the effect of feedback from C3 and 
C4 sites on other brain sites. Furthermore, it was assumed that activation of asymmetric 
hemispheric control circuits could modify distant hemispheric networks. 
Global modulation of PSD and Coherence: In a sixteen channel NF experimental 
paradigm, the effect of NF training on brain activity was not restricted to the contra-lateral 
site only but was wide spread over the whole scalp (section 4.4.6), which is similar to the 
effect of rTMS and tDCS 
324,330
.  
To the best of our knowledge, the immediate wide spread effect of NF training has not 
been examined in previous NF studies. However, short-term (beyond the training, Post NF) 
and long-term (after a number of training sessions) wide spread effect of NF training has 
been reported 
199,366,426,427
. Though patients received NF from C4 location, the effect of NF 
training was strong over the frontal region. This effect was observed in previous NF 
studies 
199,366,426,427
, where NF was used to study the connectivity changes and to enhance 
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cognitive performance in healthy adults and in patients with cognitive impairment. In 
general, the change in coherence was independent of change in PSD.  
The frontal beta and frontal midline theta mainly increases with increased concentration 
on a task 
109
. Therefore, increase in frontal PSD would be expected if it would reflect 
general concentration rather than NF training. The reduction in power at the frontal site 
during NF could be attributed to NF training rather than to general concentration on task. 
The global effect of NF training can be partially attributed to the nature of the EEG signal 
which reflects the activity of multiple sources; however patients were also able to modulate 
local sources as it was further confirmed by NF with laplacian derivative (see section 
4.4.7). A widespread modulation of EEG power can also be attributed to changes in the 
connectivity as confirmed by the analysis of coherence (Figure 4.13). 
Influence of NF training on the Intensity of Pain: All five patients who received 20 or more 
NF sessions achieved a statistically significant reduction of pain, with four patients 
reporting a clinically significant (>30%) reduction of pain (section 4.4.2). The reduction of 
pain in all patients was gradual and lasted for several weeks after termination of the 
therapy. In our study the percentage reduction in pain intensity is larger than in previous 
neurostimulation and NF studies 
142,319,335,337,345,353
, though there were only five patients.  
A negative correlation between pain intensity and the number of NF sessions suggests 
that NF had a carry-over effect (Table 4.2), resulting in gradual decrease in baseline pain 
intensity. It also demonstrates that patients would benefit from larger numbers of treatment 
sessions because the effect of NF of the pain intensity was not saturated. 
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Placebo Effect: In this study, there was no separate control group similar to fMRI feedback 
study for management of pain 
150,198
. Instead, patients were tested for placebo effect once 
they gained a skill to modulate EEG PSD in a desired direction.  
Failure to modulate EEG while receiving EEG of pre-recorded session as a feedback 
demonstrates that modulation of EEG PSD during NF with Protocol 4 was real (Figure 
4.16). A decrease in the alpha and increase in the beta band power during a single-blinded 
placebo (pre-recorded session for a feedback) might be due to increased concentration. 
Similarly, increases in the alpha PSD during NF and decreases in the alpha PSD during 
mental tasks (read and maths) further supports that modulation of EEG PSD during NF 
might be caused by a voluntary modulation of brainwaves rather than by a general 
engagement in a cognitively demanding task. 
Failure to modulate the PSD at Oz site in EO state (placebo feedback site) might be due to 
visual input that reduces the occipital alpha (Figure 4.17). This phenomenon of occipital 
alpha to visual input together with patients learning ability with Protocol 4 might make it 
further difficult to modulate the PSD with placebo feedback from Oz site. 
 As discussed in results section that patients did not report reduction of pain following 
successful modulation of EEG PSD with EC training from Oz site (Figure 4.18) and with 
Protocol 1 (Figure 4.6). This demonstrates that reduction of pain with Protocol 4 training 
might be related to the modulation of PSD in the chosen frequencies and locations rather 
than an effect of placebo. The early NF study on pain management also found that 
modulation of occipital did not help to control pain 
168
. 
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Studies using fMRI showed that placebo intervention can also activate deeper cortical 
structure (ACC, IC) which are involved in processing of pain 
428
. Thus in testing for a 
placebo treatment, one can only compare the reduction of pain between real treatment and 
placebo, rather than expecting that placebo treatment will not at all affect the intensity of 
pain. Based Watson et al., we can suggest that modulation of PSD followed by reduction 
of pain with Protocol 2 can also be considered as an effect of placebo. 
NF Training and Dominant Frequency: The increase in baseline dominant frequency 
(significant in PWP5 only) is in accordance with the results found in Chapter 3 and results 
of neuroimaging studies of pain showing decrease in dominant frequency 
46,257–259,262,403
 
(section 4.4.4). This increment in baseline dominant frequency indicates that NF training 
might enhance cognitive performance 
199,429
.  
Learned mental strategy and modulation of pain: As previously stated, one justification for 
the use of a long-term NF training was to train patients to modulate the PSD without 
feedback. This is a potential advantage of NF training over other neuromodulation 
treatments based on external stimuli to manage pain. Patients reported that self-induced 
modulation of PSD was accompanied with reduction of the intensity of pain.  
4.6. Conclusion 
The results of this pilot study demonstrate that NF training has a potential to manage CNP 
in paraplegic patients. However, a randomized double-blinded sham-controlled study is 
required to further confirm its effect on large numbers of patients.
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Chapter 5. Long-Term Neurological Outcomes of 
Neurofeedback Training on Central Neuropathic Pain 
in Paraplegic Patients  
5.1. Abstract 
Objective: The aim of this chapter is to find whether long-term neurofeedback (NF) 
training induces changes in pain related surface and deep cortical areas. 
Methods: Five paraplegic patients with Central Neuropathic Pain (CNP) from the Phase 2 
of the study also participated in the Phase 3 of the study. Electroencephalogram (EEG) was 
recorded and compared in a relaxed state and during motor imagery (MI) before the first 
day of NF training and after the last NF training day. The changes at deep cortical 
structures are analysed using standardized low resolution brain electromagnetic 
tomography (sLORETA) with the emphasis on Brodmann areas (BAs) related to pain. 
Results: In relaxed eyes open (EO) state, cortical activity in pain-related areas was 
increased in the theta (4-8 Hz) and alpha (9-12 Hz) bands, while it was decreased in the 
beta1 (12-15 Hz) and beta2 (20-30 Hz) bands. During MI tasks, the event-related 
desynchronization (ERD) of patients with CNP was reduced after NF and looks similar to 
ERD of paraplegic patients without pain and ERD of able-bodied in the theta (4-8 Hz), 
sensory-motor rhythm1 (SMR1; 8-12 Hz), and sensory-motor rhythm2 (SMR2; 16-24 Hz) 
bands.  
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Conclusion: NF training induced changes in brain activity both in the relaxed state and 
during MI tasks. This long-term change in the brain activity was noticed both at the surface 
and in the deep cortical areas related to pain matrix. 
5.2. Introduction 
Recently Jensen et. al 
353
 found that reduction of pain with hypnosis and meditation 
treatments was associated with increase in wide spread EEG amplitude in theta and alpha 
bands at the surface of the cortex, but did not analyse changes at the deeper cortical 
structures. However, Koberda et. al 
374
 reported reduction in power in theta and beta bands 
following reduction of pain with feedback from the deeper cortical structures. Saranthein 
et. al 
258
 found reduction in the theta band power of anterior cingulate cortex (ACC) 
following reduction of pain intensity with surgery of the thalamus. The above mentioned 
studies and other pain management studies (see section 2.2.2) did not provide long-term 
changes in the brain activity related to motor task.  
The objective of this study was to provide long-term global effect of NF training on EEG 
activity in a relaxed state and during MI tasks.  
5.3. Methods 
5.3.1. Participants and EEG Recordings 
Five paraplegic patients with CNP who completed NF training in the phase 2 of the study 
also participated in the phase 3 of the study. Similar to phase 1 (Chapter 3), EEG was 
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recorded with 61 channels in both spontaneous relaxed (EO and EC) state and during MI 
of the Feet (F) and upper limbs (Right hand: RH, Left hand: LH). The purpose of 
multichannel recording was to perform quantitative EEG analysis over the whole cortex in 
order to assess the long-term changes due to NF therapy.  
5.3.2. EEG Processing and LORETA imaging  
EEG data (spontaneous and MI) of five subjects recorded before and after the NF therapy 
were re-referenced to an average reference after removing artefacts (see Chapter 3) Due to 
a relatively small number of subjects, we performed group analysis and analysis of each 
subject individually before and after NF. Each subject was analysed separately because of 
variation in response to NF training in phase 2 of the study.  
The average reference data for spontaneous EEG (EO and EC states) for each subject 
was split into 4 s long epochs. Each epoch was exported to sLORETA in order to compare 
changes in brain activation before and after NF at the surface and in deep cortical levels 
430
. The current source density was calculated in four frequency bands (theta, alpha, beta1, 
and beta2 bands) for each epoch separately in order to compare frequency dependent 
changes in brain activation for each subject individually. In order to compare changes in 
spontaneous EEG activity on a group level, the current source density for each epoch was 
averaged for each patient. The above mentioned frequency bands were chosen based on 
protocols described in Chapter 4. 
sLORETA analysis was also performed to find the differences between EC and EO 
activities (EC-EO) at cortical and deep cortical levels before the first and after the last day 
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of NF training (After NF-Before NF). This was calculated in five frequency bands (theta, 
alpha, beta1, beta2, and 2-30 Hz bands) for each patient individually and on a group level. 
sLORETA software, which provides a solution to the EEG inverse problem 
431
, was used 
to estimate the cortical three dimensional distribution of EEGs current density 
430
. The 
maps generated from the EEG using LORETA indicate the locations of the underlying 
source generators. The sLORETA implementation incorporates a realistic head model 
432
 
using Montreal Neurological Institute (MNI) 152 template 
433
. The electrode coordinates 
on MNI152 scalp for 10/20, 10/10 and 10/5 were based on Jurack et. al and Osstenveld 
104,105
. sLORETA estimates sources in grey matter volume (6239 voxels) to 5mm
 
grid 
resolution using a digitized MNI probability atlas registered to a recognized probabilistic 
talairach anatomical brain atlas 
434
. Also, BAs are displayed using MNI space with 
correction/ conversion to talairach space 
435
.  
sLORETA images were statistically compared between before NF and after NF through 
voxel by voxel using non-parametric t tests 
436
. For individual subject, unpaired test was 
used and for a group level paired test was applied. A randomization procedure was applied 
to correct for multiple comparisons.  
For MI EEG data, ERD/ERS was calculated before and after NF for each trial for each 
type of MI task for each subject. The calculation of ERD/ERS for each trial separately 
would allow us to apply statistics to compare ERD/ERS before and after NF for a single 
subject. In order to perform comparison on a group level (before vs after NF), the 
ERD/ERS for each trial was averaged for each subject. For statistical analysis, a non-
parametric statistics based on permutation test was applied over each time and frequency 
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window to compare ERD/ERS before and after NF. A false discovery rate (FDR) was 
applied to correct for multiple comparison from multiple time-frequency windows.  
Scalp maps were created based on ERD/ERS averaged over certain frequency bands 
(theta, SMR1, and SMR2; similar to Chapter 3) and short time windows (0.4 s). The 
comparison between scalp maps of each individual subject (before and after NF) and on a 
group level was performed based on a non-parametric permutation statistics (p=0.05) and 
FDR was applied to account for comparison from multiple electrode sites. 
5.3.3. sLORETA Analysis on Selected BA’s 
Although sLORETA analysis provides information about the current density for the 
whole brain, we were primarily interested in the regions of the cortex related to pain. These 
areas include primary motor cortex (M1), premotor cortex (PMC), supplementary motor 
cortex (SMC), primary and secondary sensory cortices (S1 and S2), dorsolateral prefrontal 
cortex (DLPFC), posterior parietal cortex (PPC), anterior cingulate cortex (ACC), and 
insular cortex (IC). Therefore, we compared change in brain activity before and after NF in 
the following BAs (S1 (1, 2, 3), S2 (40, 43), M1 (4), PMC (6), SMC (8), DLPFC (9, 46), 
APFC (10, 11), PPC (5, 7), ACC (24, 32), PCC (23, 31), IC (13)) 
258,437–440
. 
5.4. Results 
5.4.1. Effect of NF Training on Relaxed State EO EEG Activity  
Individual Subject Analysis: Table 5.1 shows relative number of voxels (in percentage) 
showing long-term statistically significant changes in the brain activity in the BAs‘ related 
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to the pain matrix in four frequency bands (theta, alpha, beta1 and beta2) in EO state for 
each patient. The significant value was set to p<0.05. 
Table 5.1: Number of voxels (Percentage) showing change in activation in EO state for 
each patient in BA‘s related to pain  
             Areas S1 S2 M1 PMC SMC DLPFC APFC PPC ACC PCC IC 
Bands                BA 1,2,3 40,43 4 6 8 9,46 10,11 5,7 24,32 23,31 13 
T
h
et
a 
 
PWP1 2 NS 3 3 1 5 NS 2 NS NS NS 
PWP2 NS NS NS NS NS 13 NS NS 10 NS NS 
PWP3 100 100 92 99 99 98 98 97 100 99 97 
PWP4 100 100 92 99 99 99 98 97 98 99 97 
PWP5 100 100 92 99 99 99 98 95 99 81 97 
al
p
h
a 
PWP1 NS NS NS NS NS NS NS 5 NS NS NS 
PWP2 16 14 3 9 14 13 15 21 4 4 30 
PWP3 8 24 5 5 9 18 14 14 6 30 37 
PWP4 100 85 86 93 87 85 88 88 95 77 65 
PWP5 100 92 85 87 94 96 69 97 99 97 97 
b
et
a1
 
PWP1 NS NS NS NS NS NS NS NS NS NS NS 
PWP2 NS NS NS NS NS NS NS NS NS NS NS 
PWP3 2 5 3 25 27 36 34 10 46 NS NS 
PWP4 100 100 92 99 99 99 99 97 100 100 97 
PWP5 NS NS NS NS NS NS NS NS NS NS NS 
b
et
a2
 
PWP1 NS NS NS NS NS 10 NS NS NS NS 30 
PWP2 19 12 26 39 39 32 16 54 79 98 41 
PWP3 94 83 80 94 92 93 92 88 99 99 96 
PWP4 NS NS NS NS NS 4 5 NS NS NS NS 
PWP5 100 100 92 98 98 98 99 97 99 99 97 
Bold numbers show significant reduced activation, normal font numbers show 
significant increased activation, NS= non-significant reduced activation, NS=non-
significant increased activation. BA: broadmann areas, EO: eyes open, S1: primary 
secondary sensory cortex, S2: secondary sensory cortex, M1: primary cortex, PMC: 
premotor cortex, SMC: supplementary motor cortex, DLPFC: dorsolateral prefrontal 
cortex, APFC: anterior prefrontal cortex, PPC: posterior parietal cortex, ACC: anterior 
cingulate cortex, PCC: posterior cingulate cortex, IC: insular cortex.  
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In the theta band, a statistically significant reduction of activation, over a limited number 
of voxels, was noticed only in PWP1. Three patients (PWP3, PWP4 and PWP5) showed 
statistically significant increase in activation and PWP2 showed non-significant (except 
over DLPFC) increase in activation. 
In the alpha frequency band, a statistically significant increased activation was noticed in 
all pain related surfaces and deep cortical areas in three patients (PWP2, PWP4 and 
PWP5). The large number of voxels showing statistically significant increase in activation 
was noticed in PWP4 and PWP5. Other two patients (PWP1 and PWP3) showed reduced 
activation though it was statistically significant only in PWP3. 
In the beta1 frequency band, two patients (PWP3 and PWP4) showed statistically 
significant reduction of activation while PWP1 and PWP5 showed non-significant 
reduction of activation. The increased non-significant activation was noticed only in 
PWP2.   
In the beta2 frequency band each patient showed reduced activation; it was statistically 
significant over each pain related areas in three patients (PWP2, PWP3 and PWP5). Other 
two patients showed statistically significant reduction of activation over the frontal and 
insular cortices. The large number of voxels showing statistically significant reduction of 
activation was mainly noticed in PWP3 and PWP5. 
Group Analysis: The group analysis showed that surface and deep cortical activities, 
related to pain areas was reduced in the beta1 and beta2 bands, and it was increased in the 
theta and alpha bands, though statistically significant change was noticed only in the beta2 
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band. Therefore, we will discuss only beta2 band further in the following text. The 
activation value was -0.94 for p<0.05. 
Table 5.2 shows the number of voxels (percentage) and coordinates represent maximum 
significant reduction of activation in the beta2 band averaged over five subjects. Although 
the NF training was provided from the surface cortical areas, the number of voxels 
showing statistically significant reduction of activation is large in deep cortical areas 
related to pain matrix, such as ACC and IC. Also, patients received NF training from the 
right hemisphere (C4 site), but reduction of beta activity was strong on the left hemisphere. 
Table 5.2: Number of voxels (percentage) showing reduced activation averaged over five 
subjects in the beta2 band in EO state 
Cortical 
areas 
BAs 
Total voxels 
(Percentage) 
Maximum 
change in 
activation 
MNI coordinates with maximum value 
X Y Z 
S1 1, 2, 3 NS - - - - 
S2 40, 43 NS - - - - 
M1 4 NS - - - - 
PMC 6 2 -0.97 -15 25 40 
SMC 8 4 -0.96 -20  30 45 
DLPFC 9, 46 30 -0.99 -15 40 25 
APFC 10, 11 4 -0.96 -20 45 30 
PPC 5, 7 NS - - - - 
ACC 24, 32 20 -0.99 -15 35 20 
PCC 23, 31 NS - - - - 
IC 13 24 -1.01 -30 15 15 
BA: broadmann areas, EO: eyes open, MNI: Montreal Neurological Institute, NS: non-
significant change in activation. The acronyms for cortical areas are presented in Table 5.1.  
The negative value for maximum change in activation shows that brain activity is reduced 
after NF training in beta2 frequency band.  
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Figure 5.1 shows long-term changes in surface and deep cortical activity in beta2 band 
averaged over five patients. The subfigure ‗a‘ shows a surface cortical activity over 3D 
cortical map (four views: Frontal, Top, Left and Right). A reduced activation can be 
noticed over the whole cortex though it was stronger over the left part of the sensory-motor 
and frontal cortices.  
A change in activation in deep cortical structures, such as cingulate and insular cortices in 
the beta2 band is presented with MNI slice views. A subfigure (b) shows reduced 
activation at BA13 (MNI coordinate: -30 15 15, activation=-1.01) representing a left part 
of the IC. A subfigure (c) shows reduced activation at BA32 (MNI coordinate: -15 35 20, 
activation=-0.99) representing a left dorsal part of the ACC. A subfigure (d) shows reduced 
activation at BA24 (MNI coordinate: -5 25 15, activation=-0.99) representing a left ventral 
part of the ACC. 
 (a) (b) 
 (c) (d) 
Figure 5.1: Change in activity in EO state in the beta2 band before the first and after the 
last NF training day (After-Before)  averaged over five patietns band showing lateral views 
and MNI slices. (a) Lateral Views (top, left, right and frontal), (b) BA 13 [MNI coordinate: 
-30 15 15, t=-1.01], (c) BA32 [MNI coordinate: -15 35 20, t=-0.99], (d) BA 24 [MNI 
coordinate: -5 25 15, t=-0.99]. Blue aeras correspond to reduced activity after NF. 
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5.4.2. Effect of NF Training on Difference between EC and EO Activity  
A group analysis showed that a difference in the EC and EO (EC-EO) cortical activity at 
the surface and deep cortical activity related to painful areas decreased in the theta band, 
while increased in the beta1, beta2 and 2-30 Hz bands. In the alpha band, the difference in 
EC and EO activity was reduced in the frontal cortex and at the ACC, while it increased in 
the other regions. In beta2 band, a statistically significant change in activity was noticed 
only over a single voxel representing ACC [MNI 5 35 15, activation=3.4, BA 32]. The 
statistically significant threshold was 3.4 for p < 0.05. The analysis will be presented in 
only 2-30 Hz band, though non-significant, based on results of Chapter 3 and Boord study 
262
 showing reduced EC/EO activity in patients with pain over that frequency band. 
Figure 5.2 (a) shows long-term changes in the difference between EC and EO activation 
before and after NF treatment, over 3D cortical map in 2-30Hz frequency band averaged 
over five patients. The increased difference between EC and EO activity can be noticed 
over the whole surface 3D scalp.  
A change in activation in deep cortical structures, such as cingulate and insular cortices in 
beta 2-30 Hz frequency band is presented on MNI slice views (Figure 5.2, subfigures (b-
d)). Increased difference between EC and EO activity following a long-term NF training 
can be noticed over the BA32 [MNI: -15 40 15, activation=0.66] representing the left 
dorsal ACC, BA24 [MNI: -5 35 10, activation=0.63] representing the left ventral ACC, 
and BA13 [MNI: -40 15 15, activation=0.62] representing the left IC. 
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(a) (b) 
 
 
(c) (d) 
Figure 5.2: Change in difference between EC and EO activity (EC-EO) in 2-30 Hz at 
surface and deep cortical levels before the first and after the last day of NF training (After 
NF – Before NF) showing lateral views and MNI slices: (a) Lateral Views (top, left, right 
and frontal), (b) BA 32 [MNI coordinate: -15 40 15, t=0.66], (c) BA24 [MNI coordinate: -
5 35 10, t=0.63], (d) BA 13 [MNI coordinate: -40 15 15, t=0.62]. Red areas correspond to 
increased activity after NF. 
 
5.4.3. Effect of NF Training on Dynamic Activation of Sensory-Motor Cortex 
An ERD/ERS for three electrodes, Cz, C3 and C4, was analysed during MI of the 
corresponding limbs (feet for Cz, right hand for C3, and left hand for C4) before the first 
and after the last day of NF training. These areas are chosen to analyse how NF training 
influences the brain response during MI of a paralyzed painful limb and of a non-paralyzed 
non-painful limb. The effect of NF training on dynamic activation of sensory-motor will be 
presented for individual patients and averaged over five patients before the first and after 
the last day of NF training. Furthermore, dynamic activation of the sensory-motor of PWP 
group before and after NF training is also compared with the activation of the sensory-
motor cortex of paraplegic patients with no pain (PNP) and able-bodied (AB) groups 
during MI of paralyzed painful (F) and non-paralyzed non-painful (RH and LH) limbs.    
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Figure 5.3 shows ERD/ERS during MI of the paralyzed lower limb at electrode location 
Cz that corresponds to the primary motor cortex of the F. Compared to ERD/ERS before 
NF, each patient shows a reduced activation after NF. Over the whole time range, the 
reduced activation was statistically significant in theta and SMR1 bands in PWP1 and in 
both SMR and theta bands in PWP5. Three patients show significantly reduced activation 
over particular time and frequency windows.  
 
Figure 5.3: ERD/ERS time frequency map at Cz site for each patient before and after NF 
during MI of F. Figures below show area of statistically significant (p<0.05) difference in 
ERD/ ERS before and after NF. The moment when a warning cue was presented is shown 
with a dashed line (t=-1 s) and the moment when an execution cue was presented is shown 
with a solid vertical line (t=0 s). 
 
Figure 5.4 shows ERD/ERS during MI of the upper dominant right limb at electrode 
location C3 that corresponds to the cortical presentation of RH. Each patient except PWP4 
shows significantly reduced ERD; the statistically significant reduction of ERD is time- 
and frequency- specific for each patient. The PWP4 shows wide spread ERD after NF but 
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difference in ERD/ ERS (After and Before NF) is significant only around 0.7 s in a 
frequency range of SMR1 band. 
 
Figure 5.4: ERD/ERS time frequency map at C3 site for each patient before and after NF 
during MI of RH. Figures below show area of statistically significant (p<0.05) difference 
in ERD/ ERS before and after NF. The moment when a warning cue was presented is 
shown with a dashed line (t=-1 s) and the moment when an execution cue was presented is 
shown with a solid vertical line (t=0 s). 
 
Figure 5.5 shows ERD/ ERS during MI of the upper non-dominant left limb at electrode 
location C4 that corresponds to the cortical representation of the left hand. In PWP4, the 
significant reduction of ERD is noticed in the SMR1 band only, while in PWP5 the 
significant reduction of ERD is noticed in SMR1 and SMR2 bands. In PWP2, the 
significant reduction of ERD is noticed in frequencies above 20 Hz, while in PWP1 and 
PWP3 the significant reduction of ERD is noticed in the theta band. 
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Figure 5.5: ERD/ERS time frequency map at C4 site for each patient before and after NF 
during MI of LH. Figures below show area of statistically significant (p<0.05) difference 
in ERD/ERS before and after NF. The moment when a warning cue was presented is 
shown with a dashed line (t=-1 s) and the moment when an execution cue was presented is 
shown with a solid vertical line (t=0 s). 
 
Figure 5.6 (a) shows ERD/ERS time frequency map of four groups (AB, PNP, 
PWP_before and PWP_NF) at Cz, C3 and C4 sites during MI of their corresponding limbs 
(Cz during F, C3 during RH, and C4 during LH). Figure 5.6 (b) shows comparison of 
ERD/ERS of each two group (AB and PWP_ before, AB and PWP_NF, PNP and PWP_ 
before, PNP and PWP_NF, AB and PWP_ before, PWP_ before and PWP_NF) during MI 
of corresponding limbs (Cz, during F; C3 during RH; and C4 during LH). 
During MI of F, over the cortical representation of lower limbs (Cz site), the ERD of 
PWP before NF is significantly stronger than ERD of AB group in theta and SMR2 bands; 
and also stronger than ERD of PNP group in theta, SMR1, and SMR2 bands. After NF, the 
ERD of PWP group is comparable to ERD of PNP group in SMR2 band, while it is 
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comparable to ERD of AB group in the theta and SMR1 bands. Comparing ERD/ERS of 
PWP group before and after NF, the ERD is significantly reduced after NF in theta, SMR1 
and SMR2 bands. 
During MI of RH, over the cortical representation of dominant right upper limb (C3 site), 
the ERD of PWP before NF is significantly stronger than ERD of AB group in theta band; 
and ERD of PNP group in theta, SMR1 and SMR2 bands. After NF the ERD of PWP is 
comparable to ERD of AB and PNP groups in theta band, while ERD of PWP group after 
NF is still stronger than ERD of PNP in SMR1 and SMR2 bands. Comparing ERD/ERS of 
PWP group before and after NF, the ERD is significantly reduced after NF in theta band, 
while comparable in SMR1 and SMR2 bands. 
During MI of LH, over the cortical representation of non-dominant left upper limb (C4 
site), the ERD of PWP before and after NF is significantly stronger than ERD of AB and 
ERD of PNP groups in theta, SMR1, and SMR bands. Comparing ERD/ERS of PWP 
group before and after NF, the ERD is not changed in all three frequency bands of interest 
(theta, SMR1, and SMR2). 
In conclusion, during MI of F, the ERD of PWP after NF looks similar to ERD of AB in 
theta, and SMR1 bands; and ERD of PNP in SMR2 band over the cortical representation of 
F. The ERD of PWP was reduced after NF in all three frequency bands of interest (theta, 
SMR1, and SMR2). During MI of RH, the ERD of PWP after NF looks similar to ERD of 
AB and ERD of PNP in theta band over the cortical presentation of RH. The ERD of PWP 
after NF was reduced in theta band. During MI of LH, the ERD of PWP after NF was not 
changed at the cortical representation of LH. 
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(a) 
(b) 
Figure 5.6: (a) ERD/ERS time frequency maps of four groups  (AB: column1, PNP: 
column2, PWP before NF: column3, and PWP after NF: column4) during MI of F at Cz 
site: first row, during MI of RH at C3 site: second row, and during MI of LH at C4 site: 
third row. (b) Comparison of ERSP time frequency maps of four groups (AB and PWP 
before NF: column1, AB and PWP after NF: column2, PNP and PWP before NF: column3, 
PNP and PWP after NF: column4, PWP before and after NF: column5) during MI of F at 
Cz site: first row, during MI of RH at C3 site: second row, and during MI of LH at C4 site: 
third row. 
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5.4.4. Effect of NF Training on Dynamic Cortical Activation over Whole Cortex 
Cortical activation in the theta, SMR1 and SMR2 frequency bands during MI of F, RH, 
and LH (for a post-cue period t=0.4 –0.8 s) is analysed over the whole cortex before the 
first and after the last day of NF training.  
Figure 5.7 (a) shows ERD/ERS scalp maps averaged over theta band and over the post-
cue period t=0.4-0.8 s during MI of RH. In each patient, except PWP4, ERD was reduced 
mainly over the central and frontal regions. In PWP2 and PWP5 the reduced ERD is wide 
spread. The reduction in average ERD over five patients is also restricted to the central and 
frontal regions.  
Figure 5.7 (b) shows ERD/ERS scalp maps averaged over theta band and over the post-
cue period t=0.4-0.8 s during MI of F. The ERD in two patients (PWP1 and PWP4) was 
significantly reduced over the whole scalp while ERD of PWP3 was significantly reduced 
over the frontal area. The change in ERD in PWP2 and PWP5 was non-significant. The 
reduction in average ERD over five patients is also restricted to the frontal region. The 
reduction in ERD at the sensory-motor area during MI of the paralysed lower limb was not 
significant.  
Figure 5.7 (c) shows ERD/ERS scalp maps averaged over theta band and over the post-
cue period t=0.4-0.8 s during MI of LH. The ERD is significantly reduced only in two 
patients (PWP1 and PWP5). The reduction in ERD is wide spread in PWP1 while it is 
restricted to the central and frontal areas in PWP5. The reduction in average ERD over five 
patients is not significant. 
160 
 
(a) 
(b)  
(c)  
Figure 5.7: ERD/ERS over whole scalp for t=0.4-0.8 s in the theta band for each patient 
individually and averaged over five patients for different types of MI tasks (MI of RH, 
subfigure ‗a‘; MI of F, subfigure ‗b‘; MI of LH, subfigure ‗c‘). In each figure, upper row 
represents ERD/ERS maps before NF, middle row presents maps after NF. Last row on 
each subfigure shows the areas of statistically significant differences (p=0.05) between 
scalp maps before NF and after NF. A significant reduction in ERD is shown with filled 
black circles and significantly increased ERD is shown with grey filled circles. 
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Figure 5.8 (a) shows ERD/ERS scalp maps averaged over SMR1 band and over the post-
cue period t=0.4-0.8 s during MI of RH. After NF, the ERD is significantly reduced in two 
patients (PWP3 and PWP5) over the sensory-motor and frontal areas, while ERD in PWP2 
is significantly reduced over the central and posterior regions of the scalp. PWP1 shows 
ERS over the occipital area while PWP4 shows ERS over the lateral frontal area. The 
group average reduction in ERD over five patients after NF compared to ERD before NF is 
non-significant. 
Figure 5.8 (b) shows ERD/ERS scalp maps averaged over the SMR1 band and over the 
post-cue period t= 0.4-0.8 s during MI of F. After NF, the ERD of PWP5 is significantly 
reduced over whole head. The ERD of two patients (PWP3 and PWP5) is significantly 
reduced over the central and frontal regions while ERD of PWP2 is significantly reduced 
over the frontal region. The reduction in ERD in PWP4 is non-significant. The group 
average ERD is significantly reduced over the frontal region.    
Figure 5.8 (c) shows ERD/ ERS scalp maps averaged over the SMR1 band and over the 
post-cue period t=0.4-0.8 s during MI of LH. After NF, the ERD of PWP5 is significantly 
reduced over the whole scalp. The ERD of PWP1 is significantly reduced over the frontal 
region, while the ERD of PWP3 is significantly reduced over the left lateral hemisphere. 
The reduction in ERD of PWP2 is non-significant. The ERD of PWP4 is significantly 
increased over the central and frontal areas. The group averaged ERD is significantly 
reduced over the central and frontal regions. 
The largest change in ERD was noticed over the central and frontal regions during MI of 
paralyzed lower limb i.e. F and non-paralysed non-dominant hands (LH). 
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(a)  
(b)  
(c) 
Figure 5.8: ERD/ERS over whole scalp for t=0.4-0.8 s in the SMR1 band for each patient 
individually and averaged over five patients for different types of MI tasks (MI of RH, 
subfigure ‗a‘; MI of F, subfigure ‗b‘; MI of LH, subfigure ‗c‘). In each figure, upper row 
represents ERD/ERS maps before NF, middle row presents maps after NF. Last row on 
each subfigure shows the areas of statistically significant differences (p=0.05) between 
scalp maps before NF and after NF. A significant reduction in ERD is shown with filled 
black circles and significantly increased ERD is shown with grey filled circles. 
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Figure 5.9 (a) shows ERD/ ERS scalp maps averaged over the SMR2 band and over the 
post-cue period t=0.4-0.8 s during MI of RH. The ERD after NF as compared to before NF 
is significantly reduced in three patients (PWP2, PWP3 and PWP5), non-significantly 
reduced in other two patients (PWP1 and PWP4). The significant reduction in ERD in 
PWP3 and PWP5 is spread from the centro-parietal to the frontal region, while in PWP2 is 
restricted to the left frontal area. The reduction in ERD averaged over five patients is non-
significant.  
Figure 5.9 (b) shows ERD/ ERS scalp maps averaged over the SMR2 band and over the 
post-cue period t=0.4-0.8 s during MI of F. After NF, the ERD is significantly reduced 
over the whole scalp in PWP5. The reduction of ERD is significant over the posterior 
region in PWP3, while it is significant over the central and frontal regions in PWP4. The 
change in ERD in two patients (PWP1 and PWP2) is not significant. The group averaged 
ERD is significantly reduced over the frontal and the left central region. 
Figure 5.9 (c) shows ERD/ ERS scalp maps averaged over the SMR2 band and over the 
post-cue period t=0.4-0.8 s during MI of LH. After NF, the ERD was significantly reduced 
over the fronto-lateral part of right hemisphere in PWP2 and over the fronto-lateral left 
hemisphere in PWP3. The ERD in PWP5 is significantly reduced over the central and 
frontal regions. There is no change in ERD in PWP4 while ERD after NF increased in the 
occipital cortex in PWP1. The average ERD was significantly reduced over the fronto-
lateral part of the right hemisphere.  
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(a) 
(b) 
(c)  
Figure 5.9: ERD/ERS over whole scalp for t=0.4-0.8 s in the SMR2 band for each patient 
individually and averaged over five patients for different types of MI tasks (MI of RH, 
subfigure ‗a‘; MI of F, subfigure ‗b‘; MI of LH, subfigure ‗c‘). In each figure, upper row 
represents ERD/ERS maps before NF, middle row presents maps after NF. Last row on 
each subfigure shows the areas of statistically significant differences (p=0.05) between 
scalp maps before NF and after NF. A significant reduction in ERD is shown with filled 
black circles and significantly increased ERD is shown with grey filled circles. 
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In conclusion, the intensity of ERD was reduced over the whole scalp but significant 
reduction of ERD was noticed in central and frontal regions of the scalp. In theta band, this 
significant reduction of ERD was noticed during MI of RH and F, while in SMR1 and 
SMR2 bands this reduction of ERD was noticed during MI of F and LH. Common to all, 
the reduction of ERD was noticed in three frequency bands of interest (theta, SMR1 and 
SMR2) during MI of paralyzed painful lower limb i.e. F. 
5.4.5. Global Effect of NF Training on Cortical Activation over Whole Time  
Figure 5.10 shows frequency-specific spatio-temporal changes in ERD following NF 
treatment over the post-cue period t= 0.4-0.2 s averaged over 0.4 s time windows in three 
frequency bands (theta, SMR1 and SMR2) during MI of paralyzed lower and non-
paralyzed upper limbs.  
A change in ERD in the theta band for each type of MI tasks is shown in Figure 5.10 (a). 
During MI of RH, the ERD is significantly reduced over the central and frontal region for 
the period t=0.4-0.8 s and for t>1.2 s. In the period t=0.8-1.2 s, the ERD is similar before 
and after NF. During MI of F, the ERD is significantly reduced over the frontal and centro-
frontal regions in the period t=0.4-0.8 s. For t> 1.2 s, the reduction in ERD is wide spread; 
posterior to anterior region mainly over the right hemisphere. During MI of LH, a 
significant reduction in ERD could be noticed over some electrode locations around the 
central cortex. In summary, the spatio-temporal reduction in ERD in theta band can be 
noticed dominantly during MI of RH and F. This reduction in ERD is widespread during 
MI of RH while restricted to central and frontal regions during MI of F. 
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(a) 
Figure 5.10: Comparison of 
spatio-temporal change in 
ERD/ERS of PWP group before 
the first and after the last day of 
NF training. Averaged group 
scalp maps showing  statistically 
significant ERS/ERD between 
‗Before NF‘ and ‗After NF‘ 
conditions in three frequency 
bands (theta, subfigure ‗a‘; 
SMR1, subfigure ‗b‘; SMR2, 
subfigure ‗c‘) over four different 
time windows (0.4-0.8 s; 
column 1, 0.8-1.2 s; column 2, 
1.2-1.6 s; column 3, 1.6-2.0 s; 
column 4) for three types of 
motor imagination tasks (RH; 
right hand, F; foot, LH; left 
hand). The black filled circles 
represent significantly reduced 
ERD, grey filled circles 
represent increased ERD, and 
dots represent non-significant 
change in ERD/ ERS. 
(b) 
(c) 
 
RH 
0.4-0.8 s 0.8-1.2 s 1.2-1.6 s 1.6-2.0 s 
F 
LH 
RH 
0.4-0.8 s 0.8-1.2 s 1.2-1.6 s 1.6-2.0 s 
F 
LH 
RH 
0.4-0.8 s 0.8-1.2 s 1.2-1.6 s 1.6-2.0 s 
F 
LH 
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A change in ERD in SMR1 during each type of MI tasks is shown in Figure 5.10 (b). 
During MI of RH, the ERD is similar before and after NF for all time period of interest. 
During MI of F, the reduction in ERD is significant over the central and frontal regions; 
mainly for t=0.4-0.8 s and t=1.2-1.6 s. During MI of LH, the significant reduction in ERD 
can be noticed over the central and frontal regions for a time-period t=0.4-0.8 s. In 
summary, the significant reduction in ERD is restricted to the central and frontal regions 
during MI of F for a whole time period of interest and only for t=0.4-0.8 s during MI of 
LH.  
The change in ERD in SMR2 during each type of MI tasks is shown in Figure 5.10 (c). 
During MI of RH, significant reduction of ERD can be noticed for t=0.4-0.8 s followed by 
a significant increase in ERD for t>0.8 s in parieto-occipital areas. During MI of LH, the 
significant reduction in ERD over the frontal part can be noticed only for t=0.4-0.8 s. 
During MI of F, the ERD is significantly reduced over the central and frontal regions for 
all time range.  
In conclusion, the reduction in ERD over time was noticed during each type of movement 
for each frequency band. In the theta band, the reduced ERD was pronounced during MI of 
F and RH; it is mainly over the central and frontal regions. In SMR1 and SMR2 bands, the 
significant reduction in ERD over all time range was noticed during MI of F and only for 
t=0.4 to 0.8 s during MI of LH; it is mainly over the central and frontal areas. 
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5.5. Discussion  
The aim of this Chapter was to find changes in spontaneous and evoked EEG activity 
after long-term NF training. The results confirm that NF training induced changes in the 
EEG activity at the surface and in deep cortical levels related to pain matrix.  In this study, 
sLORETA analysis was performed on spontaneous EEG data, while cue-based EEG was 
analysed at the surface of the cortex. The sLORETA in addition to providing spatial 
information about deeper cortical structures also provided information on frequency 
content 
258
. 
Influence of NF Training on Spontaneous EEG in EO State: The sLORETA analysis 
showed that NF training from the surface of the cortex induced changes in relaxed state 
EEG both at the surface and deeper cortical structures. These cortical areas include S1 and 
S2 cortices which are involved in the sensory-discriminative evaluation of pain 
27
, and 
areas that function in the emotional/affective component of pain, such as the PFC, ACC 
and IC 
29–31
, as well as higher-order sensory structures involved in sensory vigilance 
processing, including the PCC. The reduced activation was noticed in beta1 and beta2 
bands, while increased activation was noticed in theta and alpha bands. Statistically 
significant changes were noticed only in the beta2 band.  The non-significant changes in 
brain activation on group analysis might be due to changes in brain activity in different 
frequency bands in each subject.  In theta band, only a single patient showed statistically 
significant reduced activity while three patients (PWP3, PWP4 and PWP5) showed 
statistically significant increased activity. PWP2 showed statistically non-significant 
increased activity. In alpha band, three patients (PWP2, PWP4 and PWP5) showed 
statistically significant increased activity, while PWP3 showed significantly reduced 
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activity at the surface and in deep cortical levels. The PWP1 showed statistically non-
significant reduction in activity. In beta1 band, three patients showed non-significant 
change in brain activity. PWP3 and PWP4 showed statistically significant reduced activity. 
In beta 2 band, the reduction of activity was statistically significant in three patients over 
all pain related areas while the reduction was significant over the frontal and insular 
cortices in PWP1 and PWP4. The changes in brain activity in deeper cortical areas 
correspond to results of fMRI and PET studies showing cortical areas affected by pain  
87,245,247
 
254,255
.  Increased alpha power on the surface of the cortex has also been reported in 
a recent NF study for pain management in SCI population 
142
 and in other pain 
management studies such as hypnosis and meditation 
353
. A reduced beta band power after 
pain management has been reported only in one NF study 
374
. Increase in the alpha power 
in open-eyes state might be associated with decrease in CSE demonstrated in TMS and  NF 
study of Ros et al 
423
. The increase in theta band power has been reported after reduction of 
pain with hypnosis treatment 
353
. This increased theta band power might be associated with 
the analgesic effect of NF training similar to antiepileptic, antidepressants and antispastic 
drugs which also increased activity of theta band 
274,412,413
. 
Difference in EC and EO Activity: The difference in EC and EO activity after NF was 
increased in beta1, beta2 and in 2-30 Hz bands, though significant increase was noticed 
only over a single voxel (BA 32) in beta2 band. In the alpha band, the difference in EC and 
EO activity was increased after NF over all regions except the frontal cortex and ACC. In 
theta band, the difference in EC and EO activity after NF was non-significantly reduced.  
Comparing Effect of Scalp EEG NF with sLORETA and fMRI Feedback: Pain 
management studies based on fMRI and sLORETA feedback mainly focussed on 
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modulating the activity of the rostral part of the ACC (BA 24), DLPFC (BA 9) and IC (BA 
13) 
150,198,372–374
. In our study, NF training resulted in reduced activation in BA 24, BA 9 
and BA 13; mainly in 20-30 Hz and 12-15 Hz bands. This demonstrates that scalp EEG 
based NF training with a single channel produced effects similar to that reported in 19 
channels sLORETA and expensive time-delayed fMRI feedback.  
Influence of NF on Dynamic Cortical Activity: NF training did not only induce effect on 
spontaneous EEG but also changes evoked EEG activity. The reduced ERD after NF was 
not restricted to the cortical areas from which patients received NF training (Chapter 4) and 
to the cortical areas corresponding to the MI tasks (Cz for F MI, C3 for RH MI, and C4 for 
LH MI) but was spread over the whole scalp; the significant reduction was mainly 
observed in the frontal and central regions. This significant reduction was noticed over all 
time range in all three frequency bands (theta, SMR1, and SMR2) during MI of F 
(paralyzed and painful lower limb). During MI of RH, the reduced ERD over all time was 
noticed only in theta band, while this reduced ERD during MI of LH was restricted to only 
t=0.4-0.8 s in SMR1 and SMR2 bands. The reduced dynamic activation over the whole 
scalp following reduction of pain is an expected phenomenon, as shown in results of 
Chapter 3 that PWP group before receiving NF training had stronger ERD than both AB 
and PNP groups. This demonstrates that reduced brain activity (reduced ERD) after NF 
might be associated with reduction in pain intensity or vice versa. 
5.6. Conclusion 
NF training induced long-term changes in the brain activity in relaxed state and during MI 
of non-painful limbs and limb perceived as being painful. In relaxed state, a statistically 
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significant reduction of activity was noticed at the surface and deep cortical areas known to 
be ‗pain matrix‘. In task-related EEG, the reduced ERD was noticed during MI of painful 
and non-painful limbs; mainly during MI of lower limb (F) perceived as being painful.    
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Chapter 6. General Discussion 
This study reported about changes in the relaxed (state) and dynamic brain activity in 
paraplegic patients following reduction of chronic central neuropathic pain (CNP) with 
long-term neurofeedback (NF) training. This study was divided into three phases: Phase 1 
(Diagnostic phase, Chapter 3), Phase 2 (Treatment phase, Chapter 4), and Phase 3 
(Neurological outcomes, Chapter 5).  
The objective of Phase 1 (Diagnostic phase) was to detect frequency dependant dynamic 
oscillatory signatures of CNP in paraplegic patients. This objective was achieved by 
comparing electroencephalogram (EEG) of three matched groups (able-bodied: AB, 
paraplegic patients with CNP: PWP, and paraplegic patients without pain: PNP). To date, 
EEG studies that aimed to compare the brain activity of paraplegic patients with pain with 
the brain activity of the able-bodied population are limited to task-unrelated eyes open 
(EO) and eyes closed (EC) relaxed states 
46,257–259,262
. Therefore, these studies only 
provides frequency information, failing to provide time-dynamics information. To the best 
of our knowledge, this was the first EEG study that compared not only spontaneous state 
EEG activity, but also compared the task-related EEG activity of three groups (AB, PNP 
and PWP). The results showed that the presence of CNP leads to frequency-specific EEG 
signatures both in a relaxed state and during motor imagery (MI) tasks. Spinal cord injury 
(SCI) patients with and without CNP showed significantly different signatures of 
spontaneous and evoked EEG activity. In the relaxed state, CNP is characterised by an 
increase in power in the theta and alpha bands and a shift in the dominant alpha frequency 
towards lower values. During MI, CNP is characterised by a dynamic, frequency 
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dependant, increase in event-related desynchronization (ERD) over the sensory-motor and 
parietal cortex, which is not somatotopically restricted to painful parts of the body. The 
spatially distributive strong ERD of the PWP group was not limited to a certain time 
period, but was spread over the period after the imagination onset. 
There were two objectives of Phase 2 of the study. The first objective was to test large 
numbers of training sessions of different NF protocols (Protocol 1 to Protocol 4) for the 
treatment of CNP in paraplegics. The second objective was to find the immediate global 
effect of NF training on the power spectral density (PSD) and coherence among each 
channel. The NF protocols were created based on the results found in Chapter 3, past 
neuroimaging studies defining the cortical areas involved in pain, and NF and 
neurostimulation studies for the management of pain 
243,248,249,346,368
. Five out of seven 
patients received 20 or more NF sessions. All five patients achieved a statistically 
significant reduction of pain and four patients (except PWP1) reported a clinically 
significant (>30 %) reduction of pain. The modulation of PSD followed by clinically and 
statistically significant reductions in pain showed that frequency dependent EEG based 
CNP signatures can be used to develop NF protocols. However, a study which will recruit 
a larger number of patients is required to further confirm the efficacy of NF training for the 
treatment of CNP. Out of four tested protocols, Protocol 4 was the most effective in 
reducing pain following modulation of PSD. The modulation of PSD and coherence over 
the whole cortex, in a sixteen channel NF system, demonstrated the NF training induced 
global effect. Furthermore, patients learned the mental strategy to modulate the PSD 
without feedback. The decrease in the alpha band PSD during mental task (maths and 
reading) and increase in alpha PSD during NF demonstrates that modulation of PSD may 
be an effect of voluntarily modulation of EEG PSD. This was further confirmed by placebo 
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sessions in which EEG of a pre-recorded session was shown as a feedback. The 
modulation of PSD in EC state and modulation of PSD with Protocol 1 demonstrates that 
the reduction of pain may be real rather than effect of placebo. 
The objective of Phase 3 (Chapter 5, objective 4, neurological outcomes) was to find 
long-term changes in the EEG activity in pain related cortical presentations following NF 
training. This was achieved by comparing the EEG of patients with CNP (PWP) before the 
first and after the last session of NF training. EEG was recorded in relaxed EO and EC 
states, and during MI of paralyzed painful limb (F) and non-paralyzed non-painful (right 
hand: RH, and left hand: LH) limbs. Spontaneous EEG activity was analysed both at the 
surface of the cortex and at the deeper cortical structures, while evoked EEG was analysed 
on the surface of the cortex only. The results showed that NF training modulates brain 
activity not only in the relaxed state, but also during MI of upper and lower limbs. The 
reduced EEG activation in the EO state was noticed in beta1 and beta2 bands, while 
increased activation was noticed in the theta and alpha bands. Statistically significant 
changes were noticed only in the beta2 band. The reduction in ERD was topographically 
distributed, mainly over the sensory-motor and frontal regions of the brain. A significant 
reduction in ERD was noticed in all three frequency bands (theta, SMR1 and SMR2) over 
the whole time range during MI of paralyzed painful lower limb i.e. F. This significant 
reduction in ERD was noticed in the theta band only over whole period of MI of RH, while 
for early times (t=0.4-0.8 s) only in SMR1 band during MI of LH. After NF, the ERD of 
PWP was similar to the ERD of AB in the theta band during MI of F and RH, and in 
SMR1 band during MI of F. The ERD of PWP was also similar to the ERD of the PNP 
group in the theta band during MI of RH and in SMR2 band during MI of F.  
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6.1. Suggestions for Further Improvements of NF Protocols 
Alpha/theta feedback in EO state: In the Phase 2 of the study, alpha was selected as a 
reward band in order to shift peak frequency from lower frequencies to high frequencies. 
In addition, the theta band was suppressed due to increased theta power in PWP compared 
to the PNP group. This suggests that patients can be trained to increase the alpha / theta 
ratio rather than to modulate theta and alpha activities simultaneously. However, results of 
NF training showed that patients did not necessarily follow a rule in both the theta and 
alpha band simultaneously. This demonstrates that it may be difficult to follow rules if the 
ratio of both bands is shown as a feedback. Another approach is to show peak frequency as 
a feedback and ask patients to move the peak frequency towards higher values similar to 
the study of Angelakis et al. 
429
.  
Feedback from the Frontal Site: Analysis of 16 channels PSD during NF training showed 
that the effect of NF training was strong in the frontal sites. Also, the reduced ERD after 
NF training was strong in the frontal site which suggests providing feedback from the 
frontal site.    
Neurofeedback from Deep Cortical Structures: Though we trained patients over the right 
hemisphere (C4 site) for most training days, the reduced activation after NF was strong on 
the left hemisphere in the beta band. This reduced activation was noticed mainly in the 
deep cortical areas related to pain, emotional and sensory vigilance processing. This 
suggests to standardized low resolution brain electromagnetic tomography (sLORETA) 
feedback studies on pain management to select beta as an inhibit band and provide 
feedback from the voxels over the left side of the limbic lobe. The effect of scalp EEG-
based NF training up to the deeper cortical structures could also assist functional magnetic 
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resonance imaging (fMRI) NF studies to specifically target brain areas that are shown to 
change cortical activation after reduction of pain with NF training.  
Connectivity-based Feedback: Although, the analysis was not performed to find the 
connectivity changes before the first and after the last day of NF training (long-term 
change in connectivity). The coherence analysis performed for sixteen channels 
experimental paradigm suggested to create NF protocols based on the connectivity 
strength/ weakness using both scalp EEG and LORETA feedback; mainly targeting the 
pain related surface and deep cortical areas. In an analysis of 16 EEG channels during NF 
training, the largest changes in connectivity were noticed in the beta2 band. This change in 
coherence was patient and electrode site specific. The connectivity changes may allow 
better understanding of the effect of NF training on structural changes in the brain in 
patients with pain. 
6.2. Suggestion for NF Placebo of Pain Treatment 
A sham protocol in repetitive transcranial magnetic stimulation (rTMS) and transcranial 
direct current stimulation (tDCS) studies is introduced by changing the position of the coil 
and intensity of current. The effect of rTMS or tDCS can be noticed from the first session. 
Therefore, the sham group does not need to attend many sessions to test its influence on 
pain.  EEG based NF training is based on voluntarily effort to learn to control brain activity 
in order to manage pain; it requires a large number of sessions to learn to modulate brain 
activity. The number of sessions is based on patients‘ learning ability. It would not be 
ethical to ask patients to attend these large number of NF sessions for a sham treatment. 
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Also failure to reduce pain might discourage patients in the sham group to continue 
training.  
Placebo effect in NF training can be performed in three ways: (i) by providing NF from 
the cortical location and/or frequency bands which are neither a part of the ‗treatment NF 
protocol‘ nor a part of the ‗pain matrix‘, (ii) by providing NF from a the cortical location 
and/or frequency bands which are part of the ‗treatment NF protocol‘ but not a part of the 
‗pain matrix‘, (iii) by providing pre-recorded NF session as a feedback. 
In the former case, the effect of NF training might fail for two reasons: a trainee might not 
be able to modulate the EEG from the novel, untrained site or a trainee could modulate 
EEG by using ‗placebo‘ protocol but the desired effect of training would fail. If a trainee 
cannot modulate EEG using the ‗placebo‘ protocol, then one can only compare the effect 
of voluntary modulation of EEG versus no voluntary modulation of EEG, but cannot 
ascertain if a ‗treatment‘ NF protocol is optimal. If one can prove that a trainee can 
modulate EEG during ‗placebo‘, but the desired effect of training is lacking, then this can 
provide evidence that NF training protocol used for ‗real‘ treatment is more effective than 
the ‗placebo‘ protocol. To prove this, patients have to be trained to modulate the PSD at 
this site. In this study, with placebo feedback from the occipital (Oz) site in EO state, 
patient did not report reduction of pain and was not able to modulate the PSD in a desired 
direction. However, immediately after the placebo test, patient report reduction of pain 
with Protocol 4 feedback. Therefore, with this placebo test, it can be shown that voluntary 
modulation of PSD with Protocol 4 is an effect of patients learning ability to modulate the 
PSD and is related to reduction of pain, but it cannot provide information whether C4 was 
better site than Oz for training.  
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In the second case, the modulation of PSD without reduction of pain can provide evidence 
that NF training protocols that are designed to target the ‗pain matrix‘ for the reduction of 
pain are more effective than protocols that do not target ‗pain matrix‘. In this study, 
patients did not report reduction of pain following modulation of PSD in the desired 
direction with feedback from the occipital site in EC state on all training days. However, 
immediately after EC feedback, patients reported reduction of pain with Protocol 4 
feedback. Therefore, this placebo test can provide information that C4 site (Protocol 4) 
compared to Oz site (feedback in EC state) is more effective in reducing pain. 
In the case of a pre-recorded NF session, a trainee cannot voluntarily modulate EEG; this 
protocol is only testing whether the voluntary modulation of brain activity really produces 
a desired effect. In a case that trainee already learned NF strategy and can apply it even 
without a feedback, a placebo test using a pre-recorded session might not be effective. 
6.3. Proposed Mechanisms of NF for Pain Management  
NF and Corticospinal Excitability (CSE): The ERD is associated with a decrease in 
neuronal synchrony, and is believed to be generated by the thalamo-cortical and/ or 
cortico-cortical loop 
406,441
. Increased corticospinal excitability (CSE) and reduced 
intracortical inhibition (ICI) in pain and thalamic lesion 
442,443
 are associated with an 
increased ERD 
444–446
. Therefore, in our study, the reduced ERD after NF may be 
associated with reduced CSE and increased ICI. Furthermore, the reduced hyper 
excitability (reduced ERD), increased ICI and reduced CSE may be linked to increased 
activity of g-amino butyric acid, which is mainly reduced in chronic pain 
76,77
. In other 
179 
 
words, it can be hypothesised that NF training may reduce central sensitization in patients 
with CNP.  
NF and Thermoregulatory Function: All patients frequently reported a pleasant sensation 
of warmth in the areas of the body perceived as ‗painful‘ that preceded pain relief and 
lasted for several hours following NF treatment. As some patients had a complete SCI and 
could not possibly feel real changes in temperature, this sensation was most likely being 
generated in the brain. The central disinhibition due to reduced activity of the posterior part 
of the ventral medial nucleus of the thalamus caused thermo-sensory loss, thus contributing 
towards development of pain 
76,81
. The pleasant warm sensation followed by reduction of 
pain and reduced cortical activity indicates that NF training may activate VMpo (thalamic 
nuclei responsible central integration of pain and temperature 
42
), thus reducing thermo-
sensory loss and central disinhibition. In other words, it can be hypothesised that NF 
training may have an effect on thermoregulatory function which supports the belief that 
pain is not only a feeling but also a behavioural drive that signals a homeostatic imbalance 
42
.  
NF and Thalamo-Cortical Dysrhythmia (TCD): The shift in dominant frequency towards 
higher frequencies and a reduction of pain following NF training is in accordance with 
EEG studies showing slowing-down of theta-alpha peak frequency 
46,257–259,262
. The 
increased difference between EC and EO (EC-EO) activity in the relaxed state, following a 
reduction in pain intensity, is in accordance with EEG studies showing reduced activity 
between EC and EO state in SCI patients with pain compared to SCI patients without pain 
and able-bodied groups 
46,257–259,262
. TCD is characterized by a shift in dominant frequency 
towards lower frequencies 
83,84
 and reduced EEG activity between EC and EO state 
262
. 
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Following NF training, the shift in dominant frequency towards higher values and 
increased difference between EC and EO EEG activity demonstrates that NF training may 
also influence TCD. 
ERD is associated with an enhanced thalamocortical transfer (sensory gate to the cortex) 
441
. The results of our study (Phase 3) showing reduced ERD after NF together with Lopes 
441
 findings demonstrate that NF training may also modulate (reduce) activity of thalamo-
cortico-thalamic circuits, which may also reduce hyperactivity of the thalamic neurons. 
Hence, it can be assumed that after NF training thalamic integrative circuits could not 
amplify nociceptive signals at the same rate and slowed down the amount of low threshold 
calcium spike burst which also controls TCD 
82
.  
It has been shown that surgery of the central lateral nucleus of the thalamus control TCD 
reduced pain and activity in anterior cingulate cortex (ACC) 
258,447
. In our study, reduced 
activity has been noticed in ACC which further supports a hypothesis that NF regulates 
TCD. 
NF and Long-term Potentiation (LTP): It has been reported that patients with pain show 
reduced widespread connectivity mainly in the default mode and attentional networks 
448,449
. Based on findings of the NF study, which showed a positive relation of default 
mode netork connectivity and resting alpha 
366
, and results of our study showing the 
immediate effect of NF training on connectivity changes among 16 channels, we expect 
that NF training may induce long-term connectivity changes. This should be confirmed by 
analysing changes in connectivity of resting state multichannel EEG before the first and 
after the last day of NF which is outside the scope of this thesis.  The knowledge of 
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connectivity changes may allow greater understanding of the pain mechanism at 
supraspinal level in terms of LTP.  
6.4. Limitation of the Study 
Ideally, Phase 1 of the study should include another group of patients with CNP without 
paralysis or amputation to assess the separate effect of pain as the paralysis and amputation 
itself affect EEG. Furthermore, we restricted our analysis to the surface cortical areas only, 
defined by the 10-10 system. Because of the nature of EEG measurement, we could only 
record the activity of surface cortical areas involved in the processing of chronic pain, such 
as the sensory-motor cortex and to an extent the frontal cortex. The source localisation 
techniques could be used to estimate ERD of deeper structures, such as ACC and insular 
cortex (IC) 
258
. Analysis of deeper cortical structures could also provide spatial information 
about areas of strongest theta, alpha and beta activity and could test whether the sources of 
different brain rhythms have spatially different locations. Surface cortical areas correspond 
to the areas which were typically targeted by non-invasive neuromodulatory treatments of 
pain. 
Phase 2 was a pilot study, therefore tested on only five patients without a control group. 
Therefore, it is necessary to test the effects of NF training on a larger population with 
chronic NP in both SCI and non-SCI patients. 
The custom made NF system developed in this study was tested on four healthy people as 
a part of an MSc thesis by another student 
450
. These results are not presented in this thesis, 
however, subjects were able to modulate the PSD in all three frequency bands; although 
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they followed a protocol in the theta band for most of the training day. In this study and 
study on healthy population (MSc project), the performance of system was not tested with 
different window size for all training protocols. It was found with PWP2 that the small 
window size made it hard for a patient to follow the change in PSD in real time with 
Protocol 4. 
Patients were not examined using standard clinical sensory tests for neuropathic pain, 
such as allodynia, hyperalgesia or quantitative sensory testing to determine thermal 
detection and pain thresholds or pinprick and light touch scores. Furthermore, we did not 
measure spasticity before and after treatment, though patients verbally reported reduced 
spasms. 
Based on increased dominant frequency, we proposed that NF training may enhance 
cognitive functions 
429
. Therefore, it is necessary to test patients with a Go/ No-Go task 
before and after the treatment to confirm whether NF training enhances cognitive 
performance in PWP.      
  Mechanisms of NF in pain management (section 6.3) should be explained by taking into 
account changes in the activity of the surface and deeper cortical level. Although we 
propose some mechanisms of action, we did not test functions of CSE and ICI using TMS 
when investigating the effect of NF training on central sensitization. Similarly, we did not 
assess changes in the thalamus when investigating the effect of NF training on TCD and 
thermo-regulatory functions. Furthermore, we did not find connectivity changes in the pain 
related surface and deep cortical areas while investigating the phenomena of NF training 
and LTP. Our conclusions were therefore mostly based on drawing a parallel between the 
effect of reduced pain following NF training and the known effect which CNP has on 
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modulation of the activity of the cortex. We also looked at the effect of other interventions 
(e.g. surgery) for the reduction of CNP and their hypothesised mechanism of action, and 
tried to correlate previously reported changes in surface cortical EEG with the results of 
our study. 
6.5. Recommendations for Future Work 
EEG based BCI is often designed for the SCI population to control the external 
environment based on the ERD. The strong and spatially distributed ERD noticed in pain 
group patients in Phase 1 of the study inform that MI based BCI performance may be 
better in PWP compared to PNP. However, similar to the study of Gustin et al. 
87
, two SCI 
patients with pain in Phase 1 of this study reported increased pain when performing MI.  
Neuromodulatory approaches aim to modulate brain activity and typically target sites in 
the motor cortex, indirectly influencing cortical areas involved in the pain matrix 
361
. 
However, the choice of stimulation site and frequency of stimulation is still a matter of 
debate. The frequency-specific dynamic oscillatory signatures of CNP (Chapter 3) can 
assist in designing more effective rTMS, tDCS, and NF treatment interventions for the 
treatment of CNP. We hypothesise that the areas of largest ERD, i.e. most active during 
motor imagery may be the most responsive to neuromodulatory treatments. Due to the 
nature of EEG recording we cannot be certain of the contribution of different cortical areas 
to the recorded ERD. However, theta, alpha and beta ERD showed a distinctive spatial 
distribution which indicates that for different stimulation frequencies of rTMS there may 
be distinctive optimal cortical areas. Finally, our results indicate that in paralyzed patients, 
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location of the most reactive cortical area may not be the same as in the other patient 
groups suffering from CNP due to a posterior shift of strongest ERD. 
The results of the Chapter 4 provide evidences that protocols for NF training for the 
management of pain can be designed. However, controlled and crossover studies with a 
large number of patients should be performed to further confirm the efficacy of NF for 
pain management. In a controlled study, the effect of NF training can be compared with 
other interventions, or patients in that study can be split into different groups receiving 
feedback with different protocols and receiving feedback of other subjects EEG. In a 
crossover study, different NF protocols can be tested on all subjects as performed in Phase 
2 of this study. However, the number of sessions and order for each protocol should be in a 
defined manner. These controlled and crossover studies can also help to better understand 
the placebo effect of NF training on reduction of pain. 
A study by Jensen et al.
29
 reported the effect of a single session of several 
neuromodulation techniques, including hypnosis, meditation, tDCS and NF. They found a 
very moderate effect of NF on reduction of pain and suggested hypnosis as a preferred 
neuromodulation technique for the treatment of CNP. It would be worthwhile to compare 
the influence of NF, tDCS and rTMS to reduce pain in a single study. This would further 
confirm the mechanism of neuromodulation techniques for pain management. For this kind 
of large study, we suggest to have more treatment sessions for the NF group than tDCS and 
rTMS groups. 
Although the effect of different protocols in Chapter 4 (Phase 2) on pain intensity was 
assessed, the results of this chapter demand to test more protocols (section 6.4). We could 
assess the effect of our NF system and protocols on heterogeneous pain population. In the 
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SCI population, it is necessary to test the effect of NF training separately for complete and 
incomplete SCI patients because some patients reported a pleasant warm sensation. A NF 
study on complete patients only would exclude the effect of sensory pathways on this 
sensation. 
All patients in this study were paraplegics with chronic pain; it should be expected that a 
similar effect could be achieved in tetraplegic patients with CNP. All patients in this study 
had CNP for several years. It has been shown that when comparing to acute pain, chronic 
pain produces anatomical structural changes 
86,451
 and involves additional cortical 
structures. Applying NF with patients who experiences this pain for a shorter period of 
time may reveal different EEG responses and may require a smaller number of NF 
sessions. In this study, we provided NF from sensory areas which are involved in the 
processing of both acute and chronic pain, so we believe that similar training sites would 
be effective in patients who experienced pain for a shorter period of time. The only 
limitation to this study would be that it is typically required that patients experience pain 
from 3-6 months before it can be classified as chronic and reliably identified as a CNP.  
Previous studies on chronic pain showed that it influences general concentration. To find 
the effect of NF training on cognitive task, a GO/ NO-GO task, or some other test 
measuring concentration, could be introduced before and after the training 
429
. 
We proposed mechanisms of NF for pain management based on reduction in ERD and 
changes in the relaxed state EEG. Therefore, the evidence for the proposed mechanism can 
be provided by establishing studies aimed to examine changes in the brain activity at sub-
cortical structures such as the thalamus. The assumption that reduced ERD is associated 
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with reduced CSE and increased ICI can be confirmed by designing studies investigating 
these factors using TMS.  
Further studies are needed to assess the effect of NF on spasm, achieved by applying 
some of standard test such as Modified Ashworth scale 
452
 or by measurement of H-reflex 
453
. As we noticed that NF training reduced ERD in pain patients, this suggests that 
designing a protocol in a direction that increased ERD may help to improve MI based BCI 
performance of SCI patients without pain.  
Regarding the data processing of the current data set, it would be worthwhile to define the 
deep cortical structures involved in pain. Furthermore, analysis of coherence among three 
groups (able-bodied, PWP and PNP) could beuseful in creating a NF protocol based on 
strengthening/weakening connections between different areas of the cortex. Also, we try to 
find changes in default mode network connectivity during NF (immediate effect) and 
before the first and after the last day of NF training (long-term). We will also try to find the 
effect of NF training on changes in the flow of information in short- and long- term. We 
also plan to study inter-frequency relation using bicoherence which help to better 
understand changes in activation of inhibitory cortical neurons at different frequencies.    
6.6. Contribution to the Literature 
 Previous studies lack frequency-specific dynamic information of the brain while 
assessing brain activity of patients with CNP. This study overcomes the above 
mentioned drawback in previous research and provides evidence that presence of CNP 
leads to EEG signatures in a relaxed state and during MI (dynamic oscillatory activity). 
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The results of the Phase 1 of this thesis inform why similar effects have been observed 
from rTMS and tDCS while stimulating different cortical areas. It could assist in 
designing more effective protocols for the treatment of pain with rTMS, tDCS, and NF. 
 This is the first study showing the effect of different NF protocols on CNP and 
provides evidence that numbers of training sessions are negatively correlated with 
reduction of pain.  
 This study shows an immediate global effect of NF training on feedback parameter i.e. 
PSD and untrained parameter i.e. coherence. The comparison between monopolar and 
laplacian feedback derivatives provides evidence that global change in EEG activity is 
an effect of NF training. Furthermore, it is shown that patients modulate both local and 
widespread alpha activity.  
 The immediate and short-term effect of NF training on whole EEG PSD spectrum is 
shown for a single representative day. The study also changes in baseline EEG PSD 
over all training days. Also, the effect of training on dominant frequency is shown for a 
single training day and over consecutive training days. 
 The evidence of patients learning ability to modulate the EEG PSD without feedback is 
also shown in this thesis. It is noticed that patients modulate the PSD in the same 
direction as with feedback. 
 Although, there is no separate control group, the study provides overview of testing 
placebo effect in terms of modulation of EEG only and in terms of effect of EEG 
modulation on reduction of pain. 
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 This is the first NF study of pain management showing long-term post training effects 
on task-related and task-unrelated EEG activity at the surface and at deep cortical 
levels. The study also provides evidence of change in ratio of EC and EO activity 
(EC/EO) at the deep cortical level following long-term NF training.   
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 Appendix  
 
 
Figure A.1: Regions of the body perceived as being painful 
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Figure A.2: ERD/ ERS comparison of each two group at Cz site for all three motor 
imagery (MI) tasks. Groups (AB= able-bodied, PNP= patient with no pain, PWP= patient 
with pain), Conditions (RH= right hand, F= foot, LH= left hand). At t=-1 s (dashed line), a 
warning cross was appeared. Participants were asked to start with motor imagery when a 
cue was appeared at t=0s (solid line) and to continue with motor imagination until t=3 s. 
ERD/ERS map shows a time period starting at t=-2 s before the cue and ending at t=2.5 s 
after the cue in a frequency range 3-55 Hz. 
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Figure A.3: ERD/ERS time frequency map at C3 site for all three groups  (AB: able 
bodied, PWP patients with pain, PNP patients with no pain) and for all three motor 
imagery (MI) tasks (RH: right hand MI, F: feet MI, LH: left hand MI. Figures far right 
show areas of statistically significant differences among three MI tasks, while figures at the 
bottom row show areas of statistically significant differences among three groups (p=0.05) 
with FDR correction for multiple comparison. At t=-1 s (dashed line), a warning cross was 
appeared. Participants were asked to start with motor imagery when a cue was appeared at 
t=0s (solid line) and to continue with motor imagination until t=3 s. ERD/ERS map shows 
a time period starting at t=-2 s before the cue and ending at t=2.5 s after the cue in a 
frequency range 3-55 Hz. 
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Figure A.4: ERD/ERS time frequency map at C4 site for all three groups  (AB: able 
bodied, PWP patients with pain, PNP patients with no pain) and for all three motor 
imagery (MI) tasks (RH: right hand MI, F: feet MI, LH: left hand MI. Figures far right 
show areas of statistically significant differences among three MI tasks, while figures at the 
bottom row show areas of statistically significant differences among three groups (p=0.05) 
with FDR correction for multiple comparison. At t=-1 s (dashed line), a warning cross was 
appeared. Participants were asked to start with motor imagery when a cue was appeared at 
t=0s (solid line) and to continue with motor imagination until t=3 s. ERD/ERS map shows 
a time period starting at t=-2 s before the cue and ending at t=2.5 s after the cue in a 
frequency range 3-55 Hz. 
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